US20190254600A1 - Body-worn vital sign monitor - Google Patents
Body-worn vital sign monitor Download PDFInfo
- Publication number
- US20190254600A1 US20190254600A1 US16/404,435 US201916404435A US2019254600A1 US 20190254600 A1 US20190254600 A1 US 20190254600A1 US 201916404435 A US201916404435 A US 201916404435A US 2019254600 A1 US2019254600 A1 US 2019254600A1
- Authority
- US
- United States
- Prior art keywords
- patient
- transceiver
- digital
- worn
- waveforms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 C=CC(C=CC1)=C*1=C Chemical compound C=CC(C=CC1)=C*1=C 0.000 description 1
- FADJUGSUYLCNJQ-UHFFFAOYSA-N CC(CCC1)C1=C Chemical compound CC(CCC1)C1=C FADJUGSUYLCNJQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6824—Arm or wrist
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
- H04W4/02—Services making use of location information
- H04W4/029—Location-based management or tracking services
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7465—Arrangements for interactive communication between patient and care services, e.g. by using a telephone network
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
- H04W4/02—Services making use of location information
Definitions
- the present invention relates to medical devices for monitoring vital signs, e.g., arterial blood pressure.
- ICU intensive care unit
- ED emergency department
- OR operating room
- Patients in these areas are generally sick and require a high degree of medical attention, typically provided by a relatively high ratio of clinicians compared to lower-acuity areas of the hospital.
- clinicians typically measure vital signs such as systolic, diastolic, and mean arterial blood pressures (SYS, DIA, MAP), respiratory rate (RR), oxygen saturation (SpO2), heart rate (HR), and temperature (TEMP) with portable or wall-mounted vital sign monitors.
- SYS systolic
- RR respiratory rate
- SpO2 oxygen saturation
- HR heart rate
- TMP temperature
- Most vital signs monitors feature a user interface that shows numerical values and waveforms associated with the vital signs, alarm parameters, and a ‘service menu’ that can be used to calibrate and maintain the monitor.
- Some monitors have internal wireless cards that communicate with a hospital network, typically using protocols such as 802.11b/g.
- blood pressure can be continuously monitored with an arterial catheter inserted in the patient's radial or femoral artery.
- blood pressure can be measured intermittently with a cuff using oscillometry, or manually by a clinician using auscultation.
- Most vital sign monitors perform both catheter and cuff-based measurements of blood pressure.
- Blood pressure can also be monitored continuously with a technique called pulse transit time (PTT), defined as the transit time for a pressure pulse launched by a heartbeat in a patient's arterial system. PTT has been shown in a number of studies to correlate to SYS, DIA, and MAP.
- PTT pulse transit time
- PTT is typically measured with a conventional vital signs monitor that includes separate modules to determine both an electrocardiogram (ECG) and SpO2.
- ECG electrocardiogram
- SpO2 a time-dependent ECG component characterized by a sharp spike called the ‘QRS complex’.
- the QRS complex indicates an initial depolarization of ventricles within the heart and, informally, marks the beginning of the heartbeat and a pressure pulse that follows.
- SpO2 is typically measured with a bandage or clothespin-shaped sensor that clips to a patient's finger and includes optical systems operating in both the red and infrared spectral regions.
- a photodetector measures radiation emitted from the optical systems that transmits through the patient's finger.
- Other body sites e.g., the ear, forehead, and nose, can also be used in place of the finger.
- a microprocessor analyses both red and infrared radiation detected by the photodetector to determine the patient's blood oxygen saturation level and a time-dependent waveform called a photoplethysmograph (PPG).
- PPG photoplethysmograph
- Typical PTT measurements determine the time separating a maximum point on the QRS complex (indicating the peak of ventricular depolarization) and a foot of the PPG waveform (indicating the beginning the pressure pulse).
- PTT depends primarily on arterial compliance, the propagation distance of the pressure pulse (which is closely approximated by the patient's arm length), and blood pressure.
- PTT-based measurements of blood pressure are typically ‘calibrated’ using a conventional blood pressure cuff and oscillometry.
- the blood pressure cuff is applied to the patient, used to make one or more blood pressure measurements, and then left for future measurements. Going forward, the calibration measurements are used, along with a change in PTT, to measure the patient's continuous blood pressure (cNIBP).
- cNIBP continuous blood pressure
- PTT typically relates inversely to blood pressure, i.e., a decrease in PTT indicates an increase in blood pressure.
- U.S. Pat. Nos. 5,316,008; 5,857,975; 5,865,755; and 5,649,543 each describe an apparatus that includes conventional sensors that measure both ECG and PPG waveforms which are then processed to determine PTT.
- a body-worn monitor that continuously measures all vital signs from a patient, provides tools for effectively monitoring the patient, and wirelessly communicates with a hospital's information technology (IT) network.
- the monitor operates algorithms featuring: 1) a low percentage of false positive alarms/alerts; and 2) a high percentage of true positive alarms/alerts.
- the term ‘alarm/alert’, as used herein, refers to an audio and/or visual alarm generated directly by a monitor worn on the patient's body, or alternatively a remote monitor (e.g., a central nursing station).
- the invention provides a body-worn monitor that measures a patient's vital signs (e.g. cNIBP, SpO2, HR, RR, and TEMP) while simultaneously characterizing their activity state (e.g. resting, walking, convulsing, falling) and posture (upright, supine).
- a patient's vital signs e.g. cNIBP, SpO2, HR, RR, and TEMP
- activity state e.g. resting, walking, convulsing, falling
- posture upright, supine
- the body-worn monitor features a graphical user interface (GUI) rendered on a touchpanel display that facilitates a number of features to simplify and improve patient monitoring and safety in both the hospital and home.
- GUI graphical user interface
- the monitor features a battery-powered, wrist-worn transceiver that processes motion-related signals generated with an internal motion sensor (e.g. an accelerometer).
- an internal motion sensor e.g. an accelerometer
- the entire unit can be swapped out by simply ‘bumping’ the original transceiver with a new one having a fully charged battery.
- Accelerometers within the transceivers detect the ‘bump’, digitize the corresponding signals, and wirelessly transmit them to a patient data server (PDS) within the hospital's network.
- PDS patient data server
- the signals are analyzed and patient information (e.g. demographic and vital sign data) formerly associated with the original transceiver is re-associated with the new transceiver.
- a clinician can view the data using a computer functioning as
- the body-worn monitor additionally includes a speaker, microphone, and software that collectively facilitate voice over IP (VOIP) communication.
- VOIP voice over IP
- the wrist-worn transceiver can be used as a two-way communicator allowing, e.g., the patient to alert a clinician during a time of need. Additionally, during medical procedures or diagnoses, the clinician can enunciate annotations directly into the transceiver. These annotations along with vital sign information are wirelessly transmitted to the PDS and ultimately a hospital's electronic medical records (EMR) system, where they are stored and used for post-hoc analysis of the patient.
- EMR electronic medical records
- the transceiver includes a barcode scanner that, prior to administering medications, scans barcodes associated with the patient, clinician, and medications.
- the transceiver sends the decoded barcode information back to the PDS, where a software program analyzes it to determine that there are no errors in the medication or the rate at which it is delivered. A signal is then sent from the PDS to the GUI, clearing the clinician to administer the medications.
- the body-worn monitor can determine a patient's location in addition to their vital signs and motion-related properties.
- the location-determining sensor and the wireless transceiver operate on a common wireless system, e.g. a wireless system based on 802.11a/b/g/n, 802.15.4, or cellular protocols.
- a location is determined by processing the wireless signal with one or more algorithms known in the art. These include, for example, triangulating signals received from at least three different wireless base stations, or simply estimating a location based on signal strength and proximity to a particular base station.
- the location sensor includes a conventional global positioning system (GPS).
- VOIP-based communications typically take place between the body-worn monitor and a remote computer or telephone interfaced to the PDS.
- the location sensor, wireless transceiver, and first and second voice interfaces can all operate on a common wireless system, such as one of the above-described systems based on 802.11 or cellular protocols.
- the remote computer for example, can be a monitor that is essentially identical to the transceiver worn by the patient, and can be carried or worn by a clinician.
- the monitor associated with the clinician features a display wherein the user can select to display information (e.g. vital signs, location, and alarms) corresponding to a particular patient.
- This monitor can also include a voice interface so the clinician can communicate with the patient.
- the wrist-worn transceiver's touchpanel display can render a variety of different GUIs that query the patient for their pain level, test their degree of ‘mentation’, i.e. mental activity, and perform other functions to assist and improve diagnosis. Additionally, the transceiver supports other GUIs that allow the patient to order food within the hospital, change the channel on their television, select entertainment content, play games, etc. To help promote safety in the hospital, the GUI can also render a photograph or video of the patient or, in the case of neo-natal patients, their family members.
- the body-worn monitor can include a software framework that generates alarms/alerts based on threshold values that are either preset or determined in real time.
- the framework additionally includes a series of ‘heuristic’ rules that take the patient's activity state and motion into account, and process the vital signs accordingly. These rules, for example, indicate that a walking patient is likely breathing and has a regular heart rate, even if their motion-corrupted vital signs suggest otherwise.
- the body-worn monitor features a series of sensors that attach to the patient to measure time-dependent PPG, ECG, ACC, oscillometric (OSC), and impedance pneumography (IP) waveforms.
- a microprocessor (CPU) within the monitor continuously processes these waveforms to determine the patient's vital signs, degree of motion, posture and activity level.
- Sensors that measure these signals typically send digitized information to the wrist-worn transceiver through a serial interface, or bus, operating on a controlled area network (CAN) protocol.
- CAN controlled area network
- the CAN bus is typically used in the automotive industry, and allows different electronic systems to effectively and robustly communicate with each other with a small number of dropped packets, even in the presence of electrically noisy environments. This is particularly advantageous for ambulatory patients that may generate signals with large amounts of motion-induced noise.
- Blood pressure is determined continuously and non-invasively using a technique, based on PTT, which does not require any source for external calibration.
- This technique referred to herein as the ‘Composite Technique’, determines blood pressure using PPG, ECG, and OSC waveforms.
- the Composite Technique is described in detail in the co-pending patent application, the contents of which are fully incorporated herein by reference: BODY-WORN SYSTEM FOR MEASURING CONTINUOUS NON-INVASIVE BLOOD PRESSURE (CNIBP) (U.S. Ser. No. 12/650,354; filed Nov. 15, 2009).
- CNIBP BODY-WORN SYSTEM FOR MEASURING CONTINUOUS NON-INVASIVE BLOOD PRESSURE
- PTT can be calculated from time-dependent waveforms other than the ECG and PPG, and then processed to determine blood pressure.
- PTT can be calculated by measuring a temporal separation between features in two or more time-dependent waveforms measured from the human body.
- PTT can be calculated from two separate PPGs measured by different optical sensors disposed on the patient's fingers, wrist, arm, chest, ear, or virtually any other location where an optical signal can be measured using a transmission or reflection-mode optical configuration.
- PTT can be calculated using at least one time-dependent waveform measured with an acoustic sensor, typically disposed on the patient's chest.
- a pressure sensor typically disposed on the patient's bicep, wrist, or finger.
- the pressure sensor can include, for example, a pressure transducer, piezoelectric sensor, actuator, polymer material, or inflatable cuff.
- the invention provides a method for monitoring a patient featuring the following steps: (a) associating a first set of vital sign information measured from the patient with a first transceiver that includes a first motion sensor; (b) storing the first set of vital sign information in a computer memory; (c) contacting the first transceiver with a second transceiver that includes a second motion sensor, the contacting causing the first motion sensor to generate a first motion signal and the second motion sensor to generate a second motion signal; (d) processing the first and second motion signals to determine that the first transceiver is to be replaced by the second transceiver; and (e) associating a second set of vital sign information with the patient, the second set of vital sign information measured with the second transceiver.
- both the first and second motion sensors are accelerometers that generate time-dependent waveforms (e.g. ACC waveforms).
- Contacting the two transceivers typically generates waveforms that include individual ‘pulses’ (e.g. a sharp spike) caused by rapid acceleration and deceleration detected by the respective accelerometers.
- the pulses are within waveforms generated along the same axes in both transceivers.
- the pulses can be collectively processed (using, e.g., an autocorrelation algorithm) to determine that they are generated during a common period of time.
- amplitudes of the first and second pulses are required to exceed a pre-determined threshold value in order for the second transceiver to replace the first transceiver.
- Pulses that meet this criterion are wirelessly transmitted to a remote server, where they are processed as described above. If the server determines that the second transceiver is ready to replace the first transceiver, it transmits instruction information to the transceivers to guide the replacement process. This instruction information, for example, is displayed by the GUIs of both transceivers.
- vital sign information measured by the second transceiver is stored along with that measured by the first transceiver in a computer memory (e.g. a database) on the remote computer.
- the vital sign information can include conventional vital signs (e.g. HR, SYS, DIA, RR, and TEMP), along with the time-dependent waveforms used to calculate the vital signs (e.g. PPG, ECG, OSC, IP) and motion-related properties (ACC).
- Patient demographic information e.g. name, gender, weight, height, date of birth
- the invention provides a method for pairing a patient monitor with a remote display device (e.g. an RVD) using a methodology similar to that described above.
- the display device is typically a portable display device (e.g. a personal digital assistant, or PDA), or a remote computer, such as a COW or central nursing station.
- PDA personal digital assistant
- COW central nursing station
- the method includes the following steps: (a) contacting either a display device or an area proximal to the display device with the transceiver to generate a motion signal with its internal accelerometer; (b) transmitting the motion signal to a computer; (c) processing the motion signal with the computer to associate the transceiver with the display device; (d) measuring a set of vital sign information from the patient with the transceiver; and (e) displaying the set of vital sign information on the display device.
- the act of contacting the display device with the transceiver generates a pulse in the ACC waveform, as described above. Processing done by the computer analyzes both the pulse and a location of the display device to associate it with the transceiver.
- the wireless transmitter within the transceiver is configured to operate on a wireless network, and algorithms operating on the remote computer and can analyze signals between the transceiver and wireless access points within the network (e.g. RSSI signals indicating signal strength) to determine an approximate location of the transceiver and thus the display device which it contacts.
- the algorithms can involve, e.g., triangulating at least three RSSI values, or simply estimating location by determining the nearest access point from a single RSSI value. Triangulation typically involves using a map grid that includes known locations of multiple wireless access points and display devices within a region of the hospital; the map grid is determined beforehand and typically stored, e.g., in a database.
- the approximate location of the transceiver can be determined using triangulation. Then the nearest display device, lying with a known location within a pre-determined radius, is paired with the transceiver. Typically the pre-determined radius is between 1 - 5 m.
- the invention provides a body-worn monitor including first and second sensors attached to the patient, and a processing component that interfaces to both sensors and processes signals from them to calculate at least one vital sign value.
- a wireless transmitter receives the vital sign value and transmits it over a wireless interface, and additionally provides a two-way communications system configured to transmit and receive audio signals over the same wireless interface.
- the two-way communications system includes a speaker and a microphone, both of which are integrated into the transceiver.
- the wireless interface is a hospital-based wireless network using an 802.11protocol (e.g. 802.11a/b/g/n).
- a VOIP system typically runs on the wireless network to supply two-way voice communications.
- the wireless network is based on a cellular protocol, such as a GSM or CDMA protocol.
- the body-worn monitor features a wrist-worn transceiver that functions as a processing component, and includes a touchpanel display configured to render both patient and clinician interfaces.
- the touchpanel display is typically a liquid crystal display (LCD) or organic light-emitting diode display (OLED) display with a clear touchpanel utilizing established resistive or capacitive technologies adhered to its front surface.
- the patient interface is typically rendered by default, and includes a graphical icon that, when initiated, activates the two-way communications system.
- the clinician interface typically requires a security code (entered using either a ‘soft’ numerical keypad or through a barcode scanner) to be activated.
- the transceiver typically includes a strap configured to wrap around the patient's arm, and most typically the wrist; this allows it to be worn like a conventional wristwatch, which is ideal for two-way communications between the patient and a clinician.
- the invention provides a wrist-worn transceiver wherein the two-way communications system described above, or a version thereof, is used as a voice annotation system.
- a voice annotation system receives audio signals (typically from a clinician), digitizes them, and transmits the resulting digital audio signals, or a set of parameters determined from these signals, over the wireless interface to a computer memory.
- the audio signals are typically used to annotate vital sign information. They can be used, for example, to indicate when a pharmaceutical compound is administered to the patient, or when the patient undergoes a specific therapy.
- the voice annotation uses the same speaker used for the two-way communication system.
- a speech-to-text converter that converts audio annotations from the clinician into text fields that can be easily stored alongside the vital sign information.
- both a text field and the original audio annotation are stored in a computer memory (e.g. database), and can be edited once stored.
- a pre-determined text field (indicating, e.g., that a specific medication is delivered at a time/date automatically determined by the transceiver) is used to annotate the vital sign information.
- a set of parameters determined from the digital audio signals can include an icon or a numerical value.
- Annotations in the database can be viewed afterwards using a GUI that renders both the vital sign information (shown, e.g., in a graphical form) and one or more of the annotations (e.g. icon, text field, numerical value, or voice annotation).
- the vital sign information shown, e.g., in a graphical form
- the annotations e.g. icon, text field, numerical value, or voice annotation
- the invention provides a wrist-worn transceiver featuring a GUI that the patient can use to indicate their level of pain.
- the GUI typically includes a touchpanel display configured to render a set of input fields, with each input field in the set indicating a different level of pain. Once contacted, the input fields generate a signal that is processed to determine the patient's level of pain. This signal can be further processed and then wirelessly transmitted to a remote computer for follow-on analysis.
- the touchpanel display features a touch-sensitive area associated with each input field that generates a digital signal (e.g. a number) after being contacted.
- Each input field is typically a unique graphical icon such as a cartoon or numerical value indicating an escalating level of pain.
- the transceiver can also include a voice annotation system similar to that described above so the patient can specifically describe their pain (e.g. its location) using their own voice.
- This information can be wirelessly transmitted to a remote computer (e.g. a PDS) featuring a display device (e.g. an RVD).
- This system can render both vital sign information and a parameter determined from the pain signal, and can additionally include an alarming system that activates an alarm if the pain signal or a parameter calculated therefrom exceeds a pre-determined threshold.
- the invention provides a wrist-worn transceiver that includes a mentation sensor configured to collect data input characterizing the patient's level of mentation (e.g. mental acuity). This information, along with traditional vital signs and the waveforms they are calculated from, is wirelessly transmitted to a remote computer for analysis.
- the mentation sensor is a touchpanel display that renders a GUI to collect information characterizing the patient's level of mentation.
- the GUI can render a series of icons, a game, test, or any other graphical or numerical construct that can be used to evaluate mentation.
- the GUI includes a set of input fields associated with a numerical value.
- the mentation ‘test’ features an algorithm to determine if the input fields are contacted by the patient in a pre-determined numerical order. Upon completion, the test results can be evaluated to generate a mentation ‘score’.
- the wrist-worn transceiver also includes a two-way communication system that receives audio information from the patient. This audio information can be used for conventional communication purposes, and can additionally be analyzed to further gauge mentation.
- the mentation score can be sent with vital sign information to a PDS/RVD for follow-on analysis.
- These systems may include an alarming system that generates an alarm if the mentation parameter or a parameter calculated therefrom exceeds a pre-determined threshold.
- the invention provides a wrist-worn transceiver featuring a motion sensor (e.g. an accelerometer, mercury switch, or tilt switch) that generates a motion signal indicating the transceiver's orientation.
- a motion sensor e.g. an accelerometer, mercury switch, or tilt switch
- the processing component within the transceiver processes the motion signal and, in response, orients the GUI so that it can be easily viewed in ‘rightside up’ configuration, i.e. with text rendered in a conventional manner from left to right. If the transceiver is moved (e.g., so that it is viewed by a clinician instead of a patient), the accelerometers generate new motion signals, and the GUI is ‘flipped’ accordingly.
- the GUI is rendered in either a first orientation or a second orientation, with the two orientations separated by 180 degs., and in some cases by 90 degs.
- the first orientation corresponds to a ‘patient GUI’
- the second orientation corresponds to a ‘clinician GUI’.
- the clinician GUI typically includes medical parameters, such as vital signs and waveforms
- the patient GUI typically includes non-medical features, such as a ‘nurse call button’, time/date, and other components described in more detail below.
- the motion sensor is a 3-axis accelerometer configured to generate a time-domain ACC waveform.
- the processing component additionally analyzes the waveform to determine parameters such as the patient's motion, posture, arm height, and degree of motion.
- the wrist-worn transceiver features a display device configured to render at least two GUIs, with the first GUI featuring medical content, and the second GUI featuring non-medical content relating to entertainment, food service, games, and photographs.
- the photograph can include an image of the patient or a relative of the patient; this latter case may be particularly useful in neo-natal hospital wards.
- the body-worn monitor may include a digital camera, or a wireless interface to a remote digital camera, such as that included in a portable computer or cellular telephone.
- the second GUI is configured to render menus describing entertainment content, such as television (e.g. different channels or pre-recorded content), movies, music, books, and video games.
- entertainment content such as television (e.g. different channels or pre-recorded content), movies, music, books, and video games.
- the touchpanel display can be used to select the content or, in embodiments, play a specific game.
- the wireless transmitter within the transceiver is further configured to transmit and receive information from a remote server configured to store digital representations of these media sources.
- the second GUI is configured to display content relating to a food-service menu.
- the wireless transmitter is further configured to transmit and receive information from a remote server configured to interface with a food-service system.
- the invention provides a system for monitoring a patient that includes a vital sign monitor configured to be worn on the patient's body, and a remote computer.
- the vital sign monitor features connection means (e.g. a flexible strap or belt) configured to attach a transceiver to the patient's body, and sensor with a sensing portion (e.g. electrodes and an optical sensor) that attaches to the patient to measure vital sign information.
- a mechanical housing included in the transceiver covers a wireless decoder, processing component, and wireless transmitter, and supports a display component.
- the wireless decoder e.g. a barcode scanner or radio frequency identification (RFID) sensor
- RFID radio frequency identification
- this information may be encoded in a barcode or RFID tag located on the patient, clinician, medication, or associated with an infusion pump.
- the processing component is configured to process: 1) the vital sign information to generate a vital sign and a time-dependent waveform; and 2) information received by the wireless decoder to generate decoded information.
- the wireless transmitter within the mechanical housing receives information from the processing component, and transmits it to a remote computer. In response the remote computer processes the information and transmits an information-containing packet back to the vital sign monitor.
- the remote computer performs an analyzing step that compares information describing both the medication and the patient to database information within a database.
- the database may include, for example, a list of acceptable medications and acceptable medication-delivery rates corresponding to the patient.
- both the vital sign information and the decoded information are collectively analyzed and compared to values in the database to affect treatment of the patient. For example, this analysis may determine that a patient with a low blood pressure should not receive medications that further lower their blood pressure. Or it may suggest changing a dosage level of the medication in order to compensate for a high heart rate value.
- the remote computer can analyze one or more vital sign values corresponding to a patient, along with the patient's demographic information, medical history, and medications, and determine acceptable medications and medication-delivery rates based on this analysis.
- the computer can transmit a packet back to the vital sign monitor, which renders its contents on the display.
- the packet can include a message confirming that a particular medication and medication-delivery rate are acceptable for the patient, and may also include a set of instructions for delivering the medication and performing other therapies.
- FIG. 1 is a schematic drawing showing the wrist-worn transceiver of the invention attached to a patient's wrist;
- FIG. 2A shows schematic drawings of the wrist-worn transceiver of FIG. 1 oriented ‘rightside up’ so that a patient can view the GUI;
- FIG. 2B shows shows schematic drawings of the wrist-worn transceiver of FIG. 1 oriented ‘upside down’ so that a clinician can view the GUI;
- FIG. 3 shows a schematic drawing of the wrist-worn transceiver of FIG. 1 and a list of features available in both a patient GUI and a clinician GUI;
- FIG. 4 shows a schematic drawing of the body-worn monitor featuring sensors for measuring ECG, PPG, ACC, OSC, and IP waveforms, and systems for processing these to determine a patient's vital signs;
- FIG. 5 shows a schematic drawing of an IT configuration of the invention where the body-worn monitor of FIG. 4 is connected through a wireless network to a PDS and hospital EMR;
- FIG. 6A shows schematic drawings of a new transceiver having a fully charged battery being swapped with an original transceiver having a depleted battery before deploying the ‘bump’ methodology
- FIG. 6B shows schematic drawings of a new transceiver having a fully charged battery being swapped with an original transceiver having a depleted battery after deploying the ‘bump’ methodology
- FIG. 7 shows a schematic drawing of transceivers undergoing the ‘bump’ methodology of FIGS. 6A and 6B and wirelessly transmitting their ACC waveforms to the PDS for analysis;
- FIG. 8 shows screen captures from a GUI used to guide a clinician through the ‘bump’ methodology of FIGS. 6A, 6B, and 7 ;
- FIG. 9 shows a schematic drawing of a transceiver being ‘bumped’ against a RVD in order to pair the two devices
- FIG. 10 shows a map indicating how the transceiver and RVD of FIG. 9 are paired to each other;
- FIG. 11 shows a schematic drawing of the wrist-worn transceiver of FIG. 1 being used for voice annotation of a patient's vital sign data
- FIG. 12 shows a schematic drawing of the wrist-worn transceiver of FIG. 11 wirelessly transmitting voice annotations to the PDS for analysis;
- FIG. 13 shows screen captures from a GUI used to guide a clinician through the voice annotation methodology of FIGS. 11 and 12 ;
- FIG. 14 shows screen captures from a GUI used when the wrist-worn transceiver functions as a two-way communicator between the patient and a clinician;
- FIG. 15 shows a screen capture from a GUI used to render a ‘pain index’ on the wrist-worn transceiver
- FIG. 16 shows a screen capture from a GUI used to render a mentation test on the wrist-worn transceiver
- FIG. 17 shows a screen capture from a GUI used to render a photograph of the patient on the wrist-worn transceiver
- FIG. 18 shows a screen capture from a GUI used to render a food menu on the wrist-worn transceiver
- FIG. 19 shows a screen capture from a GUI used to render a menu of television channels on the wrist-worn transceiver
- FIG. 20 shows a schematic drawing of the barcode scanner in the wrist-worn transceiver scanning barcodes associated with a patient, clinician, and medication, and sending the decoded barcode information to the PDS;
- FIG. 21A shows three-dimensional images of the body-worn monitor of FIG. 4 attached to a patient with a cuff-based pneumatic system used for a calibrating indexing measurement;
- FIG. 21B shows three-dimensional images of the body-worn monitor of FIG. 4 attached to a patient without a cuff-based pneumatic system used for a calibrating indexing measurement
- FIG. 22A shows three-dimensional images of the wrist-worn transceiver before receiving cables from other sensors within the body-worn monitor
- FIG. 22B shows three-dimensional images of the wrist-worn transceiver after receiving cables from other sensors within the body-worn monitor
- FIG. 23A shows a schematic drawing of a patient wearing the body-worn monitor of FIG. 21B and its associated sensors
- FIG. 23B shows graphs of time-dependent ECG, PPG, OSC, ACC, and IP waveforms generated with the body-worn monitor and sensors of FIG. 23A ;
- FIG. 24 shows screen captures from a GUI used to render vital signs and ECG, PPG, and IP waveforms on the wrist-worn transceiver;
- FIG. 25 shows a schematic drawing of the ACC, ECG, pneumatic, and auxiliary systems of the body-worn monitor communicating over the CAN protocol with the wrist-worn transceiver;
- FIG. 26 shows an alternate IT configuration of the invention where the wrist-worn transceiver of FIG. 1 communicates with the PDS through a wireless access point connected to the Internet;
- FIG. 27 shows an alternate IT configuration of the invention where the wrist-worn transceiver of FIG. 1 communicates with the PDS through a wireless device connected to the Internet;
- FIG. 28 shows an alternate IT configuration of the invention where the wrist-worn transceiver of FIG. 1 communicates with the PDS through an internal cellular modem connected to the Internet.
- FIG. 1 shows a transceiver 72 according to the invention that attaches to a patient's wrist 66 using a flexible strap 90 .
- the transceiver 72 connects through a first flexible cable 92 to a thumb-worn optical sensor 94 , and through a second flexible cable 82 to an ECG circuit and a series of chest-worn electrodes (not shown in the figure).
- the optical sensor 94 and chest-worn electrodes measure, respectively, time-dependent optical waveforms (e.g. PPG) and electrical waveforms (e.g. ECG and IP), which are processed as described below to determine vital signs and other physiological parameters such as cNIBP, SpO2, HR, RR, TEMP, pulse rate (PR), and cardiac output (CO).
- PPG time-dependent optical waveforms
- ECG and IP electrical waveforms
- the transceiver 72 wirelessly transmits these and other information to a remote PDS and RVD.
- the transceiver 72 includes a touchpanel display that renders a GUI 50 which, in turn, displays the vital signs, physiological parameters, and a variety of other features described in detail below.
- GUI 50 displays the vital signs, physiological parameters, and a variety of other features described in detail below.
- the transceiver 72 includes an embedded accelerometer that senses its motion and position, and in response can affect properties of the GUI.
- time-resolved ACC waveforms from the accelerometer can be processed with a microprocessor within the transceiver to detect orientation of the touchpanel display. This information can then be analyzed to determine if it is the clinician or patient who is viewing the display. In response, the GUI can ‘flip’ so that it is properly oriented (i.e. ‘rightside up’, as opposed to being upside down) for the viewer. For example, as shown in FIG.
- the internal accelerometer when the transceiver 72 is worn on the patient's right wrist 66 the internal accelerometer generates ACC waveforms that are processed by the microprocessor to determine this orientation.
- the GUI 50 A is adjusted according so that it is always oriented with numbers and text arranged rightside up and read from left to right.
- the ACC waveforms change accordingly because the accelerometer's axes are swapped with respect to gravity. Such a situation would occur, for example, if a clinician were to orient the patient's arm in order read the transceiver's display.
- the ACC waveforms are processed to determine the new orientation, and the GUI 50 B is flipped so it is again rightside up, and can be easily read by the clinician.
- the internal accelerometer can also detect if the transceiver is ‘bumped’ by an external object.
- the ACC waveform will feature a sharp ‘spike’ generated by rapid acceleration and deceleration caused by the bumping process.
- a bumping process can serve as a fiducial marker that initiates a specific event related to the transceiver, such as a battery swap or process that involves pairing the transceiver to an external wireless system or display.
- the accelerometer within the transceiver when combined with other accelerometers within the body-worn monitor, can also be used to determine the patient's posture, activity level, arm height and degree of motion, as described in detail below.
- Use of one or more accelerometers to detect such motion-related activities is described, for example, in the following patent applications, the contents of which are incorporated herein by reference: BODY-WORN MONITOR FEATURING ALARM SYSTEM THAT PROCESSES A PATIENT'S MOTION AND VITAL SIGNS (U.S. Ser. No. 12/469,182; filed May 20, 2009) and BODY-WORN VITAL SIGN MONITOR WITH SYSTEM FOR DETECTING AND ANALYZING MOTION (U.S. Ser. No. 12/469,094; filed May 20, 2009).
- the transceiver 72 includes a high-fidelity speaker 120 , a microphone 101 , and a barcode scanner 102 which, respectively, enunciates audible information, measures voice signals from both the patient and a clinician, and scans graphical barcodes to decode numerical information describing the patient and their medication. Signals from these and other components are processed to supply information to either a ‘patient GUI’ 52 or a ‘clinician GUI’ 54 .
- the patient GUI 52 typically includes features that are decoupled from a standard clinical diagnosis; these include a nurse call button, voice communications, a ‘pain’ index, a mentation test to estimate the patient's cognitive abilities, meal ordering within the hospital, games, and a controller for entertainment content, e.g. to adjust parameters (e.g. channels, volume) for a standard television set.
- the clinical GUI 54 in comparison, includes features that are used for clinical diagnoses and for operating the transceiver in a hospital environment. The primary features of this GUI 54 include displaying vital signs (e.g. cNIBP, SpO2, HR, RR, TEMP), other medical parameters (e.g. PR, CO), and waveforms (PPG, ECG, IP).
- vital signs e.g. cNIBP, SpO2, HR, RR, TEMP
- other medical parameters e.g. PR, CO
- waveforms PPG, ECG, IP
- Secondary features of the clinical GUI include voice communications, battery-change and pairing operations using the above-described ‘bump’ methodology, voice annotation of medical records and diagnoses, a method for checking medications using the barcode scanner 102 , and display of a photograph or video describing the patient.
- the GUI renders 50 simple icons indicating that the transceiver is powered on and operational (e.g., a ‘beating heart’), the strength of the wireless signal (e.g. a series of bars with escalating height), and the battery level (e.g. a cartoon of a battery with a charge-dependent gauge).
- the transceiver 72 displays these icons until the touchpanel display is contacted by either the patient or a clinician. This process yields the patient GUI 52 , which features a large icon 57 showing a telephone (which is used for nurse call applications, as described below), and a smaller icon 53 showing a lock which, when tapped, enables the clinician to ‘unlock’ the transceiver and utilize the clinician interface 54 .
- the transceiver 72 immediately renders a GUI that shows vital signs and waveform information if the patient's physiological condition requires immediate medical attention, e.g. in the case of cardiac arrest.
- the clinician interface 54 is password-protected to prevent the patient or any other non-clinician from viewing important and potentially confusing medical information.
- a password can either be entered as a standard personal identification number (PIN) by tapping keys on a numerical keypad (as shown in FIG. 3 ), or by simply swiping a barcode printed on the clinician's hospital badge across the barcode scanner 102 .
- PIN personal identification number
- the microprocessor within the transceiver unlocks the clinician interface following either of these events, and enables all the features associated with the interface, which are described in detail below. For example, with this interface the clinician can view vital signs and waveforms to make a medical diagnosis, as described with reference to FIG. 24 .
- the clinician can swap in a new transceiver and transfer data from the original transceiver simply by ‘bumping’ the two transceivers together, as described with reference to FIGS. 6-8 .
- Medical records can be voice-annotated and stored on the PDS or a hospital's EMR using the process shown in FIGS. 11-13 .
- the patient's medication can be checked by scanning and processing information encoded in barcodes associated with the patient, clinician, and medication, as shown in FIG. 20 . All of this functionality is programmed within the transceiver and the body-worn monitor, and can be accomplished without tethering the patient to a conventional vital sign monitor typically mounted on a wall in the hospital or a rolling stand. Ultimately this allows the patient to wear a single body-worn monitor as they transition throughout the various facilities within the hospital, e.g. the ED, ICU, x-ray facility, and operating room.
- FIGS. 4 and 5 show schematic drawings of a body-worn monitor 100 used to measure vital signs from a patient and render the different GUIs described above ( FIG. 4 ), along with a wireless system over which the transceiver 72 sends information through a hospital network 60 to either a remote RVD, e.g. a computer 62 or hand-held device 64 ( FIG. 5 ).
- the body-worn monitor 100 features a wrist-worn transceiver 72 that continuously determines vital signs and motion-related properties from an ambulatory patient in a hospital.
- the monitor 100 is small, lightweight, and comfortably worn on the patient's body during their stay in the hospital; its specific form factor is described in detail below with reference to FIGS. 21 and 22 .
- the transceiver 72 features a wireless transmitter 224 that communicates through a collection of wireless access points 56 (e.g. routers based on 802 . 11 protocols) within a hospital network 60 , which includes a PDS.
- a collection of wireless access points 56 e.g. routers based on 802 . 11 protocols
- a hospital network 60 which includes a PDS.
- From the PDS 60 data are sent to an RVD (e.g. a portable tablet computer 62 ) located at a central nursing station, or to a local computer (e.g. a hand-held PDA 64 ) carried by the clinician.
- data can be sent to the PDA 64 through a peer-to-peer wireless connection.
- the specific mode of communication can be determined automatically (using, e.g., a signal strength associated with the wireless connection), or manually through an icon on the GUI.
- the transceiver 72 features a CPU 222 that communicates through a digital CAN interface, or bus, to external systems featuring ECG 216 , external accelerometers 215 b - c, pneumatic 220 , and auxiliary 245 sensors.
- ECG 216 external accelerometers 215 b - c
- pneumatic 220 pneumatic 220
- auxiliary 245 sensors Each sensor 215 b - c, 216 , 220 , 245 is ‘distributed’ on the patient to minimize the bulk and weight normally associated with conventional vital sign monitors, which typically incorporate all electronics associated with measuring vital signs in a single plastic box.
- each of these sensors 215 b - c, 216 , 220 , 245 generate digital signals close to where they actually attach to the patient, as opposed to generating an analog signal and sending it through a relatively long cable to a central unit for processing.
- Cables 240 , 238 , 246 used in the body-worn monitor 210 to transmit packets over the CAN bus typically include five separate wires bundled together with a single protective cladding: the wires supply power and ground to the remote ECG system 216 , accelerometers 215 b - c, pneumatic 220 , and auxiliary systems 245 ; provide high/low signal transmission lines for data transmitted over the CAN protocol; and provide a grounded electrical shield for each of these four wires.
- a single pair of transmission lines in the cable i.e. the high/low signal transmission lines
- the same two wires can transmit up to twelve ECG waveforms (measured by a twelve-lead ECG system), and six ACC waveforms (measured by the accelerometers 215 b - c ). Limiting the transmission line to a pair of conductors reduces the number of wires attached to the patient, thereby decreasing the weight and any cable-related clutter.
- cable motion induced by an ambulatory patient can change the electrical properties (e.g. electrical impendence) of its internal wires. This, in turn, can add noise to an analog signal and ultimately the vital sign calculated from it.
- a digital signal in contrast, is relatively immune to such motion-induced artifacts.
- the ECG 216 , pneumatic 220 , and auxiliary 245 systems are stand-alone systems that each includes a separate CPU, analog-to-digital converter, and CAN transceiver. During a measurement, they connect to the transceiver 72 through cables 240 , 238 , 246 and connectors 230 , 228 , 232 to supply digital inputs over the CAN bus.
- the ECG system 216 for example, is completely embedded in a terminal portion of its associated cable.
- the transceiver 72 renders separate GUIs that can be selected for either the patient or a clinician. To do this, it includes a barcode scanner 242 that can scan a barcode printed, e.g., on the clinician's badge. In response it renders a GUI featuring information (e.g. vital signs, waveforms) tailored for a clinician that may not be suitable to the patient. So that the patient can communicate with the clinician, the transceiver 72 includes a speaker 241 and microphone 237 interfaced to the CPU 222 and wireless system 224 . These components allow the patient to communicate with a remote clinician using a standard VOIP protocol. A rechargeable Li:ion battery 239 powers the transceiver 72 for about four days on a single charge. When the battery charge runs low, the entire transceiver 72 is replaced using the ‘bump’ technique described in detail below.
- Three separate digital accelerometers 215 a - c are non-obtrusively integrated into the monitor's form factor; two of them 215 b - c are located on the patient's body, separate from the wrist-worn transceiver 72 , and send digitized, motion-related information through the CAN bus to the CPU 222 .
- the first accelerometer 215 a is mounted on a circuit board within the transceiver 72 , and monitors motion of the patient's wrist.
- the second accelerometer 215 b is incorporated directly into the cable 240 connecting the ECG system 216 to the transceiver 72 so that it can easily attach to the patient's bicep and measure motion and position of the patient's upper arm.
- signals from the accelerometers can be processed to compensate for hydrostatic forces associated with changes in the patient's arm height that affect the monitor's cNIBP measurement, and can be additionally used to calibrate the monitor's blood pressure measurement through the patient's ‘natural’ motion.
- the third accelerometer 215 c is typically mounted to a circuit board that supports the ECG system 216 on the terminal end of the cable, and typically attaches to the patient's chest. Motion and position of the patient's chest can be used to determine their posture and activity states, which as described below can be used with vital signs for generating alarm/alerts.
- Each accelerometer 215 a - c measures three unique ACC waveforms, each corresponding to a separate axis (x, y, or z) representing a different component of the patient's motion.
- the transceiver's CPU 222 processes signals from each accelerometer 215 a - c with a series of algorithms, described in the following pending patent applications, the contents of which have been previously incorporated herein by reference: BODY-WORN MONITOR FEATURING ALARM SYSTEM THAT PROCESSES A PATIENT'S MOTION AND VITAL SIGNS (U.S. Ser. No.
- the CPU 222 can process nine unique, time-dependent signals corresponding to the three axes measured by the three separate accelerometers.
- Algorithms determine parameters such as the patient's posture (e.g., sitting, standing, walking, resting, convulsing, falling), the degree of motion, the specific orientation of the patient's arm and how this affects vital signs (particularly cNIBP), and whether or not time-dependent signals measured by the ECG 216 , optical 218 , or pneumatic 220 systems are corrupted by motion.
- posture e.g., sitting, standing, walking, resting, convulsing, falling
- the degree of motion e.g., the degree of motion
- the specific orientation of the patient's arm e.g., how this affects vital signs (particularly cNIBP)
- vital signs particularly cNIBP
- the transceiver 72 processes ECG and PPG waveforms using a measurement called with Composite Technique, which is described in the following patent application, the contents of which have been previously incorporated herein by reference: BODY-WORN SYSTEM FOR MEASURING CONTINUOUS NON-INVASIVE BLOOD PRESSURE (cNIBP) (U.S. Ser. No. 12/650,354; filed Nov. 15, 2009).
- the Composite Technique measures ECG and PPG waveforms with, respectively, the ECG 216 and optical 218 systems.
- the optical system 218 features a thumb-worn sensor that includes LEDs operating in the red ( ⁇ ⁇ 660 nm) and infrared ( ⁇ ⁇ 900 nm) spectral regions, and a photodetector that detects their radiation after it passes through arteries within the patient's thumb.
- the ECG waveform as described above, is digitized and sent over the CAN interface to the wrist-worn transceiver 72 , while the PPG waveform is transmitted in an analog form and digitized by an analog-to-digital converter within the transceiver's circuit board.
- the pneumatic system 220 provides a digitized pressure waveform and oscillometric blood pressure measurements through the CAN interface; these are processed by the CPU 222 to make cuff-based ‘indexing’ blood pressure measurements according to the Composite Technique.
- the indexing measurement typically only takes about 40-60 seconds, after which the pneumatic system 220 is unplugged from its connector 228 so that the patient can move within the hospital without wearing an uncomfortable cuff-based system.
- the optical waveforms measured with the red and infrared wavelengths can additionally be processed to determine SpO2 values, as described in detail in the following patent application, the contents of which is incorporated herein by reference: BODY-WORN PULSE OXIMETER (U.S. Ser. No. 12/559,379; filed Sep. 14, 2009).
- a third connector 232 also supports the CAN bus and is used for auxiliary medical devices 245 (e.g. a glucometer, infusion pump, system for measuring end-tidal CO2) that is either worn by the patient or present in their hospital room.
- auxiliary medical devices 245 e.g. a glucometer, infusion pump, system for measuring end-tidal CO2
- the transceiver 72 uses the internal wireless transmitter 224 to send information in a series of packets to a PDS 60 within the hospital.
- the wireless transmitter 224 typically operates on a protocol based on 802.11, and can communicate with the PDS 60 through an existing network within the hospital as described above with reference to FIG. 5 .
- Information transmitted by the transceiver alerts the clinician if the patient begins to decompensate.
- the PDS 60 typically generates this alarm/alert once it receives the patient's vital signs, motion parameters, ECG, PPG, and ACC waveforms, and information describing their posture, and compares these parameters to preprogrammed threshold values. As described in detail below, this information, particularly vital signs and motion parameters, is closely coupled together.
- Alarm conditions corresponding to mobile and stationary patients are typically different, as motion can corrupt the accuracy of vital signs (e.g., by adding noise), and induce artificial changes in them (e.g., through acceleration of the patient's heart and respiratory rates) that may not be representative of the patient's actual physiology.
- FIGS. 6A, 6B, 7, and 8 show how a wrist-worn transceiver 72 A with a depleted battery can be swapped with a similar transceiver 72 B having a fully charged battery using the ‘bump’ methodology described above.
- both transceivers Prior to the swap, as shown in FIG. 6A , both transceivers are readied by activating the appropriate GUI 50 C, 50 D following the screens shown in FIG. 8 . This process activates firmware on each transceiver 72 A, 72 B indicating that the swap is about to occur.
- each transceiver sends a packet through the wireless access point 56 and to the hospital network and PDS 60 .
- the packet describes a transceiver-specific address, e.g. a MAC address associated with its wireless transmitter.
- the GUIs 50 C, 50 D on both transceivers 72 A, 72 B indicate to a clinician that they can be ‘bumped’ together, and that the swap can proceed.
- the new transceiver 72 B (with the fully charged battery) is then bumped against the old transceiver 72 A (with the depleted battery).
- Internal accelerometers within both transceivers 72 A, B detect the bumping process and, in response, independently generate ACC waveforms 130 , 132 , both featuring a sharp spike indicating the rapid acceleration and deceleration due to the bumping process.
- the ACC waveforms 130 , 132 correspond to the same axes in both transceivers.
- the ACC waveforms are digitized within each transceiver and then transmitted through the wireless access point 56 to the PDS 60 , where they are stored in a computer memory and analyzed with a software program that is activated when both devices are ‘readied’, as described above.
- the software program compares formatted versions of the ACC waveforms 130 ′, 132 ′ to detect the rapid spikes, as shown by the graph 140 in FIG. 7 .
- the rapid spikes in the waveforms 130 ′, 132 ′ should occur within a few microseconds of each other, as indicated by the shaded window 142 in the graph 140 .
- the software program interprets the concurrence of the spikes as indicating that data stored on the old transceiver 72 A is to be transferred to the new transceiver 72 B.
- the data for example, includes demographic information describing the patient (e.g. their name, age, height, weight, photograph), the medications they are taking, and all the vital sign and waveform information stored in memory in the old transceiver 72 A. Following the bump, this information is associated with the address corresponding to the new transceiver 72 B.
- the GUIs 50 C, 50 D on both transceivers 72 A, 72 B indicate that they can be swapped.
- cables connected to the optical sensor and ECG electrodes are unplugged from the old transceiver 72 A, and plugged into the new transceiver 72 B.
- the clinician then attaches the new transceiver to the patient's wrist, and commences measuring vital signs from the patient as described above.
- a time period corresponding to a portion (e.g. a peak value) of the motion-generated spike is determined on each of the wrist-worn transceivers that are bumped together.
- Each transceiver then sends its time period to the PDS, where they are collectively analyzed to determine if they are sufficiently close in value (e.g. within a few hundred milliseconds). If this criterion is met, software on the PDS assumes that the transceivers are ready to be swapped, and performs the above-described steps to complete this process.
- FIG. 8 shows a sequence of screens within the GUI that describe the process for swapping transceivers to the clinician.
- the process begins when a screen 158 rendered by Device A indicates that its battery is running low of charge. This is indicated by a standard low battery' icon located in the upper right-hand corner of the screen 158 , as well as a larger icon located near the bottom of the screen. A time describing the remaining life of the battery appears near this icon when this time is 5 minutes or less.
- Each transceiver includes a sealed internal Li:ion battery that cannot be easily replaced in the hospital. Instead, the transceiver is inserted in a battery charger that typically includes eight or sixteen ports, each of which charges a separate transceiver.
- the clinician taps the screen 158 to yield a new screen 160 which includes a series of six icons, each related to a unique feature.
- the icon in the lower left-hand corner shows two interchanging batteries. When tapped, this icon yields a new screen 160 indicating that Device A is ready to be swapped.
- Device B is then removed from a port in the battery charger, and a sequence of screens 150 , 152 , 154 are initiated as described with reference to Device A.
- Devices A and B both show, respectively, screens 162 , 154 , they are ready to be swapped using the ‘bumping’ process.
- a clinician ‘bumps’ Device B into Device A, which in turn generates two ACC waveforms 130 , 132 featuring sharp, time-dependent spikes indicating the bump.
- the waveforms 130 , 132 include spikes, as shown by the shaded box 142 , which are concurrent in time, and are wirelessly transmitted in a packet that indicates their origin through the pathway shown in FIG. 7 to the PDS. There, they are analyzed by the software program described above to determine that data associated with Device A (e.g. patient information, vital signs) is now associated with Device B.
- data associated with Device A e.g. patient information, vital signs
- the PDS transmits a packet back through the pathway shown in FIG. 7 to both Device A and B, indicating that the PDS is ready to transfer the data.
- Device B then renders a screen 166 asking the clinician to confirm the process. Data is transferred if the clinician taps the ‘check’ box in the lower right-hand corner of the screen; during this process Device B renders a screen 168 that shows the patient's name to further confirm with the clinician that the transfer process is valid.
- Device A is no longer active, meaning it cannot collect data or generate alarms.
- Device B renders a screen 170 that instructs the clinician to disconnect the optical and electrical sensors from Device A, and to clean this device and insert it into the battery charger.
- a screen 172 on Device B then instructs the clinician to connect the sensors and attach Device B to the patient's wrist.
- Device B renders a final confirmatory screen 176 , which when checked finalizes the swapping process.
- Device B is officially associated with the patient, renders a standard screen 178 , and commences measuring vital signs from the patient. These vital signs, along with those collected from Device A, are included in a contiguous data file characterizing the patient.
- Device B's barcode can be read and processed to facilitate swapping the transceivers.
- an icon on Device A when tapped, renders a screen 164 indicating that Device A is ready to read the barcode printed on Device B.
- Device B's barcode is swiped across Device A's barcode reader, decoded, and wirelessly transmitted to the PDS as indicated in FIG. 7 .
- the PDS uses this information to associate Device B with the patient as described above.
- Device B uses the same screens used for the ‘bumping’ transfer process (screens 166 , 168 , 170 , 172 , 176 , 178 ) to associate Device B with the patient.
- the ‘bumping’ process shown in FIG. 6 takes place along the long axes of Device A and Device B. Alternatively, it can take place along the short axes of these devices. Or the short axis of one device can be bumped against the long axis of the other device to initiate the process.
- the ‘bumping’ process described above can also be used for other applications relating to the wrist-worn transceiver. It can be used, for example, to pair the transceiver with an RVD, such as a display located at the patient's bedside, or at a central nursing station.
- a clinician selects a transceiver 72 from the battery charger and brings it near an RVD 62 . Before attaching the transceiver 72 to the patient, the clinician ‘bumps’ it against a hard surface proximal to the RVD 62 (or against the RVD itself) to generate a sharp spike in the ACC waveform 133 .
- the waveform 133 is similar in shape to that generated when two transceivers are swapped with the bumping process, as described above.
- the RVD's location needs to be determined in order to pair it with the transceiver 72 .
- all neighboring wireless access points 56 A, 56 B, 56 C transmit a ‘location beacon’ 59 A, 59 B, 59 C to the transceiver, which is received and used to calculate a value for signal strength (typically characterized by an aSSI value') between the transceiver 72 and the respective access point 56 A, 56 B, 56 C.
- the transceiver concatenates values for RSSI and identifiers for the access points into a single ‘location packet’ 59 D, which it then transmits along with the ACC waveform 133 and an identifying code describing the transceiver (not shown in the figure) through a single access point 56 B to the PDS 60 .
- the PDS 60 receives the location packet 56 D and parses it to arrive at RSSI values for the three wireless access points 56 A, 56 B, 56 C within wireless range of the transceiver 72 .
- the individual access points 56 A, 56 B, 56 C determine RSSI values characterizing the signal strength between them and the transceiver, and send these as individual packets to the PDS.
- Software on the PDS then concatenates these packets to determine signals similar to those included in the location packet.
- location-determining software operating on the PDS triangulates the signals, along with known locations of each wireless access point 56 A, 56 B, 56 C, to determine an approximate location 71 of the transceiver 72 .
- the known locations of the access points are stored within a map grid 73 in a computer memory associated with the location-determining software.
- the transceiver's approximate location typically has an accuracy of 1-3 m.
- the software uses the map grid 73 , the software then processes the approximate location 71 and a known location of any RVD 62 lying within a pre-determined radius 75 . Typically the pre-determined radius is 3-5 m.
- the RVD 62 If the location of the RVD 62 lies within the pre-determined radius 75 , the RVD 62 is automatically ‘paired’ with the transceiver 72 . Once paired, the RVD 62 then displays any follow-on waveform, motion, and vital sign information sent by the transceiver.
- the location-determining software described above uses triangulation algorithms to determine the patient's current and historical location. Such a process can be used to monitor and locate a patient in distress, and is described, for example, in the following issued patent, the contents of which are incorporated herein by reference: WIRELESS, INTERNET-BASED, MEDICAL DIAGNOSTIC SYSTEM (U.S. Pat. No. 7,396,330). If triangulation is not possible, the location-determining software may simply use proximity to a wireless access point (as determined from the strength of an RSSI value) to estimate the patient's location. Such a situation would occur if signals from at least three wireless access points were not available.
- the location of the patient is estimated with an accuracy of about 5-10 m.
- the RVD may be a central nursing station that displays vital sign, motion-related properties (e.g. posture and activity level) and location information from a group of patients.
- motion-related properties e.g. posture and activity level
- location information from a group of patients.
- BODY-WORN VITAL SIGN MONITOR U.S. Ser. No. 12/560,077, filed Sep. 15, 2009.
- the location-determining software determines the location of a patient-worn transceiver, and automatically pairs it to a RVD located nearby (e.g. within a pre-determined radius, such as that shown in FIG. 10 ). In this way, the patient's information can be displayed on different RVDs as they roam throughout the hospital.
- the patient's location can be analyzed relative to a set of pre-determined boundaries (e.g. a ‘geofence’) to determine if they have wandered into a restricted area. Or their speed can be determined from their time-dependent location, and then analyzed relative to a pre-determined parameter to determine if they are walking too fast.
- a set of pre-determined boundaries e.g. a ‘geofence’
- speed can be determined from their time-dependent location, and then analyzed relative to a pre-determined parameter to determine if they are walking too fast.
- any combination of location, motion-related properties, vital signs, and waveforms can be collectively analyzed with software operating on either the transceiver or PDS to monitor the patient. Patients can be monitored, for example, in a hospital, medical clinic, outpatient facility, or the patient's home.
- location of the transceiver can be determined using off-the-shelf software packages that operate on the PDS.
- Companies that provide such software include, for example, by Cisco Systems (170 West Tasman Drive, San Jose, Calif. 93134; www.cisco.com), Ekahau (12930 Saratoga Avenue, Suite B-8, Saratoga, Calif. 95070; www.ekahau.com), and others.
- the transceiver puts it into a ‘sleep mode’ when it is not attached to the patient. This way the transceiver can determine and transmit a location packet even when it is not used for patient monitoring.
- this allows the transceiver's location to be determined and then analyzed if it has been lost, misplaced, or stolen.
- the transceiver's serial number can be entered into the software and then used to send a ‘ping’ the transceiver.
- the transceiver responds to the ping by collecting and transmitting a location packet as described above. Or the location of all unused transceivers can be automatically rendered on a separate interface.
- the location-determining software can transmit a packet to a specific transceiver (e.g. one that is stolen) to disable it from operating further.
- the ‘bumping’ process described above can be used for a variety of applications involving the body-worn monitor, wrist-worn transceiver, PDS, and RVD.
- one or more ‘bumps’ of a transceiver can modulate the ACC waveform, which is then processed and analyzed to initiate a specific application.
- Applications include turning the transceiver on/off; attaching sensors to the transceiver; pairing the transceiver with a hand-held device (e.g.
- a cellular phone or personal digital assistant over a peer-to-peer connection (using, e.g., 802.11 or 802.15.4); pairing the transceiver with a printer connected to a hospital network to print data stored in its computer memory; associating the transceiver with a specific clinician; and initiating display of a particular GUI.
- the ‘bumping’ process can be used to initiate any application that can also be initiated with icons on the GUI.
- FIGS. 11-13 show how the wrist-worn transceiver can be used to communicate audible information from both the patient and a clinician.
- Audible information from the clinician 140 can be used, for example, to annotate vital sign information collected with the body-worn monitor.
- Audible information from the patient 141 can be transmitted to a clinician (e.g. a nurse working at a central station) to alert the clinician of a problem.
- the transceiver 72 is attached to the patient's wrist 66 as described above and used to measure vital signs and waveform information.
- Audible information is received by a microphone 101 mounted on a circuit board within the transceiver.
- a speaker 120 mounted to the same circuit board enunciates voice information to the patient.
- voice information is digitized by an internal analog-to-digital converter within the transceiver, and then wirelessly transmitted through a hospital's wireless network using conventional VOIP protocols.
- Systems that operate these protocols are marketed, for example, by Cisco Systems (170 West Tasman Drive, San Jose, Calif. 93134; www.cisco.com), Skype (22/24 Boulevard Royal, 6e etage, L-2449, Germany; www.skype.com), and others.
- FIG. 12 describes the annotation process in more detail.
- the transceiver 72 within the body-worn monitor is attached to the patient's wrist 66 to measure the patient's vital signs (e.g. blood pressure).
- the clinician uses the GUI 50 F to activate an ‘annotation’ function which enables the transceiver to receive audible signals 140 which are used, for example, to annotate different medications administered to the patient.
- the clinician orally describes the medications.
- the microphone 101 within the transceiver 72 detects the voice signals, digitizes them with associated hardware, and then sends them and an associated time/date sample using a VOIP protocol through an access point 56 and to a PDS located within the hospital network 60 .
- Vital signs are transmitted before and after the annotation function is activated, and are stored along with the annotation in a computer memory associated with the PDS. Typically these data are stored within a hospital's EMR.
- annotated vital sign data can be viewed afterwards to determine, for example, how a patient responds to specific medications.
- administration of a beta blocker as a means of lowering the patient's blood pressure is recorded on the graph by a written description of the annotation, along with an icon (a black triangle) indicating when it occurred in time.
- the PDS requires software that performs a speech-to-text conversion. Such software is available, for example, from Nuance Systems (1 Wayside Road, Burlington, Mass. 01803; www.nuance.com).
- the graph 141 shows a second annotation indicating that the patient was hydrated with saline to increase their blood pressure.
- FIG. 13 shows a series of screens within the GUI 50 F that are used to control the annotation process.
- the clinician taps an icon located in the upper right-hand portion of screen 180 .
- This action readies the voice recording features within the transceiver.
- Tapping the annotation icon drives the transceiver to render a second screen 182 that includes the type of annotation, e.g. audible content relating to medication, a specific intervention or procedure, a medical assessment, or another subject.
- annotations are delivered as audible speech, in which case the ‘Speech’ button is tapped, as shown in screen 184 .
- the annotation can be text or numerical; these can be typed in, e.g., using a ‘soft’ keyboard on the transceiver, or scanned in using the transceiver's barcode scanner.
- the annotations can also be associated with an alarm condition, such as those shown on screens 181 , 183 , 185 , 187 , 189 , 191 .
- the GUI Prior to recording an annotation, the GUI renders a screen 188 that, once tapped, initiates the recording. The recording can also be paused using screen 186 . After it is complete, the clinician taps the ‘checkbox’ on the screen 188 , thus saving the recording. It is then sent to the PDS as shown in FIG. 12 , and used to annotate the patient's medical information.
- the transceiver can include a small CCD camera that allows images of the patient or their body (e.g. a wound) to be captured and used to annotate the medical information.
- a barcode printed on medication administered to the patient can be scanned by the transceiver's barcode scanner, and the information encoded therein can be used to annotate vital sign information.
- the transceiver can integrate with other equipment in the hospital room (e.g. an infusion pump, ventilator, or patient-controlled anesthesia pump) through a wired or wireless connection, and information from this equipment can be collected and transmitted to the PDS in order to annotate the vital sign information.
- text annotations can be stored on the PDS, and then edited afterwards by the clinician.
- the speaker 120 and microphone 101 within the transceiver 72 can also function as a nurse call system that communicates both distress signals and voice information.
- the transceiver enables two-way communication between the patient and a remote clinician.
- the transceiver typically operates the ‘patient GUI’, shown schematically in FIG. 3 and in more detail in FIG. 14 .
- the GUI shows a single screen 192 that indicates a nurse call function with an icon showing a telephone.
- the transceiver When the patient taps on the telephone the transceiver initiates a call to a pre-programmed IP address, corresponding, e.g., to a computer at a central nursing station or a VOIP-enabled phone.
- the transceiver can call a pre-programmed phone number corresponding to a telephone. While the call is being place the GUI renders a screen 194 that shows the telephone's receiver being off the hook. A third screen 196 indicates that the patient is connected to the clinician. The call is terminated when the patient finishes talking to the clinician and taps the screen.
- the transceiver can include software that detects that no further voice communications are taking place, and then uses this information to terminate the call.
- the entire call can be stored in a computer memory on either the transceiver or the PDS.
- the GUI operating on the wrist-worn transceiver's touchpanel display can render several other interfaces that facilitate patient monitoring in the hospital.
- the GUI can be used to monitor the patient's pain level, a parameter often considered by clinicians to be as important as vital signs for characterizing a patient.
- the GUI 200 shown in the figure features a simple series of icons that provide a relative indication of the patient's pain level.
- An index value of 0 (corresponding to a ‘happy’ face) indicates a low level of pain; an index value of 10 (corresponding to a ‘sad’ face) indicates a high level of pain.
- the patient simply touches the icon that best characterizes their pain level.
- the numerical value corresponding to this level is then wirelessly transmitted back to the PDS and stored in the patient's EMR.
- the GUI may be automatically rendered periodically (e.g. every hour) on the transceiver to continuously monitor the patient's pain level.
- the GUI could render a graphical display that provides a more sophisticated metric for determining the patient's pain, such as the McGill Pain Questionnaire. This system described in the following journal article, the contents of which are incorporated herein by reference: ‘The McGill Pain Questionnaire: Major Properties and Scoring Methods’, Melzak, Pain, 1:277-299 (1975).
- the GUI can be used to gauge the patient's level of mentation, i.e. mental activity. Mentation has been consistently shown to be a valuable tool for diagnosing a patient, but is typically determined empirically by a clinician during a check-up or hospital visit. Such a diagnosis is somewhat arbitrary and requires the clinician to meet face-to-face with the patient, which is often impractical. But with the wrist-worn transceiver, diagnosis of mentation can be made automatically at the patient's bedside without a clinician needing to be present.
- FIG. 16 shows a GUI 202 that provides a simple ‘mentation test’ for the patient to complete.
- the mentation test involves a graphical representation of a series of non-sequential numbers.
- the patient completes this test by tapping on the numbers rendered by the touchpanel display in their numerical order.
- An algorithm then ‘scores’ the test based on accuracy and the time required to complete it. Once determined, the score is wirelessly transmitted back to the PDS, and then stored in the patient's EMR.
- Other simple tests with varying complexity can be used in place of that shown in FIG. 16 .
- the tests can vary depending on the specific mentation function to be tested. For example, unique tests can be generated for patients with head injuries, cardiac patients, patients in severe pain, Alzheimer's patients, etc.
- the tests are designed to make a quantitative assessment of the patient's mental status; the transceiver sends a numerical value representing this parameter and an identifier for the test back to the EMR for analysis.
- the transceiver can be programmed so that the GUI 202 for the mentation test, like the GUI 200 for pain level shown in FIG. 15 , is automatically rendered at basically any time interval on the touchpanel display. This time interval can be periodic and on an hourly basis, once/day, etc.
- the transceiver can include a GUI 204 that displays a photograph or video of the patient.
- the photograph could be taken by a digital camera within the transceiver, or with an external camera and then transferred to the transceiver through a variety of means, e.g. the hospital's wireless network, a peer-to-peer wireless connection, using a non-volatile memory such as an SD card, or even using a data-transfer process initiated by the ‘bump’ methodology described above.
- the same means used to port a photograph from a standard digital camera to a personal computer or other device can be used in this application.
- the transceiver displays it in either a default screen (e.g., in place of the ‘beating heart’ shown in FIGS. 1 and 3 ), or when the GUI 204 is activated through a tap of a corresponding icon. Displaying the patient's photograph in this manner provides a visual indicator which the clinician can use to correctly identify the patient.
- a photograph of someone associated with the patient e.g. a relative
- Such an embodiment may be particularly useful for neo-natal hospitals wards, wherein one or more photographs of an infant's parents could be displayed on a transceiver attached to the infant. This way a clinician could check the photograph to ensure that visitors to the neo-natal hospital ward are, in fact, the infant's parents.
- FIGS. 18 and 19 show other GUIs 206 , 208 that can be rendered on the wrist-worn transceiver's display to carry out basic features in the hospital, such as meal ordering ( FIG. 18 ), and changing the channel on a television or computer ( FIG. 19 ).
- the PDS associated with the transceiver receives a packet describing the function at hand (e.g., the meal that has been ordered, or the channel that is desired), and communicates with another software application in the hospital to complete the transaction.
- This communication can take place using a XML-based Web Services operation, such as that described in the following patent application, the contents of which are incorporated herein by reference: CUFFLESS BLOOD PRESSURE MONITOR AND ACCOMPANYING WEB SERVICES INTERFACE (U.S. Ser. No. 10/810,237, Filed Mar. 26, 2004).
- a GUI similar to that shown in FIG. 19 can be used to order movies, video games, television programs stored on a digital video recorder, books, and music. Content corresponding to these components is typically stored on a remote server, and then accessed using an XML-based operation, as described above.
- the wrist-worn transceiver 72 and its associated barcode scanner 102 can be used to check medication before it is administered to the patient.
- barcodes associated with the patient 63 , clinician 65 , and the medication 67 are read by the barcode scanner 102 within the transceiver 72 .
- the transceiver then wirelessly transmits decoded barcode information through a local access point 56 and to the PDS connected to the hospital network 60 .
- the PDS analyzes these data and communicates with the patient's record in the hospital EMR 58 to determine if the medication is appropriate for the patient.
- the software program may check to see if the patient is allergic to the medication, if the dosage is correct, or if the patient has previously exhibited any detrimental side effects that may affect the dosage.
- the transceiver may also include a GUI wherein the clinician enters ancillary information, such as the dosage of the medication or demographic information describing the patient, using a ‘soft’ keypad.
- the GUI may include a simple questionnaire that guides the clinician through the process of checking the medication, and then administering it.
- the infusion pump that delivers the medication may include a wireless connection through the access point 56 to the PDS 60 or to the transceiver 72 to automatically supply information related to the medication to the software program.
- the software program determines that it is safe to administer the medication, it sends a packet from the PDS 60 , through the access point 56 , and back to the transceiver 72 , which then renders a GUI instructing the clinician to proceed.
- the PDS 60 sends the packet through the access point 56 to either a remote computer 62 (e.g. a tablet computer) or a portable device 64 (e.g. a cellular telephone or personal digital assistant).
- FIGS. 21A and 21B show how the body-worn monitor 100 described above attaches to a patient 70 to measure RR, SpO2, cNIBP, and other vital signs.
- FIG. 21A shows the system used during the indexing portion of the Composite Technique, and includes a pneumatic, cuff-based system 85
- FIG. 21B shows the system used for subsequent measurements.
- the indexing measurement typically takes about 60 seconds, and is typically performed once every 4-8 hours. Once the indexing measurement is complete the cuff-based system 85 is typically removed from the patient. The remainder of the time the monitor 100 performs the RR, HR, SpO2 and cNIBP measurements.
- the body-worn monitor 100 features a wrist-worn transceiver 72 , described in more detail in FIGS. 22A and 22B , featuring a touch panel interface 73 that displays the various GUIs described above and in FIG. 24 .
- a wrist strap 90 affixes the transceiver 72 to the patient's wrist like a conventional wristwatch.
- a flexible cable 92 connects the transceiver 72 to an optical sensor 94 that wraps around the base of the patient's thumb. During a measurement, the optical sensor 94 generates a time-dependent PPG waveform which is processed along with an ECG to measure cNIBP, SpO2, and, in some applications, RR.
- the body-worn monitor 100 features three separate accelerometers located at different portions on the patient's arm and chest.
- the first accelerometer is surface-mounted on a circuit board in the wrist-worn transceiver 72 and measures signals associated with movement of the patient's wrist. As described above, this motion can also be indicative of that originating from the patient's fingers, which will affect the SpO2 measurement.
- the second accelerometer is included in a small bulkhead portion 96 included along the span of the cable 82 .
- a small piece of disposable tape similar in size to a conventional bandaid, affixes the bulkhead portion 96 to the patient's arm.
- the bulkhead portion 96 serves two purposes: 1) it measures a time-dependent ACC waveform from the mid-portion of the patient's arm, thereby allowing their posture and arm height to be determined as described in detail above; and 2) it secures the cable 82 to the patient's arm to increase comfort and performance of the body-worn monitor 100 , particularly when the patient is ambulatory.
- the third accelerometer is mounted in the sensor module 74 that connects through cables 80 a - c to ECG electrodes 78 a - c. Signals from these sensors are then digitized, transmitted through the cable 82 to the wrist-worn transceiver 72 , where they are processed with an algorithm as described above to determine RR.
- the cuff-based module 85 features a pneumatic system 76 that includes a pump, valve, pressure fittings, pressure sensor, manifold, analog-to-digital converter, microcontroller, and rechargeable Li:ion battery.
- the pneumatic system 76 inflates a disposable cuff 84 and performs two measurements according to the Composite Technique: 1) it performs an inflation-based measurement of oscillometry and measurement of a corresponding OSC waveform to determine values for SYS, DIA, and MAP; and 2) it determines a patient-specific relationship between PTT and MAP.
- the cuff 84 within the cuff-based pneumatic system 85 is typically disposable and features an internal, airtight bladder that wraps around the patient's bicep to deliver a uniform pressure field.
- pressure values are digitized by the internal analog-to-digital converter, and sent through a cable 86 according to a CAN protocol, along with SYS, DIA, and MAP blood pressures, to the wrist-worn transceiver 72 for processing as described above.
- the cuff-based module 85 is removed from the patient's arm and the cable 86 is disconnected from the wrist-worn transceiver 72 .
- cNIBP is then determined using PTT, as described in detail above.
- the body-worn monitor 100 features a small-scale, three-lead ECG circuit integrated directly into the sensor module 74 that terminates an ECG cable 82 .
- the ECG circuit features an integrated circuit that collects electrical signals from three chest-worn ECG electrodes 78 a - c connected through cables 80 a-c.
- the ECG electrodes 78 a - c are typically disposed in a conventional Einthoven's Triangle configuration, which is a triangle-like orientation of the electrodes 78 a - c on the patient's chest that features three unique ECG vectors.
- the ECG circuit determines up at least three ECG waveforms, each corresponding to a unique ECG vector, which are digitized using an analog-to-digital converter mounted proximal to the ECG circuit and sent through the cable 82 to the wrist-worn transceiver 72 according to the CAN protocol. There, the ECG and PPG waveforms are processed to determine the patient's blood pressure. HR and RR are determined directly from the ECG waveform using known algorithms, such as those described above. More sophisticated ECG circuits (e.g. five and twelve-lead systems) can plug into the wrist-worn transceiver to replace the three-lead system shown in FIGS. 21A and 21B .
- FIGS. 22A, 22B show three-dimensional views of the wrist-worn transceiver 72 before and after receiving cables 82 , 86 , 89 from sensors worn on the patient's upper arm and torso, as well as the cable 92 that connects to the optical sensor.
- the transceiver 72 is sealed in a water-proof plastic casing 117 featuring electrical interconnects (not shown in the figure) on its bottom surface that interface to the terminal ends 111 , 119 a-c of cables 82 , 86 , 89 , 92 leading to the monitor's various sensors.
- the electrical interconnects support serial communication through the CAN protocol, described in detail herein, particularly with reference to FIG. 25 .
- the transceiver's plastic casing 117 snaps into a plastic housing 106 , which features an opening 109 on one side to receive the terminal end 111 of the cable 92 connected to the optical sensor.
- the plastic housing 106 features three identical openings 104 a - c that receive the terminal ends 119 a - c of cables 82 , 86 , 89 connected to the ECG and accelerometer systems (cable 82 ), the pneumatic cuff-based system (cable 86 ), and ancillary systems (cable 89 ) described above.
- this design facilitates activities such as cleaning and sterilization, as the transceiver contains no openings for fluids common in the hospital, such as water and blood, to flow inside.
- fluids common in the hospital such as water and blood
- the transceiver 72 attaches to the patient's wrist using a flexible strap 90 which threads through two D-ring openings in the plastic housing 106 .
- the strap 90 features mated Velcro patches on each side that secure it to the patient's wrist during operation.
- a touchpanel display 50 renders the various GUIs described above.
- the electrical interconnects on the transceiver's bottom side line up with the openings 104 a - c, and each supports the CAN protocol to relay a digitized data stream to the transceiver's internal CPU, as described in detail with reference to FIG. 25 .
- This allows the CPU to easily interpret signals that arrive from the monitor's body-worn sensors, and means that these connectors are not associated with a specific cable. Any cable connecting to the transceiver 72 can be plugged into any opening 104 a - c. As shown in FIG.
- the first opening 104 a receives the cable 82 that transports digitized ECG waveforms determined from the ECG circuit and electrodes, and digitized ACC waveforms measured by accelerometers in the cable bulkhead and the bulkhead portion associated with the ECG cable 82 .
- the second opening 104 b receives the cable 86 that connects to the pneumatic cuff-based system used for the pressure-dependent indexing measurement.
- This connector receives a time-dependent pressure waveform delivered by the pneumatic system to the patient's arm, along with values for SYS, DIA, and MAP determined during the indexing measurement.
- the cable 86 unplugs from the opening 104 b once the indexing measurement is complete, and is plugged back in after approximately 4-8 hours for another indexing measurement.
- the final opening 104 c can be used for an auxiliary device, e.g. a glucometer, infusion pump, body-worn insulin pump, ventilator, or end-tidal CO 2 monitoring system.
- auxiliary device e.g. a glucometer, infusion pump, body-worn insulin pump, ventilator, or end-tidal CO 2 monitoring system.
- digital information generated by these systems will include a header that indicates their origin so that the CPU can process them accordingly.
- FIGS. 23A and 23B show how a network of sensors 78 a - c, 83 , 84 , 87 , 94 within the body-worn monitor 100 connect to a patient 70 to measure time-dependent ECG 261 , PPG 262 , OSC 263 , ACC 264 , and RR 265 waveforms. These, in turn, yield the patient's vital signs and motion parameters.
- Each waveform 261 - 265 relates to a unique physiological characteristic of the patient 70 . For example, each of the patient's heartbeats generates electrical impulses that pass through the body near the speed of light, along with a pressure wave that propagates through the patient's vasculature at a significantly slower speed.
- the pressure wave leaves the heart 148 and aorta 149 , passes through the subclavian artery 150 to the brachial artery 144 , and from there through the radial and ulnar arteries 145 to smaller arteries in the patient's fingers.
- Three disposable electrodes 78 a-c attached to the patient's chest measure unique electrical signals which pass to a single-chip ECG circuit 83 that terminates a distal end of the ECG cable.
- these electrodes attach to the patient's chest in a conventional ‘Einthoven's triangle’ configuration featuring three unique ‘vectors’, each corresponding to a different lead (e.g. LEAD 1, II, II).
- ECG circuit 83 signals are processed using an amplifier/filter circuit and analog-to-digital converter to generate a digital ECG waveform 261 corresponding to each lead.
- the ECG waveform 261 features a sharp, well-defined QRS complex corresponding to each heartbeat; this marks the initiation of the patient's cardiac cycle.
- Heart rate is determined directly from the ECG waveform 261 using known algorithms, such as those described in the following journal article, the contents of which are incorporated herein by reference: ‘ECG Beat Detection Using Filter Banks’, Afonso et al., IEEE Trans. Biomed Eng., 46:192-202 (1999).
- one of the ECG electrodes in the circuit 78 a is a ‘driven lead’ that injects a small amount of modulated current into the patient's torso.
- a second, non-driven electrode 78 c typically located on the opposite side of the torso, detects the current, which is further modulated by capacitance changes in the patient's chest cavity resulting from breathing. Further processing and filtering of the IP waveforms 265 yields respiratory rate.
- Respiration can also be determined using an adaptive filtering approach that processes both the IP waveform and ACC waveform 264 , as described in more detail in the following co-pending patent application, the contents of which are incorporated herein by reference: BODY-WORN MONITOR FOR MEASURING RESPIRATION RATE (U.S. Ser. No. 12/559,419, Filed Sep. 14, 2009).
- the optical sensor 94 features two LEDs and a single photodetector that collectively measure a time-dependent PPG waveform 262 corresponding to each of the LEDs.
- the sensor and algorithms for processing the PPG waveforms are described in detail in the following co-pending patent application, the contents of which have been previously incorporated herein by reference: BODY-WORN PULSE OXIMETER (U.S. Ser. No. 12/559,379; filed Sep. 14, 2009).
- the waveform 262 represents a time-dependent volumetric change in vasculature (e.g. arteries and capillaries) that is irradiated with the sensor's optical components.
- volumetric changes are induced by a pressure pulse launched by each heartbeat that travels from the heart 148 to arteries and capillaries in the thumb according to the above-describe arterial pathway. Pressure from the pressure pulse forces a bolus of blood into this vasculature, causing it to expand and increase the amount of radiation absorbed, and decrease the transmitted radiation at the photodetector.
- the pulse shown in the PPG waveform 262 therefore represents the inverse of the actual radiation detected at the photodetector. It follows the QRS complex in the ECG waveform 261 , typically by about one to two hundred milliseconds.
- the temporal difference between the peak of the QRS complex and the foot of the pulse in the PPG waveform 262 is the PTT, which as described in detail below is used to determine blood pressure according to the Composite Technique.
- PTT-based measurements made from the thumb yield excellent correlation to blood pressure measured with a femoral arterial line. This provides an accurate representation of blood pressure in the central regions of the patient's body.
- Each accelerometer generates three time-dependent ACC waveforms 264 , corresponding to the x, y, and z-axes, which collectively indicate the patient's motion, posture, and activity level.
- the body-worn monitor features three accelerometers that attach to the patient: one in the wrist-worn transceiver 72 , one in the ECG circuit 83 , and one near the bicep 87 that is included in the cable connecting these two components.
- the frequency and magnitude of change in the shape of the ACC waveform 264 indicate the type of motion that the patient is undergoing.
- the waveform 264 can feature a relatively time-invariant component indicating a period of time when the patient is relatively still, and a time-variant component when the patient's activity level increases. Magnitudes of both components will depend on the relationship between the accelerometer and a gravity vector, and can therefore be processed to determine time-invariant features, such as posture and arm height. A frequency-dependent analysis of the time-variant components yields the type and degree of patient motion. Analysis of ACC waveforms 264 is described in detail in the above-mentioned patent applications, the contents of which have been fully incorporated herein by reference.
- the OSC waveform 263 is generated from the patient's brachial artery 144 with the pneumatic system and a cuff-based sensor 84 during the pressure-dependent portion of the Composite Technique. It represents a time-dependent pressure which is applied to the brachial artery during inflation and measured by a digital pressure sensor within the pneumatic system.
- the waveform 263 is similar to waveforms measured during deflation by conventional oscillometric blood pressure monitors. During a measurement, the pressure waveform 263 increases in a mostly linear fashion as pressure applied by the cuff 84 to the brachial artery 144 increases.
- the brachial artery 144 When it reaches a pressure slightly below the patient's diastolic pressure, the brachial artery 144 begins to compress, resulting in a series time-dependent pulsations caused by each heartbeat that couple into the cuff 84 .
- the pulsations modulate the OSC waveform 263 with an amplitude that varies in a Gaussian-like distribution, with maximum modulation occurring when the applied pressure is equivalent to the patient's MAP.
- the pulsations can be filtered out and processed using digital filtering techniques, such as a digital bandpass filter that passes frequencies ranging from 0.5-20 Hz.
- the resulting waveform can be processed to determine SYS, DIA, and MAP, as is described in detail in the above-referenced patent applications, the contents of which have been previously incorporated herein by reference.
- the cuff 84 and pneumatic system are removed from the patient's bicep once the pressure-dependent component of the Composite Technique is complete.
- the high-frequency component of the OSC waveform 263 (i.e. the pulses) can be filtered out to estimate the exact pressure applied to the patient's brachial artery during oscillometry.
- PTT measured while pressure is applied will gradually increase as the brachial artery is occluded and blood flow is gradually reduced.
- the pressure-dependent increase in PTT can be fit with a model to estimate the patient-specific relationship between PTT and blood pressure. This relationship, along with SYS, MAP, and DIA determined from the OSC waveform during inflation-based oscillometry, is used during the Composite Technique's pressure-free measurements to determine blood pressure directly from PTT.
- Measurements made during inflation are relatively fast and comfortable compared to those made during deflation. Inflation-based measurements are possible because of the Composite Technique's relatively slow inflation speed (typically 5-10 mmHg/second) and the high sensitivity of the pressure sensor used within the body sensor. Such a slow inflation speed can be accomplished with a small pump that is relatively lightweight and power efficient. Moreover, measurements made during inflation can be immediately terminated once systolic blood pressure is calculated. This tends to be more comfortable than conventional cuff-based measurements made during deflation. In this case, the cuff typically applies a pressure that far exceeds the patient's systolic blood pressure; pressure within the cuff then slowly bleeds down below the diastolic pressure to complete the measurement.
- a digital temperature sensor proximal to the ECG circuit 83 measures the patient's skin temperature at their torso. This temperature is an approximation of the patient's core temperature, and is used mostly for purposes related to trending and alarms/alerts.
- FIG. 24 shows how the above-described ECG, PPG, and IP waveforms, along with vital signs calculated from them, are rendered using different screens 300 , 304 , 306 , 308 within a GUI.
- the waveforms are displayed with a rolling graphical technique, along with a moving bar that indicates the most current point in time.
- the ECG waveforms are displayed alongside a bar that indicates a signal intensity of 1 mV.
- Screen 308 shows different ECG vectors (corresponding to, e.g., Lead I, II, III, aVR, aVF) that are rendered when the clinician taps the ECG waveform on screen 300 , and then the corresponding lead on screen 308 .
- Waveforms for a particular vital sign are rendered when the clinician taps on the value of the corresponding vital sign.
- a particular vital sign e.g. a PPG waveform for the SpO2 measurement; an IP waveform for the RR measurement
- both waveforms and the vital signs calculated from them are wirelessly transmitted to the PDS, as described above.
- FIG. 25 shows a schematic drawing indicating how CAN packets 201 a - d, 212 a - e transmitted between these systems facilitate communication.
- each of the ACC 215 , ECG 216 , pneumatic 220 , and auxiliary 245 systems include a separate analog-to-digital converter, microcontroller, frequency-generating crystal oscillator (typically operating at 100 kHz), and real-time clock divider that collectively generate and transmit digital data packets 201 a - d according to the CAN protocol to the wrist-worn transceiver 72 .
- Each crystal uses the internal real-time clock on the internal microprocessor within the respective system. This allows the microcontroller within each system to be placed in a low-power state in which its real-time operating system (RTOS) dispatch system indicates that it is not ready to run a task.
- RTOS real-time operating system
- the real-time clock divider is programmed to create an interrupt which wakes up the microcontroller every 2 milliseconds.
- the wrist-worn transceiver 72 features a ‘master clock’ that generates real-time clock ‘ticks’ at the sampling rate (typically 500 Hz, or 2 ms between samples). Each tick represents an incremented sequence number. Every second, the wrist-worn transceiver 72 transmits a packet 212 e over the CAN bus that digitally encodes the sequence number.
- One of the criteria for accurate timing is that the time delay between the interrupt and the transmission of the synchronizing packet 212 e, along with the time period associated with the CAN interrupt service routine, is predictable and stable.
- the remote CAN buses do not sleep; they stay active to listen for the synchronization packet 212 e.
- the interrupt service routine for the synchronization packet 212 e then establishes the interval for the next 2 millisecond interrupt from its on-board, real-time crystal to be synchronized with the timing on the wrist-worn transceiver 72 . Offsets for the packet transmission and interrupt service delays are factored into the setting for the real-time oscillator to interrupt synchronously with the microprocessor on the wrist-worn transceiver 72 .
- the magnitude of the correction factor to the real-time counter is limited to 25% of the 2 millisecond interval to ensure stability of this system, which represents a digital phase-locked loop.
- Each remote system is driven with a 100 kHz clock, and a single count of the divider corresponds to 20 microseconds. This is because the clock divider divides the real-time clock frequency by a factor of 2. This is inherent in the microcontroller to ensure that the clock has a 50% duty cycle, and means the clock can drift +/ ⁇ 20 microseconds before the actual divider chain count will disagree by one count, at which time the software corrects the count to maintain a phase-locked state. There is thus a maximum of 40 microseconds of timing error between data transmitted from the remote systems over the CAN bus. Blood pressure is the one vital sign measured with the body-worn monitor that is calculated from time-dependent waveforms measured from different systems (e.g. PPG and ECG waveforms). For this measurement, the maximum 40-microsecond timing error corresponds to an error of +/ ⁇ 0.04 mmHg, which is well within the error (typically +/ ⁇ 5 mmHg) of the measurement.
- the wrist-worn transceiver 72 and remote systems 215 , 216 , 220 , 245 power down their respective CAN bus transceivers between data transfers.
- each system generates a sequence number based that is included in the synchronization packet 212 e.
- the sequence number represents the interval between data transfers in intervals of 2 milliseconds. It is a factor of 500 (e.g. 2, 4, 5, 10) that is the number of 2 millisecond intervals between transfers on the CAN bus.
- Each remote system enables its CAN bus during the appropriate intervals and sends its data. When it has finished sending its data, it transmits a ‘transmit complete’ packet indicating that the transmission is complete. When a device has received the ‘transmit complete’ packet it can disable its CAN transceiver to further reduce power consumption.
- each of the ACC 215 , ECG 216 , and pneumatic 220 systems generate time-dependent waveforms that are transmitted in packets 201 a - d, each representing an individual sample.
- Each packet 201 a - d features a header portion which includes the sequence number 212 a - d and an initial value 210 a - d indicating the type of packet that is transmitted.
- accelerometers used in the body-worn system are typically three-axis digital accelerometers, and generate waveforms along the x, y, and z-axes.
- the initial value 210 a encodes numerical values that indicate: 1) that the packet contains ACC data; and 2) the axis (x, y, or z) over which these data are generated.
- the ECG system 216 can generate a time-dependent ECG waveform corresponding to Lead I, II, or III, each of which represents a different vector measured along the patient's torso. Additionally, the ECG system 216 can generate processed numerical data, such as heart rate (measured from time increments separating neighboring QRS complexes), respiratory rate (from an internal impedance pneumography component), as well as alarms calculated from the ECG waveform that indicate problematic cardiovascular states such as VTAC, VFIB, and PVCs.
- the ECG system can generate error codes indicating, for example, that one of the ECG leads has fallen off.
- the ECG system typically generates an alarm/alert, as described above, corresponding to both the error codes and potentially problematic cardiovascular states.
- the initial value 210 b encodes numerical values that indicate: 1) that the packet contains ECG data; 2) the vector (Lead I, II, or III) corresponding to the ECG data; and 3) an indication if a cardiovascular state such as VTAC, VFIB, or PVCs was detected.
- the pneumatic system 220 is similar to the ECG system in that it generates both time-dependent waveforms (i.e. a pressure waveform, measured during oscillometry, characterizing the pressure applied to the arm and subsequent pulsations measured during an oscillometric measurement) and calculated vital signs (SYS, DIA, and MAP measured during oscillometry).
- time-dependent waveforms i.e. a pressure waveform, measured during oscillometry, characterizing the pressure applied to the arm and subsequent pulsations measured during an oscillometric measurement
- calculated vital signs SYS, DIA, and MAP measured during oscillometry.
- errors are encountered during the oscillometric blood pressure measurement. These include, for example, situations where blood pressure is not accurately determined, an improper OSC waveform, over-inflation of the cuff, or a measurement that is terminated before completion. In these cases the pneumatic system 220 generates a corresponding error code.
- the initial value 210 c encodes numerical values that indicate: 1) that the packet contains blood
- each packet 201 a - d includes a data field 214 a - d that encodes the actual data payload.
- Examples of data included in the data fields 214 a - d are: 1) sampled values of ACC, ECG, and pressure waveforms; 2) calculated heart rate and blood pressure values; and 3) specific error codes corresponding to the ACC 215 , ECG 216 , pneumatic 220 , and auxiliary 225 systems.
- the wrist-worn transceiver 72 Upon completion of the measurement, the wrist-worn transceiver 72 receives all the CAN packets 201 a - d, and synchronizes them in time according to the sequence number 212 a - d and identifier 210 a - d in the initial portions 216 of each packet. Every second, the CPU updates the time-dependent waveforms and calculates the patient's vital signs and motion-related properties, as described above. Typically these values are calculated as a ‘rolling average’ with an averaging window ranging from 10-20 seconds. The rolling average is typically updated every second, resulting in a new value that is displayed on the wrist-worn transceiver 72 .
- Each packet received by the transceiver 72 is also wirelessly retransmitted as a new packet 201 b ′ through a wireless access point 56 and to both an PDS and RVD within a hospital network 60 .
- the new packet 201 b ′ includes the same header 210 b ′, 212 b ′ and data field information 214 b ′ as the CAN packets transmitted between systems within the body-worn monitor. Also transmitted are additional packets encoding the cNIBP, SpO2, and processed motion states (e.g. posture, activity level, degree of motion), which unlike heart rate and SYS, DIA, and MAP are calculated by the CPU in the wrist-worn transceiver.
- processed motion states e.g. posture, activity level, degree of motion
- the RVD Upon receipt of the packet 201 b ′, the RVD displays vital signs, waveforms, motion information, and alarms/alerts, typically with a large monitor that is easily viewed by a clinician. Additionally the PDS can send information through the hospital network (e.g. in the case of an alarm/alert), store information in an internal database, and transfer it to a hospital EMR.
- the hospital network e.g. in the case of an alarm/alert
- FIG. 26 shows an alternate configuration of the invention wherein the transceiver 72 transmits both voice and data information through a wireless access point 56 A and to the Internet 55 , and from there to the hospital network and PDS 60 .
- a wireless access point 56 A and to the Internet 55 and from there to the hospital network and PDS 60 .
- Such a configuration would be used, for example, when the patient is located outside of the hospital (e.g. at home). It allows clinicians to monitor and care for a patient as if they were located in the hospital.
- Once information arrives at the PDS 60 it can be transferred to the hospital EMR system 58 , or through a wireless access point 56 B within the hospital to an external computer 62 or a portable device 64 .
- the first wireless access point 56 A shown in FIG. 26 is replaced by a wireless modem 64 A, such as a cellular telephone or personal digital assistant.
- the wireless modem 64 A receives voice and data information from the transceiver through a peer-to-peer wireless interface (e.g. an interface based on 802.11b/g or 802.15.4).
- the wireless modem 64 A then transmits the voice and data information to the Internet 55 using, e.g., a cellular connection, such as one based on GSM or CDMA.
- the transceiver 72 includes an internal long-range wireless transmitter based on a cellular protocol (e.g.
- GSM Global System for Mobile communications
- CDMA Code Division Multiple Access
- information sent through the Internet is ultimately received by the PDS 60 , and is sent from there through a wireless access point 56 to either the remote computer 62 or portable device 64 .
- the transceiver 72 features multiple wireless transmitters, and can operate in multiple modes, such as each of those shown in FIGS. 26-28 .
- the wireless protocol (based on, e.g. 802 . 11 or cellular) is manually selected using the GUI, or automatically selected based on the strength of the ambient wireless signal.
- the body-worn monitor can use a number of additional methods to calculate blood pressure and other properties from the optical and electrical waveforms. These are described in the following co-pending patent applications, the contents of which are incorporated herein by reference: 1) CUFFLESS BLOOD-PRESSURE MONITOR AND ACCOMPANYING WIRELESS, INTERNET-BASED SYSTEM (U.S. Ser. No. 10/709,015; filed Apr. 7, 2004); 2) CUFFLESS SYSTEM FOR MEASURING BLOOD PRESSURE (U.S. Ser. No. 10/709,014; filed Apr.
- processing units and probes for measuring pulse oximetry similar to those described above can be modified and worn on other portions of the patient's body.
- optical sensors with finger-ring configurations can be worn on fingers other than the thumb.
- they can be modified to attach to other conventional sites for measuring SpO2, such as the ear, forehead, and bridge of the nose.
- the processing unit can be worn in places other than the wrist, such as around the neck (and supported, e.g., by a lanyard) or on the patient's waist (supported, e.g., by a clip that attaches to the patient's belt).
- the probe and processing unit are integrated into a single unit.
- the interface rendered on the display at the central nursing station features a field that displays a map corresponding to an area with multiple sections.
- Each section corresponds to the location of the patient and includes, e.g., the patient's vital signs, motion parameter, and alarm parameter.
- the field can display a map corresponding to an area of a hospital (e.g. a hospital bay or emergency room), with each section corresponding to a specific bed, chair, or general location in the area.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Computer Networks & Wireless Communication (AREA)
- Signal Processing (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
The invention provides a body-worn vital sign monitor that measures a patient's vital signs (e.g. blood pressure, SpO2, heart rate, respiratory rate, and temperature) while simultaneously characterizing their activity state (e.g. resting, walking, convulsing, falling) and posture (upright, supine). The monitor processes this information to minimize corruption of the vital signs and associated alarms/alerts by motion-related artifacts. It also features a graphical user interface (GUI) rendered on a touchpanel display that facilitates a number of features to simplify and improve patient monitoring and safety in both the hospital and home.
Description
- This application is a continuation of U.S. patent application Ser. No. 12/762,822, filed Apr. 19, 2010, now U.S. Pat. No. 10,278,645, which claims the benefit of U.S. Provisional Application No. 61/312,624, filed Mar. 10, 2010, each of which is incorporated herein in its entirety.
- The present invention relates to medical devices for monitoring vital signs, e.g., arterial blood pressure.
- Conventional vital sign monitors are used throughout the hospital, and are particularly commonplace in high-acuity areas such as the intensive care unit (ICU), emergency department (ED), or operating room (OR). Patients in these areas are generally sick and require a high degree of medical attention, typically provided by a relatively high ratio of clinicians compared to lower-acuity areas of the hospital. Outside the ICU and OR, clinicians typically measure vital signs such as systolic, diastolic, and mean arterial blood pressures (SYS, DIA, MAP), respiratory rate (RR), oxygen saturation (SpO2), heart rate (HR), and temperature (TEMP) with portable or wall-mounted vital sign monitors. It can be difficult to effectively monitor patients in this way, however, because measurements are typically made every few hours, and the patients are often ambulatory and not constrained to a single hospital room. This poses a problem for conventional vital sign monitors, which are typically heavy and unwieldy, as they are not intended for the ambulatory population. To make a measurement, a patient is typically tethered to the monitor with a series of tubes and wires. Some companies have developed ambulatory vital sign monitors with limited capabilities (e.g. cuff-based blood pressure using oscillometry and SpO2 monitoring), but typically these devices only make intermittent, rather than continuous, measurements. And even these measurements tend to work best on stationary patients, as they are easily corrupted by motion-related artifacts.
- Most vital signs monitors feature a user interface that shows numerical values and waveforms associated with the vital signs, alarm parameters, and a ‘service menu’ that can be used to calibrate and maintain the monitor. Some monitors have internal wireless cards that communicate with a hospital network, typically using protocols such as 802.11b/g.
- One of the most important parameters measured with vital signs monitors is blood pressure. In critical care environments like the ICU and OR, blood pressure can be continuously monitored with an arterial catheter inserted in the patient's radial or femoral artery. Alternatively, blood pressure can be measured intermittently with a cuff using oscillometry, or manually by a clinician using auscultation. Most vital sign monitors perform both catheter and cuff-based measurements of blood pressure. Blood pressure can also be monitored continuously with a technique called pulse transit time (PTT), defined as the transit time for a pressure pulse launched by a heartbeat in a patient's arterial system. PTT has been shown in a number of studies to correlate to SYS, DIA, and MAP. In these studies, PTT is typically measured with a conventional vital signs monitor that includes separate modules to determine both an electrocardiogram (ECG) and SpO2. During a PTT measurement, multiple electrodes typically attach to a patient's chest to determine a time-dependent ECG component characterized by a sharp spike called the ‘QRS complex’. The QRS complex indicates an initial depolarization of ventricles within the heart and, informally, marks the beginning of the heartbeat and a pressure pulse that follows.
- SpO2 is typically measured with a bandage or clothespin-shaped sensor that clips to a patient's finger and includes optical systems operating in both the red and infrared spectral regions. A photodetector measures radiation emitted from the optical systems that transmits through the patient's finger. Other body sites, e.g., the ear, forehead, and nose, can also be used in place of the finger. During a measurement, a microprocessor analyses both red and infrared radiation detected by the photodetector to determine the patient's blood oxygen saturation level and a time-dependent waveform called a photoplethysmograph (PPG). Time-dependent features of the PPG indicate both pulse rate and a volumetric absorbance change in an underlying artery caused by the propagating pressure pulse.
- Typical PTT measurements determine the time separating a maximum point on the QRS complex (indicating the peak of ventricular depolarization) and a foot of the PPG waveform (indicating the beginning the pressure pulse). PTT depends primarily on arterial compliance, the propagation distance of the pressure pulse (which is closely approximated by the patient's arm length), and blood pressure. To account for patient-dependent properties, such as arterial compliance, PTT-based measurements of blood pressure are typically ‘calibrated’ using a conventional blood pressure cuff and oscillometry. Typically during the calibration process the blood pressure cuff is applied to the patient, used to make one or more blood pressure measurements, and then left for future measurements. Going forward, the calibration measurements are used, along with a change in PTT, to measure the patient's continuous blood pressure (cNIBP). PTT typically relates inversely to blood pressure, i.e., a decrease in PTT indicates an increase in blood pressure.
- A number of issued U.S. Patents describe the relationship between PTT and blood pressure. For example, U.S. Pat. Nos. 5,316,008; 5,857,975; 5,865,755; and 5,649,543 each describe an apparatus that includes conventional sensors that measure both ECG and PPG waveforms which are then processed to determine PTT.
- To improve the safety of hospitalized patients, particularly those in lower-acuity areas, it is desirable to have a body-worn monitor that continuously measures all vital signs from a patient, provides tools for effectively monitoring the patient, and wirelessly communicates with a hospital's information technology (IT) network. Preferably the monitor operates algorithms featuring: 1) a low percentage of false positive alarms/alerts; and 2) a high percentage of true positive alarms/alerts. The term ‘alarm/alert’, as used herein, refers to an audio and/or visual alarm generated directly by a monitor worn on the patient's body, or alternatively a remote monitor (e.g., a central nursing station). To accomplish this, the invention provides a body-worn monitor that measures a patient's vital signs (e.g. cNIBP, SpO2, HR, RR, and TEMP) while simultaneously characterizing their activity state (e.g. resting, walking, convulsing, falling) and posture (upright, supine). The body-worn monitor processes this information to minimize corruption of the vital signs and associated alarms/alerts by motion-related artifacts.
- The body-worn monitor features a graphical user interface (GUI) rendered on a touchpanel display that facilitates a number of features to simplify and improve patient monitoring and safety in both the hospital and home. For example, the monitor features a battery-powered, wrist-worn transceiver that processes motion-related signals generated with an internal motion sensor (e.g. an accelerometer). When the transceiver's battery runs low, the entire unit can be swapped out by simply ‘bumping’ the original transceiver with a new one having a fully charged battery. Accelerometers within the transceivers detect the ‘bump’, digitize the corresponding signals, and wirelessly transmit them to a patient data server (PDS) within the hospital's network. There, the signals are analyzed and patient information (e.g. demographic and vital sign data) formerly associated with the original transceiver is re-associated with the new transceiver. A clinician can view the data using a computer functioning as a remote viewing device (RVD), such as a conventional computer on wheels (COW).
- The body-worn monitor additionally includes a speaker, microphone, and software that collectively facilitate voice over IP (VOIP) communication. With these features, the wrist-worn transceiver can be used as a two-way communicator allowing, e.g., the patient to alert a clinician during a time of need. Additionally, during medical procedures or diagnoses, the clinician can enunciate annotations directly into the transceiver. These annotations along with vital sign information are wirelessly transmitted to the PDS and ultimately a hospital's electronic medical records (EMR) system, where they are stored and used for post-hoc analysis of the patient. In a related application, the transceiver includes a barcode scanner that, prior to administering medications, scans barcodes associated with the patient, clinician, and medications. The transceiver sends the decoded barcode information back to the PDS, where a software program analyzes it to determine that there are no errors in the medication or the rate at which it is delivered. A signal is then sent from the PDS to the GUI, clearing the clinician to administer the medications.
- The body-worn monitor can determine a patient's location in addition to their vital signs and motion-related properties. Typically, the location-determining sensor and the wireless transceiver operate on a common wireless system, e.g. a wireless system based on 802.11a/b/g/n, 802.15.4, or cellular protocols. In this case a location is determined by processing the wireless signal with one or more algorithms known in the art. These include, for example, triangulating signals received from at least three different wireless base stations, or simply estimating a location based on signal strength and proximity to a particular base station. In still other embodiments the location sensor includes a conventional global positioning system (GPS).
- VOIP-based communications typically take place between the body-worn monitor and a remote computer or telephone interfaced to the PDS. The location sensor, wireless transceiver, and first and second voice interfaces can all operate on a common wireless system, such as one of the above-described systems based on 802.11 or cellular protocols. In embodiments, the remote computer, for example, can be a monitor that is essentially identical to the transceiver worn by the patient, and can be carried or worn by a clinician. In this case the monitor associated with the clinician features a display wherein the user can select to display information (e.g. vital signs, location, and alarms) corresponding to a particular patient. This monitor can also include a voice interface so the clinician can communicate with the patient.
- The wrist-worn transceiver's touchpanel display can render a variety of different GUIs that query the patient for their pain level, test their degree of ‘mentation’, i.e. mental activity, and perform other functions to assist and improve diagnosis. Additionally, the transceiver supports other GUIs that allow the patient to order food within the hospital, change the channel on their television, select entertainment content, play games, etc. To help promote safety in the hospital, the GUI can also render a photograph or video of the patient or, in the case of neo-natal patients, their family members.
- The body-worn monitor can include a software framework that generates alarms/alerts based on threshold values that are either preset or determined in real time. The framework additionally includes a series of ‘heuristic’ rules that take the patient's activity state and motion into account, and process the vital signs accordingly. These rules, for example, indicate that a walking patient is likely breathing and has a regular heart rate, even if their motion-corrupted vital signs suggest otherwise.
- The body-worn monitor features a series of sensors that attach to the patient to measure time-dependent PPG, ECG, ACC, oscillometric (OSC), and impedance pneumography (IP) waveforms. A microprocessor (CPU) within the monitor continuously processes these waveforms to determine the patient's vital signs, degree of motion, posture and activity level. Sensors that measure these signals typically send digitized information to the wrist-worn transceiver through a serial interface, or bus, operating on a controlled area network (CAN) protocol. The CAN bus is typically used in the automotive industry, and allows different electronic systems to effectively and robustly communicate with each other with a small number of dropped packets, even in the presence of electrically noisy environments. This is particularly advantageous for ambulatory patients that may generate signals with large amounts of motion-induced noise.
- Blood pressure is determined continuously and non-invasively using a technique, based on PTT, which does not require any source for external calibration. This technique, referred to herein as the ‘Composite Technique’, determines blood pressure using PPG, ECG, and OSC waveforms. The Composite Technique is described in detail in the co-pending patent application, the contents of which are fully incorporated herein by reference: BODY-WORN SYSTEM FOR MEASURING CONTINUOUS NON-INVASIVE BLOOD PRESSURE (CNIBP) (U.S. Ser. No. 12/650,354; filed Nov. 15, 2009). In other embodiments, PTT can be calculated from time-dependent waveforms other than the ECG and PPG, and then processed to determine blood pressure. In general, PTT can be calculated by measuring a temporal separation between features in two or more time-dependent waveforms measured from the human body. For example, PTT can be calculated from two separate PPGs measured by different optical sensors disposed on the patient's fingers, wrist, arm, chest, ear, or virtually any other location where an optical signal can be measured using a transmission or reflection-mode optical configuration. In other embodiments, PTT can be calculated using at least one time-dependent waveform measured with an acoustic sensor, typically disposed on the patient's chest. Or it can be calculated using at least one time-dependent waveform measured using a pressure sensor, typically disposed on the patient's bicep, wrist, or finger. The pressure sensor can include, for example, a pressure transducer, piezoelectric sensor, actuator, polymer material, or inflatable cuff.
- Specifically, in one aspect, the invention provides a method for monitoring a patient featuring the following steps: (a) associating a first set of vital sign information measured from the patient with a first transceiver that includes a first motion sensor; (b) storing the first set of vital sign information in a computer memory; (c) contacting the first transceiver with a second transceiver that includes a second motion sensor, the contacting causing the first motion sensor to generate a first motion signal and the second motion sensor to generate a second motion signal; (d) processing the first and second motion signals to determine that the first transceiver is to be replaced by the second transceiver; and (e) associating a second set of vital sign information with the patient, the second set of vital sign information measured with the second transceiver.
- In embodiments, both the first and second motion sensors are accelerometers that generate time-dependent waveforms (e.g. ACC waveforms). Contacting the two transceivers typically generates waveforms that include individual ‘pulses’ (e.g. a sharp spike) caused by rapid acceleration and deceleration detected by the respective accelerometers. Typically the pulses are within waveforms generated along the same axes in both transceivers. The pulses can be collectively processed (using, e.g., an autocorrelation algorithm) to determine that they are generated during a common period of time. In embodiments, amplitudes of the first and second pulses are required to exceed a pre-determined threshold value in order for the second transceiver to replace the first transceiver. Pulses that meet this criterion are wirelessly transmitted to a remote server, where they are processed as described above. If the server determines that the second transceiver is ready to replace the first transceiver, it transmits instruction information to the transceivers to guide the replacement process. This instruction information, for example, is displayed by the GUIs of both transceivers. Once the replacement process is complete, vital sign information measured by the second transceiver is stored along with that measured by the first transceiver in a computer memory (e.g. a database) on the remote computer. The vital sign information can include conventional vital signs (e.g. HR, SYS, DIA, RR, and TEMP), along with the time-dependent waveforms used to calculate the vital signs (e.g. PPG, ECG, OSC, IP) and motion-related properties (ACC). Patient demographic information (e.g. name, gender, weight, height, date of birth) can also be associated with both the first and second sets of vital sign information.
- In another aspect, the invention provides a method for pairing a patient monitor with a remote display device (e.g. an RVD) using a methodology similar to that described above. The display device is typically a portable display device (e.g. a personal digital assistant, or PDA), or a remote computer, such as a COW or central nursing station. The method includes the following steps: (a) contacting either a display device or an area proximal to the display device with the transceiver to generate a motion signal with its internal accelerometer; (b) transmitting the motion signal to a computer; (c) processing the motion signal with the computer to associate the transceiver with the display device; (d) measuring a set of vital sign information from the patient with the transceiver; and (e) displaying the set of vital sign information on the display device. Here, the act of contacting the display device with the transceiver generates a pulse in the ACC waveform, as described above. Processing done by the computer analyzes both the pulse and a location of the display device to associate it with the transceiver.
- Several methods can be used to determine the location of the display device. For example, the wireless transmitter within the transceiver is configured to operate on a wireless network, and algorithms operating on the remote computer and can analyze signals between the transceiver and wireless access points within the network (e.g. RSSI signals indicating signal strength) to determine an approximate location of the transceiver and thus the display device which it contacts. In embodiments the algorithms can involve, e.g., triangulating at least three RSSI values, or simply estimating location by determining the nearest access point from a single RSSI value. Triangulation typically involves using a map grid that includes known locations of multiple wireless access points and display devices within a region of the hospital; the map grid is determined beforehand and typically stored, e.g., in a database. For example, the approximate location of the transceiver can be determined using triangulation. Then the nearest display device, lying with a known location within a pre-determined radius, is paired with the transceiver. Typically the pre-determined radius is between 1-5m.
- In another aspect, the invention provides a body-worn monitor including first and second sensors attached to the patient, and a processing component that interfaces to both sensors and processes signals from them to calculate at least one vital sign value. A wireless transmitter receives the vital sign value and transmits it over a wireless interface, and additionally provides a two-way communications system configured to transmit and receive audio signals over the same wireless interface. In embodiments, the two-way communications system includes a speaker and a microphone, both of which are integrated into the transceiver. Typically the wireless interface is a hospital-based wireless network using an 802.11protocol (e.g. 802.11a/b/g/n). A VOIP system typically runs on the wireless network to supply two-way voice communications. Alternatively the wireless network is based on a cellular protocol, such as a GSM or CDMA protocol.
- Typically the body-worn monitor features a wrist-worn transceiver that functions as a processing component, and includes a touchpanel display configured to render both patient and clinician interfaces. The touchpanel display is typically a liquid crystal display (LCD) or organic light-emitting diode display (OLED) display with a clear touchpanel utilizing established resistive or capacitive technologies adhered to its front surface. The patient interface is typically rendered by default, and includes a graphical icon that, when initiated, activates the two-way communications system. The clinician interface typically requires a security code (entered using either a ‘soft’ numerical keypad or through a barcode scanner) to be activated. The transceiver typically includes a strap configured to wrap around the patient's arm, and most typically the wrist; this allows it to be worn like a conventional wristwatch, which is ideal for two-way communications between the patient and a clinician.
- In a related aspect, the invention provides a wrist-worn transceiver wherein the two-way communications system described above, or a version thereof, is used as a voice annotation system. Such a system receives audio signals (typically from a clinician), digitizes them, and transmits the resulting digital audio signals, or a set of parameters determined from these signals, over the wireless interface to a computer memory. The audio signals are typically used to annotate vital sign information. They can be used, for example, to indicate when a pharmaceutical compound is administered to the patient, or when the patient undergoes a specific therapy. Typically the voice annotation uses the same speaker used for the two-way communication system. It also may include a speech-to-text converter that converts audio annotations from the clinician into text fields that can be easily stored alongside the vital sign information. In embodiments, both a text field and the original audio annotation are stored in a computer memory (e.g. database), and can be edited once stored. In other embodiments, a pre-determined text field (indicating, e.g., that a specific medication is delivered at a time/date automatically determined by the transceiver) is used to annotate the vital sign information. In still other embodiments, a set of parameters determined from the digital audio signals can include an icon or a numerical value. Annotations in the database can be viewed afterwards using a GUI that renders both the vital sign information (shown, e.g., in a graphical form) and one or more of the annotations (e.g. icon, text field, numerical value, or voice annotation).
- In another aspect, the invention provides a wrist-worn transceiver featuring a GUI that the patient can use to indicate their level of pain. Here, the GUI typically includes a touchpanel display configured to render a set of input fields, with each input field in the set indicating a different level of pain. Once contacted, the input fields generate a signal that is processed to determine the patient's level of pain. This signal can be further processed and then wirelessly transmitted to a remote computer for follow-on analysis.
- In embodiments, the touchpanel display features a touch-sensitive area associated with each input field that generates a digital signal (e.g. a number) after being contacted. Each input field is typically a unique graphical icon such as a cartoon or numerical value indicating an escalating level of pain. The transceiver can also include a voice annotation system similar to that described above so the patient can specifically describe their pain (e.g. its location) using their own voice. This information can be wirelessly transmitted to a remote computer (e.g. a PDS) featuring a display device (e.g. an RVD). This system can render both vital sign information and a parameter determined from the pain signal, and can additionally include an alarming system that activates an alarm if the pain signal or a parameter calculated therefrom exceeds a pre-determined threshold.
- In a related aspect, the invention provides a wrist-worn transceiver that includes a mentation sensor configured to collect data input characterizing the patient's level of mentation (e.g. mental acuity). This information, along with traditional vital signs and the waveforms they are calculated from, is wirelessly transmitted to a remote computer for analysis. In embodiments, the mentation sensor is a touchpanel display that renders a GUI to collect information characterizing the patient's level of mentation. For example, the GUI can render a series of icons, a game, test, or any other graphical or numerical construct that can be used to evaluate mentation. In a specific embodiment, for example, the GUI includes a set of input fields associated with a numerical value. Here, the mentation ‘test’ features an algorithm to determine if the input fields are contacted by the patient in a pre-determined numerical order. Upon completion, the test results can be evaluated to generate a mentation ‘score’. In this aspect, the wrist-worn transceiver also includes a two-way communication system that receives audio information from the patient. This audio information can be used for conventional communication purposes, and can additionally be analyzed to further gauge mentation. As in previous embodiments, the mentation score can be sent with vital sign information to a PDS/RVD for follow-on analysis. These systems may include an alarming system that generates an alarm if the mentation parameter or a parameter calculated therefrom exceeds a pre-determined threshold.
- In another aspect, the invention provides a wrist-worn transceiver featuring a motion sensor (e.g. an accelerometer, mercury switch, or tilt switch) that generates a motion signal indicating the transceiver's orientation. The processing component within the transceiver processes the motion signal and, in response, orients the GUI so that it can be easily viewed in ‘rightside up’ configuration, i.e. with text rendered in a conventional manner from left to right. If the transceiver is moved (e.g., so that it is viewed by a clinician instead of a patient), the accelerometers generate new motion signals, and the GUI is ‘flipped’ accordingly. Typically, for example, the GUI is rendered in either a first orientation or a second orientation, with the two orientations separated by 180 degs., and in some cases by 90 degs. In embodiments, the first orientation corresponds to a ‘patient GUI’, and the second orientation corresponds to a ‘clinician GUI’. This allows, for example, the appropriate GUI to be automatically rendered depending on the transceiver's orientation. The clinician GUI typically includes medical parameters, such as vital signs and waveforms, whereas the patient GUI typically includes non-medical features, such as a ‘nurse call button’, time/date, and other components described in more detail below.
- In preferred embodiments, the motion sensor is a 3-axis accelerometer configured to generate a time-domain ACC waveform. During a measurement, the processing component additionally analyzes the waveform to determine parameters such as the patient's motion, posture, arm height, and degree of motion.
- In another aspect of the invention, the wrist-worn transceiver features a display device configured to render at least two GUIs, with the first GUI featuring medical content, and the second GUI featuring non-medical content relating to entertainment, food service, games, and photographs. The photograph, for example, can include an image of the patient or a relative of the patient; this latter case may be particularly useful in neo-natal hospital wards. To capture the photograph, the body-worn monitor may include a digital camera, or a wireless interface to a remote digital camera, such as that included in a portable computer or cellular telephone.
- In other embodiments, the second GUI is configured to render menus describing entertainment content, such as television (e.g. different channels or pre-recorded content), movies, music, books, and video games. In this case, the touchpanel display can be used to select the content or, in embodiments, play a specific game. The wireless transmitter within the transceiver is further configured to transmit and receive information from a remote server configured to store digital representations of these media sources. In still other embodiments, the second GUI is configured to display content relating to a food-service menu. Here, the wireless transmitter is further configured to transmit and receive information from a remote server configured to interface with a food-service system.
- In another aspect, the invention provides a system for monitoring a patient that includes a vital sign monitor configured to be worn on the patient's body, and a remote computer. The vital sign monitor features connection means (e.g. a flexible strap or belt) configured to attach a transceiver to the patient's body, and sensor with a sensing portion (e.g. electrodes and an optical sensor) that attaches to the patient to measure vital sign information. A mechanical housing included in the transceiver covers a wireless decoder, processing component, and wireless transmitter, and supports a display component. The wireless decoder (e.g. a barcode scanner or radio frequency identification (RFID) sensor) is configured to detect information describing a medication, a medication-delivery rate, a clinician, and the patient. For example, this information may be encoded in a barcode or RFID tag located on the patient, clinician, medication, or associated with an infusion pump. The processing component is configured to process: 1) the vital sign information to generate a vital sign and a time-dependent waveform; and 2) information received by the wireless decoder to generate decoded information. The wireless transmitter within the mechanical housing receives information from the processing component, and transmits it to a remote computer. In response the remote computer processes the information and transmits an information-containing packet back to the vital sign monitor.
- In embodiments, the remote computer performs an analyzing step that compares information describing both the medication and the patient to database information within a database. The database may include, for example, a list of acceptable medications and acceptable medication-delivery rates corresponding to the patient. In some cases both the vital sign information and the decoded information are collectively analyzed and compared to values in the database to affect treatment of the patient. For example, this analysis may determine that a patient with a low blood pressure should not receive medications that further lower their blood pressure. Or it may suggest changing a dosage level of the medication in order to compensate for a high heart rate value. In general, the remote computer can analyze one or more vital sign values corresponding to a patient, along with the patient's demographic information, medical history, and medications, and determine acceptable medications and medication-delivery rates based on this analysis. In response, the computer can transmit a packet back to the vital sign monitor, which renders its contents on the display. The packet can include a message confirming that a particular medication and medication-delivery rate are acceptable for the patient, and may also include a set of instructions for delivering the medication and performing other therapies.
- Still other embodiments are found in the following detailed description of the invention, and in the claims.
-
FIG. 1 is a schematic drawing showing the wrist-worn transceiver of the invention attached to a patient's wrist; -
FIG. 2A shows schematic drawings of the wrist-worn transceiver ofFIG. 1 oriented ‘rightside up’ so that a patient can view the GUI; -
FIG. 2B shows shows schematic drawings of the wrist-worn transceiver ofFIG. 1 oriented ‘upside down’ so that a clinician can view the GUI; -
FIG. 3 shows a schematic drawing of the wrist-worn transceiver ofFIG. 1 and a list of features available in both a patient GUI and a clinician GUI; -
FIG. 4 shows a schematic drawing of the body-worn monitor featuring sensors for measuring ECG, PPG, ACC, OSC, and IP waveforms, and systems for processing these to determine a patient's vital signs; -
FIG. 5 shows a schematic drawing of an IT configuration of the invention where the body-worn monitor ofFIG. 4 is connected through a wireless network to a PDS and hospital EMR; -
FIG. 6A shows schematic drawings of a new transceiver having a fully charged battery being swapped with an original transceiver having a depleted battery before deploying the ‘bump’ methodology; -
FIG. 6B shows schematic drawings of a new transceiver having a fully charged battery being swapped with an original transceiver having a depleted battery after deploying the ‘bump’ methodology; -
FIG. 7 shows a schematic drawing of transceivers undergoing the ‘bump’ methodology ofFIGS. 6A and 6B and wirelessly transmitting their ACC waveforms to the PDS for analysis; -
FIG. 8 shows screen captures from a GUI used to guide a clinician through the ‘bump’ methodology ofFIGS. 6A, 6B, and 7 ; -
FIG. 9 shows a schematic drawing of a transceiver being ‘bumped’ against a RVD in order to pair the two devices; -
FIG. 10 shows a map indicating how the transceiver and RVD ofFIG. 9 are paired to each other; -
FIG. 11 shows a schematic drawing of the wrist-worn transceiver ofFIG. 1 being used for voice annotation of a patient's vital sign data; -
FIG. 12 shows a schematic drawing of the wrist-worn transceiver ofFIG. 11 wirelessly transmitting voice annotations to the PDS for analysis; -
FIG. 13 shows screen captures from a GUI used to guide a clinician through the voice annotation methodology ofFIGS. 11 and 12 ; -
FIG. 14 shows screen captures from a GUI used when the wrist-worn transceiver functions as a two-way communicator between the patient and a clinician; -
FIG. 15 shows a screen capture from a GUI used to render a ‘pain index’ on the wrist-worn transceiver; -
FIG. 16 shows a screen capture from a GUI used to render a mentation test on the wrist-worn transceiver; -
FIG. 17 shows a screen capture from a GUI used to render a photograph of the patient on the wrist-worn transceiver; -
FIG. 18 shows a screen capture from a GUI used to render a food menu on the wrist-worn transceiver; -
FIG. 19 shows a screen capture from a GUI used to render a menu of television channels on the wrist-worn transceiver; -
FIG. 20 shows a schematic drawing of the barcode scanner in the wrist-worn transceiver scanning barcodes associated with a patient, clinician, and medication, and sending the decoded barcode information to the PDS; -
FIG. 21A shows three-dimensional images of the body-worn monitor ofFIG. 4 attached to a patient with a cuff-based pneumatic system used for a calibrating indexing measurement; -
FIG. 21B shows three-dimensional images of the body-worn monitor ofFIG. 4 attached to a patient without a cuff-based pneumatic system used for a calibrating indexing measurement -
FIG. 22A shows three-dimensional images of the wrist-worn transceiver before receiving cables from other sensors within the body-worn monitor; -
FIG. 22B shows three-dimensional images of the wrist-worn transceiver after receiving cables from other sensors within the body-worn monitor; -
FIG. 23A shows a schematic drawing of a patient wearing the body-worn monitor ofFIG. 21B and its associated sensors; -
FIG. 23B shows graphs of time-dependent ECG, PPG, OSC, ACC, and IP waveforms generated with the body-worn monitor and sensors ofFIG. 23A ; -
FIG. 24 shows screen captures from a GUI used to render vital signs and ECG, PPG, and IP waveforms on the wrist-worn transceiver; -
FIG. 25 shows a schematic drawing of the ACC, ECG, pneumatic, and auxiliary systems of the body-worn monitor communicating over the CAN protocol with the wrist-worn transceiver; -
FIG. 26 shows an alternate IT configuration of the invention where the wrist-worn transceiver ofFIG. 1 communicates with the PDS through a wireless access point connected to the Internet; -
FIG. 27 shows an alternate IT configuration of the invention where the wrist-worn transceiver ofFIG. 1 communicates with the PDS through a wireless device connected to the Internet; and -
FIG. 28 shows an alternate IT configuration of the invention where the wrist-worn transceiver ofFIG. 1 communicates with the PDS through an internal cellular modem connected to the Internet. - System Overview
-
FIG. 1 shows atransceiver 72 according to the invention that attaches to a patient'swrist 66 using aflexible strap 90. Thetransceiver 72 connects through a firstflexible cable 92 to a thumb-wornoptical sensor 94, and through a secondflexible cable 82 to an ECG circuit and a series of chest-worn electrodes (not shown in the figure). During a measurement, theoptical sensor 94 and chest-worn electrodes measure, respectively, time-dependent optical waveforms (e.g. PPG) and electrical waveforms (e.g. ECG and IP), which are processed as described below to determine vital signs and other physiological parameters such as cNIBP, SpO2, HR, RR, TEMP, pulse rate (PR), and cardiac output (CO). Once measured, thetransceiver 72 wirelessly transmits these and other information to a remote PDS and RVD. Thetransceiver 72 includes a touchpanel display that renders aGUI 50 which, in turn, displays the vital signs, physiological parameters, and a variety of other features described in detail below. Collectively, thetransceiver 72 andGUI 50 incorporate many features that are normally reserved for non-medical applications into a body-worn vital sign monitor that continuously monitors ambulatory patients as they move throughout the hospital. - The
transceiver 72 includes an embedded accelerometer that senses its motion and position, and in response can affect properties of the GUI. Referring toFIGS. 2A and 2B , for example, time-resolved ACC waveforms from the accelerometer can be processed with a microprocessor within the transceiver to detect orientation of the touchpanel display. This information can then be analyzed to determine if it is the clinician or patient who is viewing the display. In response, the GUI can ‘flip’ so that it is properly oriented (i.e. ‘rightside up’, as opposed to being upside down) for the viewer. For example, as shown inFIG. 2A , when thetransceiver 72 is worn on the patient'sright wrist 66 the internal accelerometer generates ACC waveforms that are processed by the microprocessor to determine this orientation. TheGUI 50A is adjusted according so that it is always oriented with numbers and text arranged rightside up and read from left to right. When the patient's arm is rotated, as shown inFIG. 2B , the ACC waveforms change accordingly because the accelerometer's axes are swapped with respect to gravity. Such a situation would occur, for example, if a clinician were to orient the patient's arm in order read the transceiver's display. In this case, the ACC waveforms are processed to determine the new orientation, and theGUI 50B is flipped so it is again rightside up, and can be easily read by the clinician. - The internal accelerometer can also detect if the transceiver is ‘bumped’ by an external object. In this case, the ACC waveform will feature a sharp ‘spike’ generated by rapid acceleration and deceleration caused by the bumping process. As described in detail below, such a bumping process can serve as a fiducial marker that initiates a specific event related to the transceiver, such as a battery swap or process that involves pairing the transceiver to an external wireless system or display.
- The accelerometer within the transceiver, when combined with other accelerometers within the body-worn monitor, can also be used to determine the patient's posture, activity level, arm height and degree of motion, as described in detail below. Use of one or more accelerometers to detect such motion-related activities is described, for example, in the following patent applications, the contents of which are incorporated herein by reference: BODY-WORN MONITOR FEATURING ALARM SYSTEM THAT PROCESSES A PATIENT'S MOTION AND VITAL SIGNS (U.S. Ser. No. 12/469,182; filed May 20, 2009) and BODY-WORN VITAL SIGN MONITOR WITH SYSTEM FOR DETECTING AND ANALYZING MOTION (U.S. Ser. No. 12/469,094; filed May 20, 2009).
- Referring to
FIG. 3 , in addition to theGUI 50, thetransceiver 72 includes a high-fidelity speaker 120, amicrophone 101, and abarcode scanner 102 which, respectively, enunciates audible information, measures voice signals from both the patient and a clinician, and scans graphical barcodes to decode numerical information describing the patient and their medication. Signals from these and other components are processed to supply information to either a ‘patient GUI’ 52 or a ‘clinician GUI’ 54. Thepatient GUI 52, for example, typically includes features that are decoupled from a standard clinical diagnosis; these include a nurse call button, voice communications, a ‘pain’ index, a mentation test to estimate the patient's cognitive abilities, meal ordering within the hospital, games, and a controller for entertainment content, e.g. to adjust parameters (e.g. channels, volume) for a standard television set. Theclinical GUI 54, in comparison, includes features that are used for clinical diagnoses and for operating the transceiver in a hospital environment. The primary features of thisGUI 54 include displaying vital signs (e.g. cNIBP, SpO2, HR, RR, TEMP), other medical parameters (e.g. PR, CO), and waveforms (PPG, ECG, IP). Secondary features of the clinical GUI include voice communications, battery-change and pairing operations using the above-described ‘bump’ methodology, voice annotation of medical records and diagnoses, a method for checking medications using thebarcode scanner 102, and display of a photograph or video describing the patient. - During normal operation, the GUI renders 50 simple icons indicating that the transceiver is powered on and operational (e.g., a ‘beating heart’), the strength of the wireless signal (e.g. a series of bars with escalating height), and the battery level (e.g. a cartoon of a battery with a charge-dependent gauge). The
transceiver 72 displays these icons until the touchpanel display is contacted by either the patient or a clinician. This process yields thepatient GUI 52, which features alarge icon 57 showing a telephone (which is used for nurse call applications, as described below), and asmaller icon 53 showing a lock which, when tapped, enables the clinician to ‘unlock’ the transceiver and utilize theclinician interface 54. Thetransceiver 72 immediately renders a GUI that shows vital signs and waveform information if the patient's physiological condition requires immediate medical attention, e.g. in the case of cardiac arrest. - The
clinician interface 54 is password-protected to prevent the patient or any other non-clinician from viewing important and potentially confusing medical information. A password can either be entered as a standard personal identification number (PIN) by tapping keys on a numerical keypad (as shown inFIG. 3 ), or by simply swiping a barcode printed on the clinician's hospital badge across thebarcode scanner 102. The microprocessor within the transceiver unlocks the clinician interface following either of these events, and enables all the features associated with the interface, which are described in detail below. For example, with this interface the clinician can view vital signs and waveforms to make a medical diagnosis, as described with reference toFIG. 24 . If the transceiver's battery charge is running low, the clinician can swap in a new transceiver and transfer data from the original transceiver simply by ‘bumping’ the two transceivers together, as described with reference toFIGS. 6-8 . Medical records can be voice-annotated and stored on the PDS or a hospital's EMR using the process shown inFIGS. 11-13 . The patient's medication can be checked by scanning and processing information encoded in barcodes associated with the patient, clinician, and medication, as shown inFIG. 20 . All of this functionality is programmed within the transceiver and the body-worn monitor, and can be accomplished without tethering the patient to a conventional vital sign monitor typically mounted on a wall in the hospital or a rolling stand. Ultimately this allows the patient to wear a single body-worn monitor as they transition throughout the various facilities within the hospital, e.g. the ED, ICU, x-ray facility, and operating room. - Hardware in Body-Worn Monitor
-
FIGS. 4 and 5 show schematic drawings of a body-wornmonitor 100 used to measure vital signs from a patient and render the different GUIs described above (FIG. 4 ), along with a wireless system over which thetransceiver 72 sends information through ahospital network 60 to either a remote RVD, e.g. acomputer 62 or hand-held device 64 (FIG. 5 ). Referring toFIG. 4 , the body-wornmonitor 100 features a wrist-worntransceiver 72 that continuously determines vital signs and motion-related properties from an ambulatory patient in a hospital. Themonitor 100 is small, lightweight, and comfortably worn on the patient's body during their stay in the hospital; its specific form factor is described in detail below with reference toFIGS. 21 and 22 . It provides continuous monitoring, and features a software framework that determines alarms/alerts if the patient begins to decompensate. Such systems are described in the following co-pending patent applications, the contents of which have been previously incorporated herein by reference: BODY-WORN MONITOR FEATURING ALARM SYSTEM THAT PROCESSES A PATIENT'S MOTION AND VITAL SIGNS (U.S. Ser. No. 12/469,182; filed May 20, 2009) and BODY-WORN VITAL SIGN MONITOR WITH SYSTEM FOR DETECTING AND ANALYZING MOTION (U.S. Ser. No. 12/469,094; filed May 20, 2009). The framework processes both the patient's motion and their vital sign information with algorithms that reduce the occurrence of false alarms. - A combination of features makes the body-worn
monitor 100 ideal for ambulatory patients within the hospital. For example, as shown inFIG. 5 , thetransceiver 72 features awireless transmitter 224 that communicates through a collection of wireless access points 56 (e.g. routers based on 802.11 protocols) within ahospital network 60, which includes a PDS. From thePDS 60 data are sent to an RVD (e.g. a portable tablet computer 62) located at a central nursing station, or to a local computer (e.g. a hand-held PDA 64) carried by the clinician. In embodiments, data can be sent to thePDA 64 through a peer-to-peer wireless connection. The specific mode of communication can be determined automatically (using, e.g., a signal strength associated with the wireless connection), or manually through an icon on the GUI. - The
transceiver 72 features aCPU 222 that communicates through a digital CAN interface, or bus, to externalsystems featuring ECG 216,external accelerometers 215 b-c, pneumatic 220, and auxiliary 245 sensors. Eachsensor 215 b-c, 216, 220, 245 is ‘distributed’ on the patient to minimize the bulk and weight normally associated with conventional vital sign monitors, which typically incorporate all electronics associated with measuring vital signs in a single plastic box. Moreover, each of thesesensors 215 b-c, 216, 220, 245 generate digital signals close to where they actually attach to the patient, as opposed to generating an analog signal and sending it through a relatively long cable to a central unit for processing. This can reduce noise due to cable motion which is often mapped onto analog signals.Cables remote ECG system 216,accelerometers 215 b-c, pneumatic 220, andauxiliary systems 245; provide high/low signal transmission lines for data transmitted over the CAN protocol; and provide a grounded electrical shield for each of these four wires. There are several advantages to this approach. First, a single pair of transmission lines in the cable (i.e. the high/low signal transmission lines) can transmit multiple digital waveforms generated by completely different sensors. This includes multiple ECG waveforms (corresponding, e.g., to vectors associated with three, five, and twelve-lead ECG systems) from the ECG circuit, along with ACC waveforms associated with the x, y, and z axes of accelerometers within the body-wornmonitor 100. The same two wires, for example, can transmit up to twelve ECG waveforms (measured by a twelve-lead ECG system), and six ACC waveforms (measured by theaccelerometers 215 b-c). Limiting the transmission line to a pair of conductors reduces the number of wires attached to the patient, thereby decreasing the weight and any cable-related clutter. Second, cable motion induced by an ambulatory patient can change the electrical properties (e.g. electrical impendence) of its internal wires. This, in turn, can add noise to an analog signal and ultimately the vital sign calculated from it. A digital signal, in contrast, is relatively immune to such motion-induced artifacts. - The
ECG 216, pneumatic 220, and auxiliary 245 systems are stand-alone systems that each includes a separate CPU, analog-to-digital converter, and CAN transceiver. During a measurement, they connect to thetransceiver 72 throughcables connectors ECG system 216, for example, is completely embedded in a terminal portion of its associated cable. Systems for three, five, and twelve-lead ECG monitoring can be swapped in an out simply by plugging the appropriate cable (which includes the ECG system 216) into aCAN connector 230 on the wrist-worntransceiver 72, and the attaching associated electrodes to the patient's body. - As described above, the
transceiver 72 renders separate GUIs that can be selected for either the patient or a clinician. To do this, it includes abarcode scanner 242 that can scan a barcode printed, e.g., on the clinician's badge. In response it renders a GUI featuring information (e.g. vital signs, waveforms) tailored for a clinician that may not be suitable to the patient. So that the patient can communicate with the clinician, thetransceiver 72 includes aspeaker 241 andmicrophone 237 interfaced to theCPU 222 andwireless system 224. These components allow the patient to communicate with a remote clinician using a standard VOIP protocol. A rechargeable Li:ion battery 239 powers thetransceiver 72 for about four days on a single charge. When the battery charge runs low, theentire transceiver 72 is replaced using the ‘bump’ technique described in detail below. - Three separate
digital accelerometers 215 a-c are non-obtrusively integrated into the monitor's form factor; two of them 215 b-c are located on the patient's body, separate from the wrist-worntransceiver 72, and send digitized, motion-related information through the CAN bus to theCPU 222. Thefirst accelerometer 215 a is mounted on a circuit board within thetransceiver 72, and monitors motion of the patient's wrist. Thesecond accelerometer 215 b is incorporated directly into thecable 240 connecting theECG system 216 to thetransceiver 72 so that it can easily attach to the patient's bicep and measure motion and position of the patient's upper arm. As described below, this can be used to orient the screen for viewing by either the patient or clinician. Additionally, signals from the accelerometers can be processed to compensate for hydrostatic forces associated with changes in the patient's arm height that affect the monitor's cNIBP measurement, and can be additionally used to calibrate the monitor's blood pressure measurement through the patient's ‘natural’ motion. Thethird accelerometer 215 c is typically mounted to a circuit board that supports theECG system 216 on the terminal end of the cable, and typically attaches to the patient's chest. Motion and position of the patient's chest can be used to determine their posture and activity states, which as described below can be used with vital signs for generating alarm/alerts. Eachaccelerometer 215 a-c measures three unique ACC waveforms, each corresponding to a separate axis (x, y, or z) representing a different component of the patient's motion. To determine posture, arm height, activity level, and degree of motion, the transceiver'sCPU 222 processes signals from eachaccelerometer 215 a-c with a series of algorithms, described in the following pending patent applications, the contents of which have been previously incorporated herein by reference: BODY-WORN MONITOR FEATURING ALARM SYSTEM THAT PROCESSES A PATIENT'S MOTION AND VITAL SIGNS (U.S. Ser. No. 12/469,182; filed May 20, 2009) and BODY-WORN VITAL SIGN MONITOR WITH SYSTEM FOR DETECTING AND ANALYZING MOTION (U.S. Ser. No. 12/469,094; filed May 20, 2009). In total, theCPU 222 can process nine unique, time-dependent signals corresponding to the three axes measured by the three separate accelerometers. Algorithms determine parameters such as the patient's posture (e.g., sitting, standing, walking, resting, convulsing, falling), the degree of motion, the specific orientation of the patient's arm and how this affects vital signs (particularly cNIBP), and whether or not time-dependent signals measured by theECG 216, optical 218, or pneumatic 220 systems are corrupted by motion. - To determine blood pressure, the
transceiver 72 processes ECG and PPG waveforms using a measurement called with Composite Technique, which is described in the following patent application, the contents of which have been previously incorporated herein by reference: BODY-WORN SYSTEM FOR MEASURING CONTINUOUS NON-INVASIVE BLOOD PRESSURE (cNIBP) (U.S. Ser. No. 12/650,354; filed Nov. 15, 2009). The Composite Technique measures ECG and PPG waveforms with, respectively, theECG 216 and optical 218 systems. Theoptical system 218 features a thumb-worn sensor that includes LEDs operating in the red (λ˜660 nm) and infrared (λ˜900 nm) spectral regions, and a photodetector that detects their radiation after it passes through arteries within the patient's thumb. The ECG waveform, as described above, is digitized and sent over the CAN interface to the wrist-worntransceiver 72, while the PPG waveform is transmitted in an analog form and digitized by an analog-to-digital converter within the transceiver's circuit board. Thepneumatic system 220 provides a digitized pressure waveform and oscillometric blood pressure measurements through the CAN interface; these are processed by theCPU 222 to make cuff-based ‘indexing’ blood pressure measurements according to the Composite Technique. The indexing measurement typically only takes about 40-60 seconds, after which thepneumatic system 220 is unplugged from itsconnector 228 so that the patient can move within the hospital without wearing an uncomfortable cuff-based system. The optical waveforms measured with the red and infrared wavelengths can additionally be processed to determine SpO2 values, as described in detail in the following patent application, the contents of which is incorporated herein by reference: BODY-WORN PULSE OXIMETER (U.S. Ser. No. 12/559,379; filed Sep. 14, 2009). - Collectively, these
systems 215 a-c, 216, 218, and 220 continuously measure the patient's vital signs and motion, and supply information to the software framework that calculates alarms/alerts. Athird connector 232 also supports the CAN bus and is used for auxiliary medical devices 245 (e.g. a glucometer, infusion pump, system for measuring end-tidal CO2) that is either worn by the patient or present in their hospital room. - Once a measurement is complete, the
transceiver 72 uses theinternal wireless transmitter 224 to send information in a series of packets to aPDS 60 within the hospital. Thewireless transmitter 224 typically operates on a protocol based on 802.11, and can communicate with thePDS 60 through an existing network within the hospital as described above with reference toFIG. 5 . Information transmitted by the transceiver alerts the clinician if the patient begins to decompensate. ThePDS 60 typically generates this alarm/alert once it receives the patient's vital signs, motion parameters, ECG, PPG, and ACC waveforms, and information describing their posture, and compares these parameters to preprogrammed threshold values. As described in detail below, this information, particularly vital signs and motion parameters, is closely coupled together. Alarm conditions corresponding to mobile and stationary patients are typically different, as motion can corrupt the accuracy of vital signs (e.g., by adding noise), and induce artificial changes in them (e.g., through acceleration of the patient's heart and respiratory rates) that may not be representative of the patient's actual physiology. - Swapping and Pairing Transceivers Using ‘Bump’ Methodology
-
FIGS. 6A, 6B, 7, and 8 show how a wrist-worntransceiver 72A with a depleted battery can be swapped with asimilar transceiver 72B having a fully charged battery using the ‘bump’ methodology described above. Prior to the swap, as shown inFIG. 6A , both transceivers are readied by activating theappropriate GUI FIG. 8 . This process activates firmware on eachtransceiver wireless access point 56 and to the hospital network andPDS 60. The packet describes a transceiver-specific address, e.g. a MAC address associated with its wireless transmitter. Once this is done, theGUIs transceivers - At this point, as shown in
FIG. 6A , thenew transceiver 72B (with the fully charged battery) is then bumped against theold transceiver 72A (with the depleted battery). Internal accelerometers within bothtransceivers 72A, B detect the bumping process and, in response, independently generateACC waveforms ACC waveforms wireless access point 56 to thePDS 60, where they are stored in a computer memory and analyzed with a software program that is activated when both devices are ‘readied’, as described above. The software program compares formatted versions of theACC waveforms 130′, 132′ to detect the rapid spikes, as shown by thegraph 140 inFIG. 7 . The rapid spikes in thewaveforms 130′, 132′ should occur within a few microseconds of each other, as indicated by the shadedwindow 142 in thegraph 140. Other transceivers operating on the network may generate similar motion-related spikes due to movements of the patient wearing them, but the probability that such spikes occur at the exact same time as the transceivers being swapped is extremely low. The software program interprets the concurrence of the spikes as indicating that data stored on theold transceiver 72A is to be transferred to thenew transceiver 72B. The data, for example, includes demographic information describing the patient (e.g. their name, age, height, weight, photograph), the medications they are taking, and all the vital sign and waveform information stored in memory in theold transceiver 72A. Following the bump, this information is associated with the address corresponding to thenew transceiver 72B. At this time information may also be sent from the PDS so it can be stored locally on the new transceiver. When all the relevant information is transferred over, theGUIs transceivers old transceiver 72A, and plugged into thenew transceiver 72B. The clinician then attaches the new transceiver to the patient's wrist, and commences measuring vital signs from the patient as described above. - In other embodiments, a time period corresponding to a portion (e.g. a peak value) of the motion-generated spike is determined on each of the wrist-worn transceivers that are bumped together. Each transceiver then sends its time period to the PDS, where they are collectively analyzed to determine if they are sufficiently close in value (e.g. within a few hundred milliseconds). If this criterion is met, software on the PDS assumes that the transceivers are ready to be swapped, and performs the above-described steps to complete this process.
-
FIG. 8 shows a sequence of screens within the GUI that describe the process for swapping transceivers to the clinician. The process begins when ascreen 158 rendered by Device A indicates that its battery is running low of charge. This is indicated by a standard low battery' icon located in the upper right-hand corner of thescreen 158, as well as a larger icon located near the bottom of the screen. A time describing the remaining life of the battery appears near this icon when this time is 5 minutes or less. Each transceiver includes a sealed internal Li:ion battery that cannot be easily replaced in the hospital. Instead, the transceiver is inserted in a battery charger that typically includes eight or sixteen ports, each of which charges a separate transceiver. To swap Device A with Device B, the clinician taps thescreen 158 to yield anew screen 160 which includes a series of six icons, each related to a unique feature. The icon in the lower left-hand corner shows two interchanging batteries. When tapped, this icon yields anew screen 160 indicating that Device A is ready to be swapped. Device B is then removed from a port in the battery charger, and a sequence ofscreens - When Devices A and B both show, respectively, screens 162, 154, they are ready to be swapped using the ‘bumping’ process. At this point, as described above, a clinician ‘bumps’ Device B into Device A, which in turn generates two
ACC waveforms waveforms box 142, which are concurrent in time, and are wirelessly transmitted in a packet that indicates their origin through the pathway shown inFIG. 7 to the PDS. There, they are analyzed by the software program described above to determine that data associated with Device A (e.g. patient information, vital signs) is now associated with Device B. When this association is complete, the PDS transmits a packet back through the pathway shown inFIG. 7 to both Device A and B, indicating that the PDS is ready to transfer the data. Device B then renders ascreen 166 asking the clinician to confirm the process. Data is transferred if the clinician taps the ‘check’ box in the lower right-hand corner of the screen; during this process Device B renders ascreen 168 that shows the patient's name to further confirm with the clinician that the transfer process is valid. When it is complete, Device A is no longer active, meaning it cannot collect data or generate alarms. Device B renders ascreen 170 that instructs the clinician to disconnect the optical and electrical sensors from Device A, and to clean this device and insert it into the battery charger. During this process all alarms are paused for Device B. Ascreen 172 on Device B then instructs the clinician to connect the sensors and attach Device B to the patient's wrist. When this is complete, Device B renders a finalconfirmatory screen 176, which when checked finalizes the swapping process. At this point Device B is officially associated with the patient, renders astandard screen 178, and commences measuring vital signs from the patient. These vital signs, along with those collected from Device A, are included in a contiguous data file characterizing the patient. - As an alternative to the ‘bumping’ process, Device B's barcode can be read and processed to facilitate swapping the transceivers. In this case, an icon on Device A, when tapped, renders a
screen 164 indicating that Device A is ready to read the barcode printed on Device B. At this point, Device B's barcode is swiped across Device A's barcode reader, decoded, and wirelessly transmitted to the PDS as indicated inFIG. 7 . The PDS uses this information to associate Device B with the patient as described above. Once this is complete, Device B uses the same screens used for the ‘bumping’ transfer process (screens FIG. 6 takes place along the long axes of Device A and Device B. Alternatively, it can take place along the short axes of these devices. Or the short axis of one device can be bumped against the long axis of the other device to initiate the process. - The ‘bumping’ process described above can also be used for other applications relating to the wrist-worn transceiver. It can be used, for example, to pair the transceiver with an RVD, such as a display located at the patient's bedside, or at a central nursing station. In this embodiment, indicated in
FIGS. 9 and 10 , a clinician selects atransceiver 72 from the battery charger and brings it near anRVD 62. Before attaching thetransceiver 72 to the patient, the clinician ‘bumps’ it against a hard surface proximal to the RVD 62 (or against the RVD itself) to generate a sharp spike in theACC waveform 133. Thewaveform 133 is similar in shape to that generated when two transceivers are swapped with the bumping process, as described above. The RVD's location needs to be determined in order to pair it with thetransceiver 72. To do this, at a pre-determined time period (e.g. every few minutes) all neighboringwireless access points transceiver 72 and therespective access point ACC waveform 133 and an identifying code describing the transceiver (not shown in the figure) through asingle access point 56B to thePDS 60. ThePDS 60 receives the location packet 56D and parses it to arrive at RSSI values for the threewireless access points transceiver 72. In other embodiments, theindividual access points - Referring to
FIG. 10 , location-determining software operating on the PDS triangulates the signals, along with known locations of eachwireless access point transceiver 72. The known locations of the access points are stored within amap grid 73 in a computer memory associated with the location-determining software. The transceiver's approximate location typically has an accuracy of 1-3 m. Using themap grid 73, the software then processes the approximate location 71 and a known location of anyRVD 62 lying within apre-determined radius 75. Typically the pre-determined radius is 3-5 m. If the location of theRVD 62 lies within thepre-determined radius 75, theRVD 62 is automatically ‘paired’ with thetransceiver 72. Once paired, theRVD 62 then displays any follow-on waveform, motion, and vital sign information sent by the transceiver. - In related embodiments, the location-determining software described above uses triangulation algorithms to determine the patient's current and historical location. Such a process can be used to monitor and locate a patient in distress, and is described, for example, in the following issued patent, the contents of which are incorporated herein by reference: WIRELESS, INTERNET-BASED, MEDICAL DIAGNOSTIC SYSTEM (U.S. Pat. No. 7,396,330). If triangulation is not possible, the location-determining software may simply use proximity to a wireless access point (as determined from the strength of an RSSI value) to estimate the patient's location. Such a situation would occur if signals from at least three wireless access points were not available. In this case, the location of the patient is estimated with an accuracy of about 5-10 m. In embodiments, the RVD may be a central nursing station that displays vital sign, motion-related properties (e.g. posture and activity level) and location information from a group of patients. Such embodiments are described in the following co-pending patent application, the contents of which are fully incorporated herein by reference: BODY-WORN VITAL SIGN MONITOR (U.S. Ser. No. 12/560,077, filed Sep. 15, 2009). In other embodiments, the location-determining software determines the location of a patient-worn transceiver, and automatically pairs it to a RVD located nearby (e.g. within a pre-determined radius, such as that shown in
FIG. 10 ). In this way, the patient's information can be displayed on different RVDs as they roam throughout the hospital. - In embodiments, the patient's location can be analyzed relative to a set of pre-determined boundaries (e.g. a ‘geofence’) to determine if they have wandered into a restricted area. Or their speed can be determined from their time-dependent location, and then analyzed relative to a pre-determined parameter to determine if they are walking too fast. In general, any combination of location, motion-related properties, vital signs, and waveforms can be collectively analyzed with software operating on either the transceiver or PDS to monitor the patient. Patients can be monitored, for example, in a hospital, medical clinic, outpatient facility, or the patient's home.
- In the embodiments described above, location of the transceiver can be determined using off-the-shelf software packages that operate on the PDS. Companies that provide such software include, for example, by Cisco Systems (170 West Tasman Drive, San Jose, Calif. 93134; www.cisco.com), Ekahau (12930 Saratoga Avenue, Suite B-8, Saratoga, Calif. 95070; www.ekahau.com), and others.
- In still other embodiments, software operating on the transceiver puts it into a ‘sleep mode’ when it is not attached to the patient. This way the transceiver can determine and transmit a location packet even when it is not used for patient monitoring. Using the above-described location-determining software, this allows the transceiver's location to be determined and then analyzed if it has been lost, misplaced, or stolen. For example, the transceiver's serial number can be entered into the software and then used to send a ‘ping’ the transceiver. The transceiver responds to the ping by collecting and transmitting a location packet as described above. Or the location of all unused transceivers can be automatically rendered on a separate interface. In still other embodiments, the location-determining software can transmit a packet to a specific transceiver (e.g. one that is stolen) to disable it from operating further.
- In other embodiments, the ‘bumping’ process described above can be used for a variety of applications involving the body-worn monitor, wrist-worn transceiver, PDS, and RVD. In embodiments, for example, one or more ‘bumps’ of a transceiver can modulate the ACC waveform, which is then processed and analyzed to initiate a specific application. Applications include turning the transceiver on/off; attaching sensors to the transceiver; pairing the transceiver with a hand-held device (e.g. a cellular phone or personal digital assistant) over a peer-to-peer connection (using, e.g., 802.11 or 802.15.4); pairing the transceiver with a printer connected to a hospital network to print data stored in its computer memory; associating the transceiver with a specific clinician; and initiating display of a particular GUI. In general, the ‘bumping’ process can be used to initiate any application that can also be initiated with icons on the GUI.
- Annotating the Medical Record Using the Wrist-Worn Transceiver
-
FIGS. 11-13 show how the wrist-worn transceiver can be used to communicate audible information from both the patient and a clinician. Audible information from theclinician 140 can be used, for example, to annotate vital sign information collected with the body-worn monitor. Audible information from thepatient 141 can be transmitted to a clinician (e.g. a nurse working at a central station) to alert the clinician of a problem. In both applications, thetransceiver 72 is attached to the patient'swrist 66 as described above and used to measure vital signs and waveform information. Audible information is received by amicrophone 101 mounted on a circuit board within the transceiver. Aspeaker 120 mounted to the same circuit board enunciates voice information to the patient. In these and other voice-related applications, voice information is digitized by an internal analog-to-digital converter within the transceiver, and then wirelessly transmitted through a hospital's wireless network using conventional VOIP protocols. Systems that operate these protocols are marketed, for example, by Cisco Systems (170 West Tasman Drive, San Jose, Calif. 93134; www.cisco.com), Skype (22/24 Boulevard Royal, 6e etage, L-2449, Luxembourg; www.skype.com), and others. -
FIG. 12 describes the annotation process in more detail. In this case, thetransceiver 72 within the body-worn monitor is attached to the patient'swrist 66 to measure the patient's vital signs (e.g. blood pressure). During the measurement process, the clinician uses theGUI 50F to activate an ‘annotation’ function which enables the transceiver to receiveaudible signals 140 which are used, for example, to annotate different medications administered to the patient. After the annotation function is activated, the clinician orally describes the medications. Themicrophone 101 within thetransceiver 72 detects the voice signals, digitizes them with associated hardware, and then sends them and an associated time/date sample using a VOIP protocol through anaccess point 56 and to a PDS located within thehospital network 60. Vital signs are transmitted before and after the annotation function is activated, and are stored along with the annotation in a computer memory associated with the PDS. Typically these data are stored within a hospital's EMR. - As shown in
graph 141, annotated vital sign data can be viewed afterwards to determine, for example, how a patient responds to specific medications. In this case, administration of a beta blocker as a means of lowering the patient's blood pressure is recorded on the graph by a written description of the annotation, along with an icon (a black triangle) indicating when it occurred in time. To generate the written description the PDS requires software that performs a speech-to-text conversion. Such software is available, for example, from Nuance Systems (1 Wayside Road, Burlington, Mass. 01803; www.nuance.com). Similarly, thegraph 141 shows a second annotation indicating that the patient was hydrated with saline to increase their blood pressure. -
FIG. 13 shows a series of screens within theGUI 50F that are used to control the annotation process. As described above, to annotate medical information the clinician taps an icon located in the upper right-hand portion ofscreen 180. This action readies the voice recording features within the transceiver. Tapping the annotation icon drives the transceiver to render asecond screen 182 that includes the type of annotation, e.g. audible content relating to medication, a specific intervention or procedure, a medical assessment, or another subject. Typically annotations are delivered as audible speech, in which case the ‘Speech’ button is tapped, as shown inscreen 184. Alternatively the annotation can be text or numerical; these can be typed in, e.g., using a ‘soft’ keyboard on the transceiver, or scanned in using the transceiver's barcode scanner. The annotations can also be associated with an alarm condition, such as those shown onscreens screen 188 that, once tapped, initiates the recording. The recording can also be paused usingscreen 186. After it is complete, the clinician taps the ‘checkbox’ on thescreen 188, thus saving the recording. It is then sent to the PDS as shown inFIG. 12 , and used to annotate the patient's medical information. - Other forms of annotation are also possible with the transceiver. For example, it can include a small CCD camera that allows images of the patient or their body (e.g. a wound) to be captured and used to annotate the medical information. In other applications, a barcode printed on medication administered to the patient can be scanned by the transceiver's barcode scanner, and the information encoded therein can be used to annotate vital sign information. In other embodiments, the transceiver can integrate with other equipment in the hospital room (e.g. an infusion pump, ventilator, or patient-controlled anesthesia pump) through a wired or wireless connection, and information from this equipment can be collected and transmitted to the PDS in order to annotate the vital sign information. In other embodiments, text annotations can be stored on the PDS, and then edited afterwards by the clinician.
- Other GUI Applications
- As shown in
FIGS. 11 and 14 , thespeaker 120 andmicrophone 101 within thetransceiver 72, combined with VOIP software operating on the hospital network, can also function as a nurse call system that communicates both distress signals and voice information. Here, the transceiver enables two-way communication between the patient and a remote clinician. During this application, the transceiver typically operates the ‘patient GUI’, shown schematically inFIG. 3 and in more detail inFIG. 14 . Here, the GUI shows asingle screen 192 that indicates a nurse call function with an icon showing a telephone. When the patient taps on the telephone the transceiver initiates a call to a pre-programmed IP address, corresponding, e.g., to a computer at a central nursing station or a VOIP-enabled phone. Alternatively the transceiver can call a pre-programmed phone number corresponding to a telephone. While the call is being place the GUI renders ascreen 194 that shows the telephone's receiver being off the hook. Athird screen 196 indicates that the patient is connected to the clinician. The call is terminated when the patient finishes talking to the clinician and taps the screen. Alternatively, the transceiver can include software that detects that no further voice communications are taking place, and then uses this information to terminate the call. In embodiments, the entire call can be stored in a computer memory on either the transceiver or the PDS. - The GUI operating on the wrist-worn transceiver's touchpanel display can render several other interfaces that facilitate patient monitoring in the hospital. For example, referring to
FIG. 15 , the GUI can be used to monitor the patient's pain level, a parameter often considered by clinicians to be as important as vital signs for characterizing a patient. TheGUI 200 shown in the figure features a simple series of icons that provide a relative indication of the patient's pain level. An index value of 0 (corresponding to a ‘happy’ face) indicates a low level of pain; an index value of 10 (corresponding to a ‘sad’ face) indicates a high level of pain. During a measurement, the patient simply touches the icon that best characterizes their pain level. The numerical value corresponding to this level is then wirelessly transmitted back to the PDS and stored in the patient's EMR. The GUI, for example, may be automatically rendered periodically (e.g. every hour) on the transceiver to continuously monitor the patient's pain level. In other embodiments, the GUI could render a graphical display that provides a more sophisticated metric for determining the patient's pain, such as the McGill Pain Questionnaire. This system described in the following journal article, the contents of which are incorporated herein by reference: ‘The McGill Pain Questionnaire: Major Properties and Scoring Methods’, Melzak, Pain, 1:277-299 (1975). - In a similar manner, the GUI can be used to gauge the patient's level of mentation, i.e. mental activity. Mentation has been consistently shown to be a valuable tool for diagnosing a patient, but is typically determined empirically by a clinician during a check-up or hospital visit. Such a diagnosis is somewhat arbitrary and requires the clinician to meet face-to-face with the patient, which is often impractical. But with the wrist-worn transceiver, diagnosis of mentation can be made automatically at the patient's bedside without a clinician needing to be present.
FIG. 16 , for example, shows aGUI 202 that provides a simple ‘mentation test’ for the patient to complete. In this case, the mentation test involves a graphical representation of a series of non-sequential numbers. The patient completes this test by tapping on the numbers rendered by the touchpanel display in their numerical order. An algorithm then ‘scores’ the test based on accuracy and the time required to complete it. Once determined, the score is wirelessly transmitted back to the PDS, and then stored in the patient's EMR. Other simple tests with varying complexity can be used in place of that shown inFIG. 16 . The tests can vary depending on the specific mentation function to be tested. For example, unique tests can be generated for patients with head injuries, cardiac patients, patients in severe pain, Alzheimer's patients, etc. In all cases, the tests are designed to make a quantitative assessment of the patient's mental status; the transceiver sends a numerical value representing this parameter and an identifier for the test back to the EMR for analysis. The transceiver can be programmed so that theGUI 202 for the mentation test, like theGUI 200 for pain level shown inFIG. 15 , is automatically rendered at basically any time interval on the touchpanel display. This time interval can be periodic and on an hourly basis, once/day, etc. - As shown in
FIG. 17 , the transceiver can include aGUI 204 that displays a photograph or video of the patient. The photograph could be taken by a digital camera within the transceiver, or with an external camera and then transferred to the transceiver through a variety of means, e.g. the hospital's wireless network, a peer-to-peer wireless connection, using a non-volatile memory such as an SD card, or even using a data-transfer process initiated by the ‘bump’ methodology described above. In general, the same means used to port a photograph from a standard digital camera to a personal computer or other device can be used in this application. Once the photograph is received, software on the transceiver displays it in either a default screen (e.g., in place of the ‘beating heart’ shown inFIGS. 1 and 3 ), or when theGUI 204 is activated through a tap of a corresponding icon. Displaying the patient's photograph in this manner provides a visual indicator which the clinician can use to correctly identify the patient. In other embodiments, a photograph of someone associated with the patient (e.g. a relative) can also be displayed on theGUI 204. Such an embodiment may be particularly useful for neo-natal hospitals wards, wherein one or more photographs of an infant's parents could be displayed on a transceiver attached to the infant. This way a clinician could check the photograph to ensure that visitors to the neo-natal hospital ward are, in fact, the infant's parents. -
FIGS. 18 and 19 showother GUIs FIG. 18 ), and changing the channel on a television or computer (FIG. 19 ). In these cases, the PDS associated with the transceiver receives a packet describing the function at hand (e.g., the meal that has been ordered, or the channel that is desired), and communicates with another software application in the hospital to complete the transaction. This communication, for example, can take place using a XML-based Web Services operation, such as that described in the following patent application, the contents of which are incorporated herein by reference: CUFFLESS BLOOD PRESSURE MONITOR AND ACCOMPANYING WEB SERVICES INTERFACE (U.S. Ser. No. 10/810,237, Filed Mar. 26, 2004). In related embodiments, a GUI similar to that shown inFIG. 19 can be used to order movies, video games, television programs stored on a digital video recorder, books, and music. Content corresponding to these components is typically stored on a remote server, and then accessed using an XML-based operation, as described above. - In yet another application, as shown in
FIG. 20 , the wrist-worntransceiver 72 and its associatedbarcode scanner 102 can be used to check medication before it is administered to the patient. In this embodiment, barcodes associated with thepatient 63,clinician 65, and themedication 67 are read by thebarcode scanner 102 within thetransceiver 72. The transceiver then wirelessly transmits decoded barcode information through alocal access point 56 and to the PDS connected to thehospital network 60. Using a software program, the PDS analyzes these data and communicates with the patient's record in thehospital EMR 58 to determine if the medication is appropriate for the patient. For example, the software program may check to see if the patient is allergic to the medication, if the dosage is correct, or if the patient has previously exhibited any detrimental side effects that may affect the dosage. In related embodiments, the transceiver may also include a GUI wherein the clinician enters ancillary information, such as the dosage of the medication or demographic information describing the patient, using a ‘soft’ keypad. Or the GUI may include a simple questionnaire that guides the clinician through the process of checking the medication, and then administering it. In still other embodiments, the infusion pump that delivers the medication may include a wireless connection through theaccess point 56 to thePDS 60 or to thetransceiver 72 to automatically supply information related to the medication to the software program. - Once the software program determines that it is safe to administer the medication, it sends a packet from the
PDS 60, through theaccess point 56, and back to thetransceiver 72, which then renders a GUI instructing the clinician to proceed. In other embodiments, thePDS 60 sends the packet through theaccess point 56 to either a remote computer 62 (e.g. a tablet computer) or a portable device 64 (e.g. a cellular telephone or personal digital assistant). - Form Factor of the Body-Worn Monitor
-
FIGS. 21A and 21B show how the body-wornmonitor 100 described above attaches to a patient 70 to measure RR, SpO2, cNIBP, and other vital signs. These figures show two configurations of the system:FIG. 21A shows the system used during the indexing portion of the Composite Technique, and includes a pneumatic, cuff-basedsystem 85, whileFIG. 21B shows the system used for subsequent measurements. The indexing measurement typically takes about 60 seconds, and is typically performed once every 4-8 hours. Once the indexing measurement is complete the cuff-basedsystem 85 is typically removed from the patient. The remainder of the time themonitor 100 performs the RR, HR, SpO2 and cNIBP measurements. - The body-worn
monitor 100 features a wrist-worntransceiver 72, described in more detail inFIGS. 22A and 22B , featuring atouch panel interface 73 that displays the various GUIs described above and inFIG. 24 . Awrist strap 90 affixes thetransceiver 72 to the patient's wrist like a conventional wristwatch. Aflexible cable 92 connects thetransceiver 72 to anoptical sensor 94 that wraps around the base of the patient's thumb. During a measurement, theoptical sensor 94 generates a time-dependent PPG waveform which is processed along with an ECG to measure cNIBP, SpO2, and, in some applications, RR. To determine ACC waveforms the body-wornmonitor 100 features three separate accelerometers located at different portions on the patient's arm and chest. The first accelerometer is surface-mounted on a circuit board in the wrist-worntransceiver 72 and measures signals associated with movement of the patient's wrist. As described above, this motion can also be indicative of that originating from the patient's fingers, which will affect the SpO2 measurement. The second accelerometer is included in asmall bulkhead portion 96 included along the span of thecable 82. During a measurement, a small piece of disposable tape, similar in size to a conventional bandaid, affixes thebulkhead portion 96 to the patient's arm. In this way thebulkhead portion 96 serves two purposes: 1) it measures a time-dependent ACC waveform from the mid-portion of the patient's arm, thereby allowing their posture and arm height to be determined as described in detail above; and 2) it secures thecable 82 to the patient's arm to increase comfort and performance of the body-wornmonitor 100, particularly when the patient is ambulatory. The third accelerometer is mounted in thesensor module 74 that connects throughcables 80 a-c to ECG electrodes 78 a-c. Signals from these sensors are then digitized, transmitted through thecable 82 to the wrist-worntransceiver 72, where they are processed with an algorithm as described above to determine RR. - The cuff-based
module 85 features apneumatic system 76 that includes a pump, valve, pressure fittings, pressure sensor, manifold, analog-to-digital converter, microcontroller, and rechargeable Li:ion battery. During an indexing measurement, thepneumatic system 76 inflates adisposable cuff 84 and performs two measurements according to the Composite Technique: 1) it performs an inflation-based measurement of oscillometry and measurement of a corresponding OSC waveform to determine values for SYS, DIA, and MAP; and 2) it determines a patient-specific relationship between PTT and MAP. These measurements are described in detail in the co-pending patent application entitled: ‘VITAL SIGN MONITOR FOR MEASURING BLOOD PRESSURE USING OPTICAL, ELECTRICAL, AND PRESSURE WAVEFORMS’ (U.S. Ser. No. 12/138,194; filed Jun. 12, 2008), the contents of which are incorporated herein by reference. - The
cuff 84 within the cuff-basedpneumatic system 85 is typically disposable and features an internal, airtight bladder that wraps around the patient's bicep to deliver a uniform pressure field. During the indexing measurement, pressure values are digitized by the internal analog-to-digital converter, and sent through acable 86 according to a CAN protocol, along with SYS, DIA, and MAP blood pressures, to the wrist-worntransceiver 72 for processing as described above. Once the cuff-based measurement is complete, the cuff-basedmodule 85 is removed from the patient's arm and thecable 86 is disconnected from the wrist-worntransceiver 72. cNIBP is then determined using PTT, as described in detail above. - To determine an ECG, the body-worn
monitor 100 features a small-scale, three-lead ECG circuit integrated directly into thesensor module 74 that terminates anECG cable 82. The ECG circuit features an integrated circuit that collects electrical signals from three chest-worn ECG electrodes 78 a-c connected throughcables 80a-c. As described above, the ECG electrodes 78 a-c are typically disposed in a conventional Einthoven's Triangle configuration, which is a triangle-like orientation of the electrodes 78 a-c on the patient's chest that features three unique ECG vectors. From these electrical signals the ECG circuit determines up at least three ECG waveforms, each corresponding to a unique ECG vector, which are digitized using an analog-to-digital converter mounted proximal to the ECG circuit and sent through thecable 82 to the wrist-worntransceiver 72 according to the CAN protocol. There, the ECG and PPG waveforms are processed to determine the patient's blood pressure. HR and RR are determined directly from the ECG waveform using known algorithms, such as those described above. More sophisticated ECG circuits (e.g. five and twelve-lead systems) can plug into the wrist-worn transceiver to replace the three-lead system shown inFIGS. 21A and 21B . -
FIGS. 22A, 22B show three-dimensional views of the wrist-worntransceiver 72 before and after receivingcables cable 92 that connects to the optical sensor. Thetransceiver 72 is sealed in a water-proofplastic casing 117 featuring electrical interconnects (not shown in the figure) on its bottom surface that interface to the terminal ends 111, 119a-c ofcables FIG. 25 . During operation, the transceiver'splastic casing 117 snaps into aplastic housing 106, which features anopening 109 on one side to receive theterminal end 111 of thecable 92 connected to the optical sensor. On the opposing side theplastic housing 106 features three identical openings 104 a-c that receive the terminal ends 119 a-c ofcables transceiver 72 is simply detached from theplastic housing 106 and then cleaned. - The
transceiver 72 attaches to the patient's wrist using aflexible strap 90 which threads through two D-ring openings in theplastic housing 106. Thestrap 90 features mated Velcro patches on each side that secure it to the patient's wrist during operation. Atouchpanel display 50 renders the various GUIs described above. - The electrical interconnects on the transceiver's bottom side line up with the openings 104 a-c, and each supports the CAN protocol to relay a digitized data stream to the transceiver's internal CPU, as described in detail with reference to
FIG. 25 . This allows the CPU to easily interpret signals that arrive from the monitor's body-worn sensors, and means that these connectors are not associated with a specific cable. Any cable connecting to thetransceiver 72 can be plugged into any opening 104 a-c. As shown inFIG. 22A , thefirst opening 104 a receives thecable 82 that transports digitized ECG waveforms determined from the ECG circuit and electrodes, and digitized ACC waveforms measured by accelerometers in the cable bulkhead and the bulkhead portion associated with theECG cable 82. - The second opening 104 b receives the
cable 86 that connects to the pneumatic cuff-based system used for the pressure-dependent indexing measurement. This connector receives a time-dependent pressure waveform delivered by the pneumatic system to the patient's arm, along with values for SYS, DIA, and MAP determined during the indexing measurement. Thecable 86 unplugs from the opening 104 b once the indexing measurement is complete, and is plugged back in after approximately 4-8 hours for another indexing measurement. - The final opening 104 c can be used for an auxiliary device, e.g. a glucometer, infusion pump, body-worn insulin pump, ventilator, or end-tidal CO2 monitoring system. As described with reference to
FIG. 25 , digital information generated by these systems will include a header that indicates their origin so that the CPU can process them accordingly. - Measuring and Displaying Time-Dependent Physiological Signals
-
FIGS. 23A and 23B show how a network of sensors 78 a-c, 83, 84, 87, 94 within the body-wornmonitor 100 connect to a patient 70 to measure time-dependent ECG 261,PPG 262,OSC 263,ACC 264, andRR 265 waveforms. These, in turn, yield the patient's vital signs and motion parameters. Each waveform 261-265 relates to a unique physiological characteristic of thepatient 70. For example, each of the patient's heartbeats generates electrical impulses that pass through the body near the speed of light, along with a pressure wave that propagates through the patient's vasculature at a significantly slower speed. Immediately after the heartbeat, the pressure wave leaves theheart 148 andaorta 149, passes through thesubclavian artery 150 to thebrachial artery 144, and from there through the radial andulnar arteries 145 to smaller arteries in the patient's fingers. Threedisposable electrodes 78a-c attached to the patient's chest measure unique electrical signals which pass to a single-chip ECG circuit 83 that terminates a distal end of the ECG cable. Typically, these electrodes attach to the patient's chest in a conventional ‘Einthoven's triangle’ configuration featuring three unique ‘vectors’, each corresponding to a different lead (e.g. LEAD 1, II, II). Related configurations can also be used when five and twelve-lead ECG systems are used in place of the three-lead system, as described above with reference toFIGS. 21A, 21B . Within theECG circuit 83 signals are processed using an amplifier/filter circuit and analog-to-digital converter to generate adigital ECG waveform 261 corresponding to each lead. TheECG waveform 261 features a sharp, well-defined QRS complex corresponding to each heartbeat; this marks the initiation of the patient's cardiac cycle. Heart rate is determined directly from theECG waveform 261 using known algorithms, such as those described in the following journal article, the contents of which are incorporated herein by reference: ‘ECG Beat Detection Using Filter Banks’, Afonso et al., IEEE Trans. Biomed Eng., 46:192-202 (1999). - To generate an
IP waveform 265, one of the ECG electrodes in thecircuit 78 a is a ‘driven lead’ that injects a small amount of modulated current into the patient's torso. A second,non-driven electrode 78 c, typically located on the opposite side of the torso, detects the current, which is further modulated by capacitance changes in the patient's chest cavity resulting from breathing. Further processing and filtering of theIP waveforms 265 yields respiratory rate. Respiration can also be determined using an adaptive filtering approach that processes both the IP waveform andACC waveform 264, as described in more detail in the following co-pending patent application, the contents of which are incorporated herein by reference: BODY-WORN MONITOR FOR MEASURING RESPIRATION RATE (U.S. Ser. No. 12/559,419, Filed Sep. 14, 2009). - The
optical sensor 94 features two LEDs and a single photodetector that collectively measure a time-dependent PPG waveform 262 corresponding to each of the LEDs. The sensor and algorithms for processing the PPG waveforms are described in detail in the following co-pending patent application, the contents of which have been previously incorporated herein by reference: BODY-WORN PULSE OXIMETER (U.S. Ser. No. 12/559,379; filed Sep. 14, 2009). Thewaveform 262 represents a time-dependent volumetric change in vasculature (e.g. arteries and capillaries) that is irradiated with the sensor's optical components. Volumetric changes are induced by a pressure pulse launched by each heartbeat that travels from theheart 148 to arteries and capillaries in the thumb according to the above-describe arterial pathway. Pressure from the pressure pulse forces a bolus of blood into this vasculature, causing it to expand and increase the amount of radiation absorbed, and decrease the transmitted radiation at the photodetector. The pulse shown in thePPG waveform 262 therefore represents the inverse of the actual radiation detected at the photodetector. It follows the QRS complex in theECG waveform 261, typically by about one to two hundred milliseconds. The temporal difference between the peak of the QRS complex and the foot of the pulse in thePPG waveform 262 is the PTT, which as described in detail below is used to determine blood pressure according to the Composite Technique. PTT-based measurements made from the thumb yield excellent correlation to blood pressure measured with a femoral arterial line. This provides an accurate representation of blood pressure in the central regions of the patient's body. - Each accelerometer generates three time-
dependent ACC waveforms 264, corresponding to the x, y, and z-axes, which collectively indicate the patient's motion, posture, and activity level. The body-worn monitor, as described above, features three accelerometers that attach to the patient: one in the wrist-worntransceiver 72, one in theECG circuit 83, and one near thebicep 87 that is included in the cable connecting these two components. The frequency and magnitude of change in the shape of theACC waveform 264 indicate the type of motion that the patient is undergoing. For example, thewaveform 264 can feature a relatively time-invariant component indicating a period of time when the patient is relatively still, and a time-variant component when the patient's activity level increases. Magnitudes of both components will depend on the relationship between the accelerometer and a gravity vector, and can therefore be processed to determine time-invariant features, such as posture and arm height. A frequency-dependent analysis of the time-variant components yields the type and degree of patient motion. Analysis ofACC waveforms 264 is described in detail in the above-mentioned patent applications, the contents of which have been fully incorporated herein by reference. - The
OSC waveform 263 is generated from the patient'sbrachial artery 144 with the pneumatic system and a cuff-basedsensor 84 during the pressure-dependent portion of the Composite Technique. It represents a time-dependent pressure which is applied to the brachial artery during inflation and measured by a digital pressure sensor within the pneumatic system. Thewaveform 263 is similar to waveforms measured during deflation by conventional oscillometric blood pressure monitors. During a measurement, thepressure waveform 263 increases in a mostly linear fashion as pressure applied by thecuff 84 to thebrachial artery 144 increases. When it reaches a pressure slightly below the patient's diastolic pressure, thebrachial artery 144 begins to compress, resulting in a series time-dependent pulsations caused by each heartbeat that couple into thecuff 84. The pulsations modulate theOSC waveform 263 with an amplitude that varies in a Gaussian-like distribution, with maximum modulation occurring when the applied pressure is equivalent to the patient's MAP. The pulsations can be filtered out and processed using digital filtering techniques, such as a digital bandpass filter that passes frequencies ranging from 0.5-20 Hz. The resulting waveform can be processed to determine SYS, DIA, and MAP, as is described in detail in the above-referenced patent applications, the contents of which have been previously incorporated herein by reference. Thecuff 84 and pneumatic system are removed from the patient's bicep once the pressure-dependent component of the Composite Technique is complete. - The high-frequency component of the OSC waveform 263 (i.e. the pulses) can be filtered out to estimate the exact pressure applied to the patient's brachial artery during oscillometry. According to the Composite Technique, PTT measured while pressure is applied will gradually increase as the brachial artery is occluded and blood flow is gradually reduced. The pressure-dependent increase in PTT can be fit with a model to estimate the patient-specific relationship between PTT and blood pressure. This relationship, along with SYS, MAP, and DIA determined from the OSC waveform during inflation-based oscillometry, is used during the Composite Technique's pressure-free measurements to determine blood pressure directly from PTT.
- There are several advantages to making the indexing measurement during inflation, as opposed to deflation. Measurements made during inflation are relatively fast and comfortable compared to those made during deflation. Inflation-based measurements are possible because of the Composite Technique's relatively slow inflation speed (typically 5-10 mmHg/second) and the high sensitivity of the pressure sensor used within the body sensor. Such a slow inflation speed can be accomplished with a small pump that is relatively lightweight and power efficient. Moreover, measurements made during inflation can be immediately terminated once systolic blood pressure is calculated. This tends to be more comfortable than conventional cuff-based measurements made during deflation. In this case, the cuff typically applies a pressure that far exceeds the patient's systolic blood pressure; pressure within the cuff then slowly bleeds down below the diastolic pressure to complete the measurement.
- A digital temperature sensor proximal to the
ECG circuit 83 measures the patient's skin temperature at their torso. This temperature is an approximation of the patient's core temperature, and is used mostly for purposes related to trending and alarms/alerts. -
FIG. 24 shows how the above-described ECG, PPG, and IP waveforms, along with vital signs calculated from them, are rendered usingdifferent screens screen 300, and then the corresponding lead on screen 308. Waveforms for a particular vital sign (e.g. a PPG waveform for the SpO2 measurement; an IP waveform for the RR measurement) are rendered when the clinician taps on the value of the corresponding vital sign. During a measurement both waveforms and the vital signs calculated from them are wirelessly transmitted to the PDS, as described above. - Communicating with Multiple Systems Using the CAN Protocol
- As described above, the ECG, ACC, and pneumatic systems within the body-worn system send digitized information to the wrist-worn transceiver through the CAN protocol.
FIG. 25 shows a schematic drawing indicating how CAN packets 201 a-d, 212 a-e transmitted between these systems facilitate communication. Specifically, each of theACC 215,ECG 216, pneumatic 220, and auxiliary 245 systems include a separate analog-to-digital converter, microcontroller, frequency-generating crystal oscillator (typically operating at 100 kHz), and real-time clock divider that collectively generate and transmit digital data packets 201 a-d according to the CAN protocol to the wrist-worntransceiver 72. Each crystal uses the internal real-time clock on the internal microprocessor within the respective system. This allows the microcontroller within each system to be placed in a low-power state in which its real-time operating system (RTOS) dispatch system indicates that it is not ready to run a task. The real-time clock divider is programmed to create an interrupt which wakes up the microcontroller every 2 milliseconds. - The wrist-worn
transceiver 72 features a ‘master clock’ that generates real-time clock ‘ticks’ at the sampling rate (typically 500 Hz, or 2 ms between samples). Each tick represents an incremented sequence number. Every second, the wrist-worntransceiver 72 transmits apacket 212 e over the CAN bus that digitally encodes the sequence number. One of the criteria for accurate timing is that the time delay between the interrupt and the transmission of the synchronizingpacket 212 e, along with the time period associated with the CAN interrupt service routine, is predictable and stable. During initialization, the remote CAN buses do not sleep; they stay active to listen for thesynchronization packet 212 e. The interrupt service routine for thesynchronization packet 212 e then establishes the interval for the next 2 millisecond interrupt from its on-board, real-time crystal to be synchronized with the timing on the wrist-worntransceiver 72. Offsets for the packet transmission and interrupt service delays are factored into the setting for the real-time oscillator to interrupt synchronously with the microprocessor on the wrist-worntransceiver 72. The magnitude of the correction factor to the real-time counter is limited to 25% of the 2 millisecond interval to ensure stability of this system, which represents a digital phase-locked loop. - When receipt of the
synchronization packet 212 e results in a timing correction offset of either a 0, +1, or −1 count on the remote system's oscillator divider, software running on the internal microcontroller declares that the system is phase-locked and synchronized. At this point, it begins its power-down operation and enables measurement of data as described above. - Each remote system is driven with a 100 kHz clock, and a single count of the divider corresponds to 20 microseconds. This is because the clock divider divides the real-time clock frequency by a factor of 2. This is inherent in the microcontroller to ensure that the clock has a 50% duty cycle, and means the clock can drift +/−20 microseconds before the actual divider chain count will disagree by one count, at which time the software corrects the count to maintain a phase-locked state. There is thus a maximum of 40 microseconds of timing error between data transmitted from the remote systems over the CAN bus. Blood pressure is the one vital sign measured with the body-worn monitor that is calculated from time-dependent waveforms measured from different systems (e.g. PPG and ECG waveforms). For this measurement, the maximum 40-microsecond timing error corresponds to an error of +/−0.04 mmHg, which is well within the error (typically +/−5 mmHg) of the measurement.
- In order to minimize power consumption, the wrist-worn
transceiver 72 andremote systems synchronization packet 212 e. The sequence number represents the interval between data transfers in intervals of 2 milliseconds. It is a factor of 500 (e.g. 2, 4, 5, 10) that is the number of 2 millisecond intervals between transfers on the CAN bus. Each remote system enables its CAN bus during the appropriate intervals and sends its data. When it has finished sending its data, it transmits a ‘transmit complete’ packet indicating that the transmission is complete. When a device has received the ‘transmit complete’ packet it can disable its CAN transceiver to further reduce power consumption. - Software in each of the
ACC 215,ECG 216, pneumatic 220, and auxiliary 245 systems receive thesequence packet 212 e and the corresponding sequence number, and set their clocks accordingly. There is typically some inherent error in this process due to small frequency differences in the crystals (from the ideal frequency of 100 kHz) associated with each system. Typically this error is on the order of microseconds, and has only a small impact on time-dependent measurements, such as PTT, which are typically several hundred milliseconds. - Once timing on the CAN bus is established using the above-described procedure, each of the
ACC 215,ECG 216, and pneumatic 220 systems generate time-dependent waveforms that are transmitted in packets 201 a-d, each representing an individual sample. Each packet 201 a-d features a header portion which includes the sequence number 212 a-d and an initial value 210 a-d indicating the type of packet that is transmitted. For example, accelerometers used in the body-worn system are typically three-axis digital accelerometers, and generate waveforms along the x, y, and z-axes. In this case, the initial value 210 a encodes numerical values that indicate: 1) that the packet contains ACC data; and 2) the axis (x, y, or z) over which these data are generated. Similarly, theECG system 216 can generate a time-dependent ECG waveform corresponding to Lead I, II, or III, each of which represents a different vector measured along the patient's torso. Additionally, theECG system 216 can generate processed numerical data, such as heart rate (measured from time increments separating neighboring QRS complexes), respiratory rate (from an internal impedance pneumography component), as well as alarms calculated from the ECG waveform that indicate problematic cardiovascular states such as VTAC, VFIB, and PVCs. Additionally, the ECG system can generate error codes indicating, for example, that one of the ECG leads has fallen off. The ECG system typically generates an alarm/alert, as described above, corresponding to both the error codes and potentially problematic cardiovascular states. In this case, theinitial value 210 b encodes numerical values that indicate: 1) that the packet contains ECG data; 2) the vector (Lead I, II, or III) corresponding to the ECG data; and 3) an indication if a cardiovascular state such as VTAC, VFIB, or PVCs was detected. - The
pneumatic system 220 is similar to the ECG system in that it generates both time-dependent waveforms (i.e. a pressure waveform, measured during oscillometry, characterizing the pressure applied to the arm and subsequent pulsations measured during an oscillometric measurement) and calculated vital signs (SYS, DIA, and MAP measured during oscillometry). In some cases errors are encountered during the oscillometric blood pressure measurement. These include, for example, situations where blood pressure is not accurately determined, an improper OSC waveform, over-inflation of the cuff, or a measurement that is terminated before completion. In these cases thepneumatic system 220 generates a corresponding error code. For thepneumatic system 220 theinitial value 210 c encodes numerical values that indicate: 1) that the packet contains blood pressure data; 2) an indication that the packet includes an error code. - In addition to the initial values 210 a-d, each packet 201 a-d includes a data field 214 a-d that encodes the actual data payload. Examples of data included in the data fields 214 a-d are: 1) sampled values of ACC, ECG, and pressure waveforms; 2) calculated heart rate and blood pressure values; and 3) specific error codes corresponding to the
ACC 215,ECG 216, pneumatic 220, and auxiliary 225 systems. - Upon completion of the measurement, the wrist-worn
transceiver 72 receives all the CAN packets 201 a-d, and synchronizes them in time according to the sequence number 212 a-d and identifier 210 a-d in theinitial portions 216 of each packet. Every second, the CPU updates the time-dependent waveforms and calculates the patient's vital signs and motion-related properties, as described above. Typically these values are calculated as a ‘rolling average’ with an averaging window ranging from 10-20 seconds. The rolling average is typically updated every second, resulting in a new value that is displayed on the wrist-worntransceiver 72. Each packet received by thetransceiver 72 is also wirelessly retransmitted as anew packet 201 b′ through awireless access point 56 and to both an PDS and RVD within ahospital network 60. Thenew packet 201 b′ includes thesame header 210 b′, 212 b′ anddata field information 214 b′ as the CAN packets transmitted between systems within the body-worn monitor. Also transmitted are additional packets encoding the cNIBP, SpO2, and processed motion states (e.g. posture, activity level, degree of motion), which unlike heart rate and SYS, DIA, and MAP are calculated by the CPU in the wrist-worn transceiver. Upon receipt of thepacket 201 b′, the RVD displays vital signs, waveforms, motion information, and alarms/alerts, typically with a large monitor that is easily viewed by a clinician. Additionally the PDS can send information through the hospital network (e.g. in the case of an alarm/alert), store information in an internal database, and transfer it to a hospital EMR. - Alternate IT Configurations
-
FIG. 26 shows an alternate configuration of the invention wherein thetransceiver 72 transmits both voice and data information through awireless access point 56A and to theInternet 55, and from there to the hospital network andPDS 60. Such a configuration would be used, for example, when the patient is located outside of the hospital (e.g. at home). It allows clinicians to monitor and care for a patient as if they were located in the hospital. Once information arrives at thePDS 60, it can be transferred to thehospital EMR system 58, or through awireless access point 56B within the hospital to anexternal computer 62 or aportable device 64. - In an alternate embodiment, as shown in
FIG. 27 , the firstwireless access point 56A shown inFIG. 26 is replaced by awireless modem 64A, such as a cellular telephone or personal digital assistant. Here, thewireless modem 64A receives voice and data information from the transceiver through a peer-to-peer wireless interface (e.g. an interface based on 802.11b/g or 802.15.4). Thewireless modem 64A then transmits the voice and data information to theInternet 55 using, e.g., a cellular connection, such as one based on GSM or CDMA. In yet another embodiment, as shown inFIG. 28 , thetransceiver 72 includes an internal long-range wireless transmitter based on a cellular protocol (e.g. GSM or CDMA), allowing it to transmit voice and data information directly to theInternet 55. In the embodiments shown in bothFIGS. 27 and 28 , information sent through the Internet is ultimately received by thePDS 60, and is sent from there through awireless access point 56 to either theremote computer 62 orportable device 64. - In embodiments, the
transceiver 72 features multiple wireless transmitters, and can operate in multiple modes, such as each of those shown inFIGS. 26-28 . In this case the wireless protocol (based on, e.g. 802.11 or cellular) is manually selected using the GUI, or automatically selected based on the strength of the ambient wireless signal. - In addition to those methods described above, the body-worn monitor can use a number of additional methods to calculate blood pressure and other properties from the optical and electrical waveforms. These are described in the following co-pending patent applications, the contents of which are incorporated herein by reference: 1) CUFFLESS BLOOD-PRESSURE MONITOR AND ACCOMPANYING WIRELESS, INTERNET-BASED SYSTEM (U.S. Ser. No. 10/709,015; filed Apr. 7, 2004); 2) CUFFLESS SYSTEM FOR MEASURING BLOOD PRESSURE (U.S. Ser. No. 10/709,014; filed Apr. 7, 2004); 3) CUFFLESS BLOOD PRESSURE MONITOR AND ACCOMPANYING WEB SERVICES INTERFACE (U.S. Ser. No. 10/810,237; filed Mar. 26, 2004); 4) BILATERAL DEVICE, SYSTEM AND METHOD FOR MONITORING VITAL SIGNS (U.S. Ser. No. 11/420,774; filed May 27, 2006); 5) CUFFLESS BLOOD PRESSURE MONITOR AND ACCOMPANYING WIRELESS MOBILE DEVICE (U.S. Ser. No. 10/967,511; filed Oct. 18, 2004); 6) BLOOD PRESSURE MONITORING DEVICE FEATURING A CALIBRATION-BASED ANALYSIS (U.S. Ser. No. 10/967,610; filed Oct. 18, 2004); 7) PERSONAL COMPUTER-BASED VITAL SIGN MONITOR (U.S. Ser. No. 10/906,342; filed Feb. 15, 2005); 8) PATCH SENSOR FOR MEASURING BLOOD PRESSURE WITHOUT A CUFF (U.S. Ser. No. 10/906,315; filed Feb. 14, 2005); 9) PATCH SENSOR FOR MEASURING VITAL SIGNS (U.S. Ser. No. 11/160,957; filed Jul. 18, 2005); 10) WIRELESS, INTERNET-BASED SYSTEM FOR MEASURING VITAL SIGNS FROM A PLURALITY OF PATIENTS IN A HOSPITAL OR MEDICAL CLINIC (U.S. Ser. No. 11/162,719; filed Sep. 9, 2005); 11) HAND-HELD MONITOR FOR MEASURING VITAL SIGNS (U.S. Ser. No. 11/162,742; filed Sep. 21, 2005); 12) CHEST STRAP FOR MEASURING VITAL SIGNS (U.S. Ser. No. 11/306,243; filed Dec. 20, 2005); 13) SYSTEM FOR MEASURING VITAL SIGNS USING AN OPTICAL MODULE FEATURING A GREEN LIGHT SOURCE (U.S. Ser. No. 11/307,375; filed Feb. 3, 2006); 14) BILATERAL DEVICE, SYSTEM AND METHOD FOR MONITORING VITAL SIGNS (U.S. Ser. No. 11/420,281; filed May 25, 2006); 15) SYSTEM FOR MEASURING VITAL SIGNS USING BILATERAL PULSE TRANSIT TIME (U.S. Ser. No. 11/420,652; filed May 26, 2006); 16) BLOOD PRESSURE MONITOR (U.S. Ser. No. 11/530,076; filed Sep. 8, 2006); 17) TWO-PART PATCH SENSOR FOR MONITORING VITAL SIGNS (U.S. Ser. No. 11/558,538; filed Nov. 10, 2006); and, 18) MONITOR FOR MEASURING VITAL SIGNS AND RENDERING VIDEO IMAGES (U.S. Ser. No. 11/682,177; filed Mar. 5, 2007).
- Other embodiments are also within the scope of the invention. For example, other measurement techniques, such as conventional oscillometry measured during deflation, can be used to determine SYS, DIA, and MAP for the above-described algorithms. Additionally, processing units and probes for measuring pulse oximetry similar to those described above can be modified and worn on other portions of the patient's body. For example, optical sensors with finger-ring configurations can be worn on fingers other than the thumb. Or they can be modified to attach to other conventional sites for measuring SpO2, such as the ear, forehead, and bridge of the nose. In these embodiments the processing unit can be worn in places other than the wrist, such as around the neck (and supported, e.g., by a lanyard) or on the patient's waist (supported, e.g., by a clip that attaches to the patient's belt). In still other embodiments the probe and processing unit are integrated into a single unit.
- In embodiments, the interface rendered on the display at the central nursing station features a field that displays a map corresponding to an area with multiple sections. Each section corresponds to the location of the patient and includes, e.g., the patient's vital signs, motion parameter, and alarm parameter. For example, the field can display a map corresponding to an area of a hospital (e.g. a hospital bay or emergency room), with each section corresponding to a specific bed, chair, or general location in the area.
- Further embodiments of the invention are within the scope of the following claims:
Claims (8)
1. A monitoring network for measuring and displaying vital sign information from an ambulatory patient within a hospital, comprising:
a sensor module configured to attach to the patient's chest, comprising (i) at least three electrodes configured to attach to the patient's chest, (ii) an electrocardiogram (ECG) module configured to receive signals from the at least three electrodes and generate digital ECG waveforms corresponding to the signal received from each lead, (iii) an impedance module configured to inject a current into one of the at least three electrodes, measure a current modulated by capacitance changes in the patient's chest at a different one of the at least three electrodes, and generate a digital impedance waveform from the measured current, (iv) an accelerometer module configured to generate digital motion waveforms corresponding to an x-, y-, and z-axis of the accelerometer, (iv) a temperature module configured to measure a skin temperature for the patient and generate a digital temperature signal, and (v) a first transceiver configured to transmit the digital ECG waveforms, the digital impedance waveform, the digital motion waveforms, and the digital temperature signal as separate digital data packet streams along a single transmission path;
a processing module configured to attach to the patient's arm, comprising (i) a second transceiver configured to receive the digital ECG waveforms, the digital impedance waveform, the digital motion waveforms, and the digital temperature signal, and (ii) a transmitter configured to transmit the digital ECG waveforms, the digital impedance waveform, the digital motion waveforms, and the digital temperature signal wirelessly to an access point within a hospital wireless network;
a remote display device operably connected to the hospital wireless network and configured to receive and display the digital ECG waveforms, the digital impedance waveform, the digital motion waveforms, and the digital temperature signal,
wherein the processing module transmits a synchronization packet to the sensor module to establish a phase-locked state for data transmission between the sensor module and the processing module having a maximum 40 microsecond timing error.
2. A hospital monitoring network according to claim 1 , further comprising a photoplethysmogram (PPG) module configured to attach to a finger of the patient, generate a PPG waveform, and transmit the PPG waveform to the processing module.
3. A hospital monitoring network according to claim 1 , wherein the processing module is configured to determine a heart rate and a respiration rate using the digital ECG waveforms and the digital impedance waveform.
4. A hospital monitoring network according to claim 2 , wherein
the processing module is configured to continuously determine a heart rate and a respiration rate using the digital ECG waveforms and the digital impedance waveform, and continuously determine an SpO2 value from the PPG waveform, and to transmit the continuous heart rate, respiration rate, and SpO2 value wirelessly to the access point; and
the remote display is configured to receive and display the continuous heart rate, respiration rate, and SpO2 value.
5. A hospital monitoring network according to claim 1 , wherein the first and second transceivers operate according to the CAN protocol.
6. A hospital monitoring network according to claim 2 , wherein the first and second transceivers operate according to the CAN protocol.
7. A hospital monitoring network according to claim 3 , wherein the first and second transceivers operate according to the CAN protocol.
8. A hospital monitoring network according to claim 4 , wherein the first and second transceivers operate according to the CAN protocol.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/404,435 US20190254600A1 (en) | 2010-03-10 | 2019-05-06 | Body-worn vital sign monitor |
US17/501,787 US20220031246A1 (en) | 2009-09-15 | 2021-10-14 | Body-worn vital sign monitor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31262410P | 2010-03-10 | 2010-03-10 | |
US12/762,822 US10278645B2 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US16/404,435 US20190254600A1 (en) | 2010-03-10 | 2019-05-06 | Body-worn vital sign monitor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/762,822 Continuation US10278645B2 (en) | 2009-09-15 | 2010-04-19 | Body-worn vital sign monitor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/501,787 Continuation-In-Part US20220031246A1 (en) | 2009-09-15 | 2021-10-14 | Body-worn vital sign monitor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190254600A1 true US20190254600A1 (en) | 2019-08-22 |
Family
ID=44560603
Family Applications (11)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/762,836 Abandoned US20110224499A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,810 Active 2031-11-08 US8727977B2 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,846 Abandoned US20110224500A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,726 Active 2036-07-16 US10213159B2 (en) | 2009-09-15 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,822 Active 2031-02-08 US10278645B2 (en) | 2009-09-15 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,777 Abandoned US20110224556A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,790 Abandoned US20110224498A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,733 Active 2031-02-26 US8591411B2 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,751 Abandoned US20110224564A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US16/285,015 Abandoned US20190183422A1 (en) | 2009-09-15 | 2019-02-25 | Body-worn vital sign monitor |
US16/404,435 Abandoned US20190254600A1 (en) | 2009-09-15 | 2019-05-06 | Body-worn vital sign monitor |
Family Applications Before (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/762,836 Abandoned US20110224499A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,810 Active 2031-11-08 US8727977B2 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,846 Abandoned US20110224500A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,726 Active 2036-07-16 US10213159B2 (en) | 2009-09-15 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,822 Active 2031-02-08 US10278645B2 (en) | 2009-09-15 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,777 Abandoned US20110224556A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,790 Abandoned US20110224498A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,733 Active 2031-02-26 US8591411B2 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US12/762,751 Abandoned US20110224564A1 (en) | 2010-03-10 | 2010-04-19 | Body-worn vital sign monitor |
US16/285,015 Abandoned US20190183422A1 (en) | 2009-09-15 | 2019-02-25 | Body-worn vital sign monitor |
Country Status (4)
Country | Link |
---|---|
US (11) | US20110224499A1 (en) |
EP (1) | EP2544584B1 (en) |
SG (1) | SG183973A1 (en) |
WO (1) | WO2011112782A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11657175B2 (en) * | 2016-02-23 | 2023-05-23 | Philips Medical Systems Technologies Ltd | Patient medical data acquisition system and method using an external device |
WO2024178376A1 (en) * | 2023-02-24 | 2024-08-29 | Arthur Wallace | Audio visual detection platform for patient monitoring |
Families Citing this family (338)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8784336B2 (en) | 2005-08-24 | 2014-07-22 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
US8924248B2 (en) | 2006-09-26 | 2014-12-30 | Fitbit, Inc. | System and method for activating a device based on a record of physical activity |
US8602997B2 (en) | 2007-06-12 | 2013-12-10 | Sotera Wireless, Inc. | Body-worn system for measuring continuous non-invasive blood pressure (cNIBP) |
US11330988B2 (en) | 2007-06-12 | 2022-05-17 | Sotera Wireless, Inc. | Body-worn system for measuring continuous non-invasive blood pressure (cNIBP) |
US11607152B2 (en) | 2007-06-12 | 2023-03-21 | Sotera Wireless, Inc. | Optical sensors for use in vital sign monitoring |
US8419649B2 (en) | 2007-06-12 | 2013-04-16 | Sotera Wireless, Inc. | Vital sign monitor for measuring blood pressure using optical, electrical and pressure waveforms |
US8781555B2 (en) | 2007-11-26 | 2014-07-15 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
US9521961B2 (en) | 2007-11-26 | 2016-12-20 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
US9456766B2 (en) | 2007-11-26 | 2016-10-04 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
AU2008329807B2 (en) | 2007-11-26 | 2014-02-27 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
US8672854B2 (en) | 2009-05-20 | 2014-03-18 | Sotera Wireless, Inc. | System for calibrating a PTT-based blood pressure measurement using arm height |
US8909330B2 (en) | 2009-05-20 | 2014-12-09 | Sotera Wireless, Inc. | Body-worn device and associated system for alarms/alerts based on vital signs and motion |
US11896350B2 (en) | 2009-05-20 | 2024-02-13 | Sotera Wireless, Inc. | Cable system for generating signals for detecting motion and measuring vital signs |
US9532724B2 (en) | 2009-06-12 | 2017-01-03 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
US20100324388A1 (en) | 2009-06-17 | 2010-12-23 | Jim Moon | Body-worn pulse oximeter |
US20110208015A1 (en) | 2009-07-20 | 2011-08-25 | Masimo Corporation | Wireless patient monitoring system |
US8545417B2 (en) | 2009-09-14 | 2013-10-01 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US11253169B2 (en) | 2009-09-14 | 2022-02-22 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US8527038B2 (en) | 2009-09-15 | 2013-09-03 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US10420476B2 (en) | 2009-09-15 | 2019-09-24 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US20110066044A1 (en) | 2009-09-15 | 2011-03-17 | Jim Moon | Body-worn vital sign monitor |
US10806351B2 (en) | 2009-09-15 | 2020-10-20 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8364250B2 (en) | 2009-09-15 | 2013-01-29 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8321004B2 (en) | 2009-09-15 | 2012-11-27 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US20110208013A1 (en) * | 2010-02-24 | 2011-08-25 | Edwards Lifesciences Corporation | Body Parameter Sensor and Monitor Interface |
US20110224499A1 (en) | 2010-03-10 | 2011-09-15 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8888700B2 (en) | 2010-04-19 | 2014-11-18 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9173593B2 (en) | 2010-04-19 | 2015-11-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8747330B2 (en) | 2010-04-19 | 2014-06-10 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9339209B2 (en) | 2010-04-19 | 2016-05-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9173594B2 (en) | 2010-04-19 | 2015-11-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8979765B2 (en) | 2010-04-19 | 2015-03-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9585620B2 (en) | 2010-07-27 | 2017-03-07 | Carefusion 303, Inc. | Vital-signs patch having a flexible attachment to electrodes |
US9615792B2 (en) | 2010-07-27 | 2017-04-11 | Carefusion 303, Inc. | System and method for conserving battery power in a patient monitoring system |
US9357929B2 (en) | 2010-07-27 | 2016-06-07 | Carefusion 303, Inc. | System and method for monitoring body temperature of a person |
US9420952B2 (en) | 2010-07-27 | 2016-08-23 | Carefusion 303, Inc. | Temperature probe suitable for axillary reading |
US9055925B2 (en) | 2010-07-27 | 2015-06-16 | Carefusion 303, Inc. | System and method for reducing false alarms associated with vital-signs monitoring |
US9017255B2 (en) | 2010-07-27 | 2015-04-28 | Carefusion 303, Inc. | System and method for saving battery power in a patient monitoring system |
US8814792B2 (en) | 2010-07-27 | 2014-08-26 | Carefusion 303, Inc. | System and method for storing and forwarding data from a vital-signs monitor |
US11243093B2 (en) | 2010-09-30 | 2022-02-08 | Fitbit, Inc. | Methods, systems and devices for generating real-time activity data updates to display devices |
US9390427B2 (en) | 2010-09-30 | 2016-07-12 | Fitbit, Inc. | Methods, systems and devices for automatic linking of activity tracking devices to user devices |
US8744803B2 (en) | 2010-09-30 | 2014-06-03 | Fitbit, Inc. | Methods, systems and devices for activity tracking device data synchronization with computing devices |
US8615377B1 (en) | 2010-09-30 | 2013-12-24 | Fitbit, Inc. | Methods and systems for processing social interactive data and sharing of tracked activity associated with locations |
US8954290B2 (en) | 2010-09-30 | 2015-02-10 | Fitbit, Inc. | Motion-activated display of messages on an activity monitoring device |
US8805646B2 (en) | 2010-09-30 | 2014-08-12 | Fitbit, Inc. | Methods, systems and devices for linking user devices to activity tracking devices |
US9241635B2 (en) | 2010-09-30 | 2016-01-26 | Fitbit, Inc. | Portable monitoring devices for processing applications and processing analysis of physiological conditions of a user associated with the portable monitoring device |
US8620617B2 (en) | 2010-09-30 | 2013-12-31 | Fitbit, Inc. | Methods and systems for interactive goal setting and recommender using events having combined activity and location information |
US8954291B2 (en) | 2010-09-30 | 2015-02-10 | Fitbit, Inc. | Alarm setting and interfacing with gesture contact interfacing controls |
US9253168B2 (en) | 2012-04-26 | 2016-02-02 | Fitbit, Inc. | Secure pairing of devices via pairing facilitator-intermediary device |
US9188460B2 (en) | 2010-09-30 | 2015-11-17 | Fitbit, Inc. | Methods, systems and devices for generating real-time activity data updates to display devices |
US8712724B2 (en) | 2010-09-30 | 2014-04-29 | Fitbit, Inc. | Calendar integration methods and systems for presentation of events having combined activity and location information |
US10983945B2 (en) | 2010-09-30 | 2021-04-20 | Fitbit, Inc. | Method of data synthesis |
US10004406B2 (en) | 2010-09-30 | 2018-06-26 | Fitbit, Inc. | Portable monitoring devices for processing applications and processing analysis of physiological conditions of a user associated with the portable monitoring device |
US8762101B2 (en) | 2010-09-30 | 2014-06-24 | Fitbit, Inc. | Methods and systems for identification of event data having combined activity and location information of portable monitoring devices |
US9310909B2 (en) | 2010-09-30 | 2016-04-12 | Fitbit, Inc. | Methods, systems and devices for physical contact activated display and navigation |
US8762102B2 (en) | 2010-09-30 | 2014-06-24 | Fitbit, Inc. | Methods and systems for generation and rendering interactive events having combined activity and location information |
US8694282B2 (en) | 2010-09-30 | 2014-04-08 | Fitbit, Inc. | Methods and systems for geo-location optimized tracking and updating for events having combined activity and location information |
US8738321B2 (en) | 2010-09-30 | 2014-05-27 | Fitbit, Inc. | Methods and systems for classification of geographic locations for tracked activity |
US8849610B2 (en) | 2010-09-30 | 2014-09-30 | Fitbit, Inc. | Tracking user physical activity with multiple devices |
US9148483B1 (en) | 2010-09-30 | 2015-09-29 | Fitbit, Inc. | Tracking user physical activity with multiple devices |
US8738323B2 (en) | 2010-09-30 | 2014-05-27 | Fitbit, Inc. | Methods and systems for metrics analysis and interactive rendering, including events having combined activity and location information |
JP2014502172A (en) * | 2010-10-18 | 2014-01-30 | スリーエム イノベイティブ プロパティズ カンパニー | Multifunctional medical device for telemedicine applications |
US9852271B2 (en) | 2010-12-13 | 2017-12-26 | Nike, Inc. | Processing data of a user performing an athletic activity to estimate energy expenditure |
US9977874B2 (en) | 2011-11-07 | 2018-05-22 | Nike, Inc. | User interface for remote joint workout session |
US9283429B2 (en) | 2010-11-05 | 2016-03-15 | Nike, Inc. | Method and system for automated personal training |
US9457256B2 (en) * | 2010-11-05 | 2016-10-04 | Nike, Inc. | Method and system for automated personal training that includes training programs |
CA2816589A1 (en) | 2010-11-05 | 2012-05-10 | Nike International Ltd. | Method and system for automated personal training |
US20120130203A1 (en) * | 2010-11-24 | 2012-05-24 | Fujitsu Limited | Inductively-Powered Ring-Based Sensor |
US8928671B2 (en) | 2010-11-24 | 2015-01-06 | Fujitsu Limited | Recording and analyzing data on a 3D avatar |
US8633818B2 (en) * | 2010-12-15 | 2014-01-21 | Dell Products L.P. | Mobile and automated emergency service provider contact system |
US20120158428A1 (en) * | 2010-12-16 | 2012-06-21 | General Electric Company | Dynamic patient data monitoring system and method |
US8771185B2 (en) * | 2010-12-22 | 2014-07-08 | Sleepsafe Drivers, Inc. | System and method for reliable sleep diagnostic testing |
US20140249432A1 (en) | 2010-12-28 | 2014-09-04 | Matt Banet | Body-worn system for continuous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure |
US9251685B2 (en) * | 2011-02-17 | 2016-02-02 | International Business Machines Corporation | System and method for medical diagnosis using geospatial location data integrated with biomedical sensor information |
WO2012112891A1 (en) * | 2011-02-18 | 2012-08-23 | Sotera Wireless, Inc. | Modular wrist-worn processor for patient monitoring |
EP2675346B1 (en) | 2011-02-18 | 2024-04-10 | Sotera Wireless, Inc. | Optical sensor for measuring physiological properties |
WO2012117689A1 (en) * | 2011-03-01 | 2012-09-07 | パナソニック株式会社 | Information terminal device and biological sample measurement device |
US8738925B1 (en) | 2013-01-07 | 2014-05-27 | Fitbit, Inc. | Wireless portable biometric device syncing |
US20120319840A1 (en) * | 2011-06-15 | 2012-12-20 | David Amis | Systems and methods to activate a security protocol using an object with embedded safety technology |
US20150124415A1 (en) * | 2011-07-12 | 2015-05-07 | Aliphcom | Protective covering for wearable devices |
US20130015968A1 (en) * | 2011-07-13 | 2013-01-17 | Honeywell International Inc. | System and method of alarm installation and configuration |
CN202210337U (en) * | 2011-09-29 | 2012-05-02 | 西安中星测控有限公司 | Human body tumble detection alarm |
US9811639B2 (en) | 2011-11-07 | 2017-11-07 | Nike, Inc. | User interface and fitness meters for remote joint workout session |
US20130144536A1 (en) * | 2011-12-06 | 2013-06-06 | Welch Allyn, Inc. | Medical Device with Wireless Communication Bus |
US9339691B2 (en) | 2012-01-05 | 2016-05-17 | Icon Health & Fitness, Inc. | System and method for controlling an exercise device |
US10307111B2 (en) | 2012-02-09 | 2019-06-04 | Masimo Corporation | Patient position detection system |
US10149616B2 (en) | 2012-02-09 | 2018-12-11 | Masimo Corporation | Wireless patient monitoring device |
WO2013122958A1 (en) * | 2012-02-13 | 2013-08-22 | Leiderman Jonathan | Multifunctional auscultation sensor pad |
KR20130126760A (en) * | 2012-03-05 | 2013-11-21 | 한국전자통신연구원 | Apparatus and method for textile-type interface in human wearing band |
ITCR20120004A1 (en) * | 2012-03-07 | 2013-09-08 | Luigi Angelo Sala | ELECTRONIC DEVICE FOR CARDIOVASCULAR HOME-MAKING MONITORING |
US9041530B2 (en) * | 2012-04-18 | 2015-05-26 | Qualcomm Incorporated | Biometric attribute anomaly detection system with adjusting notifications |
TWI475976B (en) * | 2012-05-21 | 2015-03-11 | You Ming Chiu | Measurement devices |
WO2013184679A1 (en) | 2012-06-04 | 2013-12-12 | Nike International Ltd. | Combinatory score having a fitness sub-score and an athleticism sub-score |
US10867695B2 (en) * | 2012-06-04 | 2020-12-15 | Pharmalto, Llc | System and method for comprehensive health and wellness mobile management |
US9641239B2 (en) | 2012-06-22 | 2017-05-02 | Fitbit, Inc. | Adaptive data transfer using bluetooth |
US20140051941A1 (en) * | 2012-08-17 | 2014-02-20 | Rare Light, Inc. | Obtaining physiological measurements using a portable device |
US9060745B2 (en) | 2012-08-22 | 2015-06-23 | Covidien Lp | System and method for detecting fluid responsiveness of a patient |
US8731649B2 (en) | 2012-08-30 | 2014-05-20 | Covidien Lp | Systems and methods for analyzing changes in cardiac output |
US9357937B2 (en) | 2012-09-06 | 2016-06-07 | Covidien Lp | System and method for determining stroke volume of an individual |
EP2892429B1 (en) | 2012-09-10 | 2019-07-24 | Koninklijke Philips N.V. | Device and method to improve dependability of physiological parameter measurements |
US9241646B2 (en) | 2012-09-11 | 2016-01-26 | Covidien Lp | System and method for determining stroke volume of a patient |
US20140073969A1 (en) * | 2012-09-12 | 2014-03-13 | Neurosky, Inc. | Mobile cardiac health monitoring |
US20140081152A1 (en) | 2012-09-14 | 2014-03-20 | Nellcor Puritan Bennett Llc | System and method for determining stability of cardiac output |
US20140085101A1 (en) * | 2012-09-25 | 2014-03-27 | Aliphcom | Devices and methods to facilitate affective feedback using wearable computing devices |
WO2014066703A2 (en) * | 2012-10-24 | 2014-05-01 | Basis Science, Inc. | Smart contextual display for a wearable device |
US8740806B2 (en) | 2012-11-07 | 2014-06-03 | Somnarus Inc. | Methods for detection of respiratory effort and sleep apnea monitoring devices |
US20140130906A1 (en) * | 2012-11-14 | 2014-05-15 | Mindray Ds Usa, Inc. | Systems and methods for electronically controlling the flow rates of fluids |
US10456089B2 (en) | 2012-12-14 | 2019-10-29 | Koninklijke Philips N.V. | Patient monitoring for sub-acute patients based on activity state and posture |
US10725047B2 (en) * | 2012-12-20 | 2020-07-28 | Glucome, Ltd. | Methods and systems for analyzing a blood sample |
US8977348B2 (en) | 2012-12-21 | 2015-03-10 | Covidien Lp | Systems and methods for determining cardiac output |
US10528135B2 (en) | 2013-01-14 | 2020-01-07 | Ctrl-Labs Corporation | Wearable muscle interface systems, devices and methods that interact with content displayed on an electronic display |
US8827906B2 (en) * | 2013-01-15 | 2014-09-09 | Fitbit, Inc. | Methods, systems and devices for measuring fingertip heart rate |
US9039614B2 (en) | 2013-01-15 | 2015-05-26 | Fitbit, Inc. | Methods, systems and devices for measuring fingertip heart rate |
US9728059B2 (en) | 2013-01-15 | 2017-08-08 | Fitbit, Inc. | Sedentary period detection utilizing a wearable electronic device |
WO2014134631A1 (en) * | 2013-03-01 | 2014-09-04 | Virtusense Technologies | Palpation evaluation or diagnosis device, system, and method |
US9414776B2 (en) * | 2013-03-06 | 2016-08-16 | Navigated Technologies, LLC | Patient permission-based mobile health-linked information collection and exchange systems and methods |
US20140257048A1 (en) * | 2013-03-08 | 2014-09-11 | Jassin Jouria | Omnisign medical device |
EP2969058B1 (en) | 2013-03-14 | 2020-05-13 | Icon Health & Fitness, Inc. | Strength training apparatus with flywheel and related methods |
PT2967879T (en) | 2013-03-15 | 2022-04-06 | Canary Medical Inc | Devices, systems and methods for monitoring hip replacements |
WO2014145942A2 (en) | 2013-03-15 | 2014-09-18 | Smart Patents L.L.C. | Wearable devices and associated systems |
US9858052B2 (en) * | 2013-03-21 | 2018-01-02 | Razer (Asia-Pacific) Pte. Ltd. | Decentralized operating system |
WO2014186370A1 (en) | 2013-05-13 | 2014-11-20 | Thalmic Labs Inc. | Systems, articles and methods for wearable electronic devices that accommodate different user forms |
RS61560B1 (en) | 2013-06-23 | 2021-04-29 | Canary Medical Inc | Devices, systems and methods for monitoring knee replacements |
WO2015009980A1 (en) * | 2013-07-18 | 2015-01-22 | Tesseract Sensors, LLC | Medical data acquisition systems and methods for monitoring and diagnosis |
USD751934S1 (en) | 2013-07-24 | 2016-03-22 | Meterist LLC | Wrist meter-mount system |
US9164126B1 (en) | 2013-07-24 | 2015-10-20 | Meterist LLC | Wrist meter-mount system |
US20150124566A1 (en) | 2013-10-04 | 2015-05-07 | Thalmic Labs Inc. | Systems, articles and methods for wearable electronic devices employing contact sensors |
US11921471B2 (en) | 2013-08-16 | 2024-03-05 | Meta Platforms Technologies, Llc | Systems, articles, and methods for wearable devices having secondary power sources in links of a band for providing secondary power in addition to a primary power source |
US11426123B2 (en) * | 2013-08-16 | 2022-08-30 | Meta Platforms Technologies, Llc | Systems, articles and methods for signal routing in wearable electronic devices that detect muscle activity of a user using a set of discrete and separately enclosed pod structures |
US10042422B2 (en) | 2013-11-12 | 2018-08-07 | Thalmic Labs Inc. | Systems, articles, and methods for capacitive electromyography sensors |
US9788789B2 (en) | 2013-08-30 | 2017-10-17 | Thalmic Labs Inc. | Systems, articles, and methods for stretchable printed circuit boards |
GB2518369A (en) * | 2013-09-18 | 2015-03-25 | Biomet Global Supply Chain Ct B V | Apparatus and Method for User Exercise Monitoring |
US10251576B2 (en) | 2013-09-25 | 2019-04-09 | Bardy Diagnostics, Inc. | System and method for ECG data classification for use in facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
US9408545B2 (en) | 2013-09-25 | 2016-08-09 | Bardy Diagnostics, Inc. | Method for efficiently encoding and compressing ECG data optimized for use in an ambulatory ECG monitor |
US9504423B1 (en) | 2015-10-05 | 2016-11-29 | Bardy Diagnostics, Inc. | Method for addressing medical conditions through a wearable health monitor with the aid of a digital computer |
US9433367B2 (en) | 2013-09-25 | 2016-09-06 | Bardy Diagnostics, Inc. | Remote interfacing of extended wear electrocardiography and physiological sensor monitor |
US10624551B2 (en) | 2013-09-25 | 2020-04-21 | Bardy Diagnostics, Inc. | Insertable cardiac monitor for use in performing long term electrocardiographic monitoring |
US9345414B1 (en) | 2013-09-25 | 2016-05-24 | Bardy Diagnostics, Inc. | Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer |
US10433751B2 (en) | 2013-09-25 | 2019-10-08 | Bardy Diagnostics, Inc. | System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data |
US20190167139A1 (en) | 2017-12-05 | 2019-06-06 | Gust H. Bardy | Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring |
US10165946B2 (en) | 2013-09-25 | 2019-01-01 | Bardy Diagnostics, Inc. | Computer-implemented system and method for providing a personal mobile device-triggered medical intervention |
US10888239B2 (en) | 2013-09-25 | 2021-01-12 | Bardy Diagnostics, Inc. | Remote interfacing electrocardiography patch |
US9433380B1 (en) | 2013-09-25 | 2016-09-06 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch |
US9717432B2 (en) | 2013-09-25 | 2017-08-01 | Bardy Diagnostics, Inc. | Extended wear electrocardiography patch using interlaced wire electrodes |
US10433748B2 (en) | 2013-09-25 | 2019-10-08 | Bardy Diagnostics, Inc. | Extended wear electrocardiography and physiological sensor monitor |
US10736531B2 (en) | 2013-09-25 | 2020-08-11 | Bardy Diagnostics, Inc. | Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection |
US10799137B2 (en) | 2013-09-25 | 2020-10-13 | Bardy Diagnostics, Inc. | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer |
US9655537B2 (en) | 2013-09-25 | 2017-05-23 | Bardy Diagnostics, Inc. | Wearable electrocardiography and physiology monitoring ensemble |
US9717433B2 (en) | 2013-09-25 | 2017-08-01 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US10667711B1 (en) | 2013-09-25 | 2020-06-02 | Bardy Diagnostics, Inc. | Contact-activated extended wear electrocardiography and physiological sensor monitor recorder |
US11723575B2 (en) | 2013-09-25 | 2023-08-15 | Bardy Diagnostics, Inc. | Electrocardiography patch |
US9364155B2 (en) | 2013-09-25 | 2016-06-14 | Bardy Diagnostics, Inc. | Self-contained personal air flow sensing monitor |
WO2015048194A1 (en) | 2013-09-25 | 2015-04-02 | Bardy Diagnostics, Inc. | Self-contained personal air flow sensing monitor |
US9615763B2 (en) | 2013-09-25 | 2017-04-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation |
US10736529B2 (en) | 2013-09-25 | 2020-08-11 | Bardy Diagnostics, Inc. | Subcutaneous insertable electrocardiography monitor |
US9700227B2 (en) | 2013-09-25 | 2017-07-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US9408551B2 (en) | 2013-11-14 | 2016-08-09 | Bardy Diagnostics, Inc. | System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
US9737224B2 (en) | 2013-09-25 | 2017-08-22 | Bardy Diagnostics, Inc. | Event alerting through actigraphy embedded within electrocardiographic data |
US9775536B2 (en) | 2013-09-25 | 2017-10-03 | Bardy Diagnostics, Inc. | Method for constructing a stress-pliant physiological electrode assembly |
US9655538B2 (en) | 2013-09-25 | 2017-05-23 | Bardy Diagnostics, Inc. | Self-authenticating electrocardiography monitoring circuit |
US9619660B1 (en) | 2013-09-25 | 2017-04-11 | Bardy Diagnostics, Inc. | Computer-implemented system for secure physiological data collection and processing |
US10463269B2 (en) | 2013-09-25 | 2019-11-05 | Bardy Diagnostics, Inc. | System and method for machine-learning-based atrial fibrillation detection |
US10806360B2 (en) | 2013-09-25 | 2020-10-20 | Bardy Diagnostics, Inc. | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US10820801B2 (en) | 2013-09-25 | 2020-11-03 | Bardy Diagnostics, Inc. | Electrocardiography monitor configured for self-optimizing ECG data compression |
US11213237B2 (en) | 2013-09-25 | 2022-01-04 | Bardy Diagnostics, Inc. | System and method for secure cloud-based physiological data processing and delivery |
US9730593B2 (en) | 2013-09-25 | 2017-08-15 | Bardy Diagnostics, Inc. | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US9795299B2 (en) | 2013-09-27 | 2017-10-24 | Covidien Lp | Modular physiological sensing patch |
JPWO2015049963A1 (en) * | 2013-10-03 | 2017-03-09 | コニカミノルタ株式会社 | Biological information measuring apparatus and method |
US9396643B2 (en) | 2013-10-23 | 2016-07-19 | Quanttus, Inc. | Biometric authentication |
WO2015081113A1 (en) | 2013-11-27 | 2015-06-04 | Cezar Morun | Systems, articles, and methods for electromyography sensors |
US20150172893A1 (en) * | 2013-12-12 | 2015-06-18 | Gerard St. Germain | Mobile Companion |
US9403047B2 (en) | 2013-12-26 | 2016-08-02 | Icon Health & Fitness, Inc. | Magnetic resistance mechanism in a cable machine |
USD754149S1 (en) * | 2013-12-30 | 2016-04-19 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with graphical user interface |
EP2896359B1 (en) | 2014-01-07 | 2016-12-14 | Samsung Electronics Co., Ltd | Method and system for measuring heart rate in electronic device using photoplethysmography |
JP2015141293A (en) * | 2014-01-28 | 2015-08-03 | ソニー株式会社 | Display control apparatus, display control method, program, and display device |
WO2015123175A1 (en) * | 2014-02-14 | 2015-08-20 | Global Nutrition & Health, Inc. | Transcutaneous photoplethysmography |
US9031812B2 (en) | 2014-02-27 | 2015-05-12 | Fitbit, Inc. | Notifications on a user device based on activity detected by an activity monitoring device |
US11990019B2 (en) | 2014-02-27 | 2024-05-21 | Fitbit, Inc. | Notifications on a user device based on activity detected by an activity monitoring device |
US10433612B2 (en) | 2014-03-10 | 2019-10-08 | Icon Health & Fitness, Inc. | Pressure sensor to quantify work |
US9636023B2 (en) | 2014-03-12 | 2017-05-02 | John M. Geesbreght | Portable rapid vital sign apparatus and method |
EP3117355A1 (en) * | 2014-03-13 | 2017-01-18 | Koninklijke Philips N.V. | Patient watch-dog and intervention/event timeline |
US10199008B2 (en) | 2014-03-27 | 2019-02-05 | North Inc. | Systems, devices, and methods for wearable electronic devices as state machines |
US10758130B2 (en) | 2014-03-31 | 2020-09-01 | Welch Allyn, Inc. | Single site vitals |
CN103892810A (en) * | 2014-04-11 | 2014-07-02 | 南京航空航天大学 | Multi-media intelligent housekeeping system |
US11055980B2 (en) | 2014-04-16 | 2021-07-06 | Murata Vios, Inc. | Patient care and health information management systems and methods |
US9288298B2 (en) | 2014-05-06 | 2016-03-15 | Fitbit, Inc. | Notifications regarding interesting or unusual activity detected from an activity monitoring device |
KR102238330B1 (en) * | 2014-05-16 | 2021-04-09 | 엘지전자 주식회사 | Display device and operating method thereof |
US10452875B2 (en) | 2014-05-22 | 2019-10-22 | Avery Dennison Retail Information Services, Llc | Using RFID devices integrated or included in the packaging of medical devices to facilitate a secure and authorized pairing with a host system |
US10401380B2 (en) * | 2014-05-22 | 2019-09-03 | The Trustees Of The University Of Pennsylvania | Wearable system for accelerometer-based detection and classification of firearm use |
WO2015191445A1 (en) | 2014-06-09 | 2015-12-17 | Icon Health & Fitness, Inc. | Cable system incorporated into a treadmill |
US9880632B2 (en) | 2014-06-19 | 2018-01-30 | Thalmic Labs Inc. | Systems, devices, and methods for gesture identification |
WO2015195965A1 (en) | 2014-06-20 | 2015-12-23 | Icon Health & Fitness, Inc. | Post workout massage device |
WO2016019040A1 (en) | 2014-07-29 | 2016-02-04 | Kurt Stump | Computer-implemented systems and methods of automated physiological monitoring, prognosis, and triage |
US12089914B2 (en) | 2014-07-29 | 2024-09-17 | Sempulse Corporation | Enhanced physiological monitoring devices and computer-implemented systems and methods of remote physiological monitoring of subjects |
WO2016023151A1 (en) * | 2014-08-11 | 2016-02-18 | 深圳迈瑞生物医疗电子股份有限公司 | Medical apparatus data transmitting system and method |
US10617357B2 (en) * | 2014-08-24 | 2020-04-14 | Halo Wearables, Llc | Swappable wearable device |
WO2016036743A1 (en) * | 2014-09-02 | 2016-03-10 | Segterra Inc. | Providing personalized dietary recommendations |
SG11201702153YA (en) | 2014-09-17 | 2017-04-27 | Canary Medical Inc | Devices, systems and methods for using and monitoring medical devices |
US20160073915A1 (en) * | 2014-09-17 | 2016-03-17 | Louis Felice | Wireless EKG System |
ES2747822T3 (en) | 2014-09-25 | 2020-03-11 | Aseptika Ltd | Medical device |
KR101700217B1 (en) * | 2014-10-02 | 2017-01-26 | (주)직토 | Biometricmethod using wearable device and portalbe device |
WO2016073644A2 (en) * | 2014-11-04 | 2016-05-12 | Aliphcom | Physiological information generation based on bioimpedance signals |
US9685744B2 (en) * | 2014-11-14 | 2017-06-20 | Foxconn Interconnect Technology Limited | Machine case with improved electrical connector |
US9572503B2 (en) * | 2014-11-14 | 2017-02-21 | Eric DeForest | Personal safety and security mobile application responsive to changes in heart rate |
CN106999065B (en) | 2014-11-27 | 2020-08-04 | 皇家飞利浦有限公司 | Wearable pain monitor using accelerometry |
US9807221B2 (en) | 2014-11-28 | 2017-10-31 | Thalmic Labs Inc. | Systems, devices, and methods effected in response to establishing and/or terminating a physical communications link |
BR112017013076A2 (en) * | 2014-12-22 | 2018-01-02 | Koninklijke Philips N.V. | first aid kit and body worn device |
KR102313220B1 (en) | 2015-01-09 | 2021-10-15 | 삼성전자주식회사 | Wearable device and method for controlling thereof |
CN104656896B (en) | 2015-02-10 | 2018-09-18 | 北京智谷睿拓技术服务有限公司 | The method and apparatus for determining input information |
WO2016137698A1 (en) * | 2015-02-24 | 2016-09-01 | Quanttus, Inc. | Calculating pulse transit time from chest vibrations |
US10391361B2 (en) | 2015-02-27 | 2019-08-27 | Icon Health & Fitness, Inc. | Simulating real-world terrain on an exercise device |
PL411674A1 (en) * | 2015-03-20 | 2016-09-26 | Heart Spółka Z Ograniczoną Odpowiedzialnością | Device for monitoring perceptible pain |
WO2016151099A1 (en) * | 2015-03-24 | 2016-09-29 | Koninklijke Philips N.V. | Learning mode for context identification |
DE102015104432A1 (en) * | 2015-03-24 | 2016-09-29 | Beurer Gmbh | BDM system for the long-term measurement of blood pressure |
WO2016154256A1 (en) * | 2015-03-25 | 2016-09-29 | Quanttus, Inc. | Contact-less blood pressure measurement |
US10557881B2 (en) | 2015-03-27 | 2020-02-11 | Analog Devices Global | Electrical overstress reporting |
US10078435B2 (en) | 2015-04-24 | 2018-09-18 | Thalmic Labs Inc. | Systems, methods, and computer program products for interacting with electronically displayed presentation materials |
US10470692B2 (en) | 2015-06-12 | 2019-11-12 | ChroniSense Medical Ltd. | System for performing pulse oximetry |
US10952638B2 (en) | 2015-06-12 | 2021-03-23 | ChroniSense Medical Ltd. | System and method for monitoring respiratory rate and oxygen saturation |
US11160459B2 (en) | 2015-06-12 | 2021-11-02 | ChroniSense Medical Ltd. | Monitoring health status of people suffering from chronic diseases |
US10687742B2 (en) | 2015-06-12 | 2020-06-23 | ChroniSense Medical Ltd. | Using invariant factors for pulse oximetry |
US11464457B2 (en) | 2015-06-12 | 2022-10-11 | ChroniSense Medical Ltd. | Determining an early warning score based on wearable device measurements |
US11160461B2 (en) | 2015-06-12 | 2021-11-02 | ChroniSense Medical Ltd. | Blood pressure measurement using a wearable device |
US11712190B2 (en) * | 2015-06-12 | 2023-08-01 | ChroniSense Medical Ltd. | Wearable device electrocardiogram |
US10420515B2 (en) | 2015-06-15 | 2019-09-24 | Vital Labs, Inc. | Method and system for acquiring data for assessment of cardiovascular disease |
US10420475B2 (en) | 2015-06-15 | 2019-09-24 | Vital Labs, Inc. | Method and system for cardiovascular disease assessment and management |
US10349890B2 (en) * | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
US11116397B2 (en) * | 2015-07-14 | 2021-09-14 | Welch Allyn, Inc. | Method and apparatus for managing sensors |
CN107920760B (en) | 2015-08-21 | 2021-09-17 | 皇家飞利浦有限公司 | Monitoring device for monitoring blood pressure of a subject |
KR102612874B1 (en) | 2015-08-31 | 2023-12-12 | 마시모 코오퍼레이션 | Wireless patient monitoring systems and methods |
US10398321B2 (en) * | 2015-09-01 | 2019-09-03 | Siemens Healthcare Gmbh | Thermal patient signal analysis |
US9717424B2 (en) | 2015-10-19 | 2017-08-01 | Garmin Switzerland Gmbh | System and method for generating a PPG signal |
US10918340B2 (en) | 2015-10-22 | 2021-02-16 | Welch Allyn, Inc. | Method and apparatus for detecting a biological condition |
US20180344239A1 (en) * | 2015-11-13 | 2018-12-06 | Segterra, Inc. | Managing Evidence-Based Rules |
US10438123B2 (en) * | 2015-11-19 | 2019-10-08 | International Business Machines Corporation | Cognitive publication subscriber system, method, and recording medium with a firewall |
US10758143B2 (en) * | 2015-11-26 | 2020-09-01 | Huawei Technologies Co., Ltd. | Blood pressure parameter detection method and user equipment |
US20170156606A1 (en) * | 2015-12-02 | 2017-06-08 | Echo Labs, Inc. | Systems and methods for non-invasive blood pressure measurement |
WO2017096291A1 (en) * | 2015-12-02 | 2017-06-08 | Wyllness Llc | Pain behavior analysis system |
US10646144B2 (en) | 2015-12-07 | 2020-05-12 | Marcelo Malini Lamego | Wireless, disposable, extended use pulse oximeter apparatus and methods |
USD781881S1 (en) | 2015-12-09 | 2017-03-21 | Facebook, Inc. | Display screen with animated graphical user interface |
US9883800B2 (en) | 2016-02-11 | 2018-02-06 | General Electric Company | Wireless patient monitoring system and method |
US9814388B2 (en) | 2016-02-11 | 2017-11-14 | General Electric Company | Wireless patient monitoring system and method |
US10080530B2 (en) | 2016-02-19 | 2018-09-25 | Fitbit, Inc. | Periodic inactivity alerts and achievement messages |
US11000235B2 (en) | 2016-03-14 | 2021-05-11 | ChroniSense Medical Ltd. | Monitoring procedure for early warning of cardiac episodes |
US10493349B2 (en) | 2016-03-18 | 2019-12-03 | Icon Health & Fitness, Inc. | Display on exercise device |
US10625137B2 (en) | 2016-03-18 | 2020-04-21 | Icon Health & Fitness, Inc. | Coordinated displays in an exercise device |
US10272317B2 (en) | 2016-03-18 | 2019-04-30 | Icon Health & Fitness, Inc. | Lighted pace feature in a treadmill |
EP3432781A4 (en) | 2016-03-23 | 2020-04-01 | Canary Medical Inc. | Implantable reporting processor for an alert implant |
US10118696B1 (en) | 2016-03-31 | 2018-11-06 | Steven M. Hoffberg | Steerable rotating projectile |
JP6868039B2 (en) * | 2016-04-21 | 2021-05-12 | シグニファイ ホールディング ビー ヴィSignify Holding B.V. | Systems and methods for localizing sensing devices |
US10098558B2 (en) | 2016-04-25 | 2018-10-16 | General Electric Company | Wireless patient monitoring system and method |
US20170332922A1 (en) * | 2016-05-18 | 2017-11-23 | Welch Allyn, Inc. | Stroke detection using ocular pulse estimation |
US10617302B2 (en) | 2016-07-07 | 2020-04-14 | Masimo Corporation | Wearable pulse oximeter and respiration monitor |
USD859452S1 (en) * | 2016-07-18 | 2019-09-10 | Emojot, Inc. | Display screen for media players with graphical user interface |
US11216069B2 (en) | 2018-05-08 | 2022-01-04 | Facebook Technologies, Llc | Systems and methods for improved speech recognition using neuromuscular information |
WO2020112986A1 (en) | 2018-11-27 | 2020-06-04 | Facebook Technologies, Inc. | Methods and apparatus for autocalibration of a wearable electrode sensor system |
US11635736B2 (en) | 2017-10-19 | 2023-04-25 | Meta Platforms Technologies, Llc | Systems and methods for identifying biological structures associated with neuromuscular source signals |
EP3487395A4 (en) | 2016-07-25 | 2020-03-04 | CTRL-Labs Corporation | Methods and apparatus for predicting musculo-skeletal position information using wearable autonomous sensors |
US10973416B2 (en) * | 2016-08-02 | 2021-04-13 | Welch Allyn, Inc. | Method and apparatus for monitoring biological conditions |
CN106308782B (en) * | 2016-08-30 | 2019-06-25 | 福州康达八方电子科技有限公司 | A kind of blood pressure instrument of band simulation sphygomanometers |
CN106264516A (en) * | 2016-08-30 | 2017-01-04 | 欧东波 | A kind of 12 lead cardiac electrophysiology monitoring and transmission equipment and system thereof |
GB201615899D0 (en) * | 2016-09-19 | 2016-11-02 | Oxehealth Ltd | Method and apparatus for image processing |
US10671705B2 (en) | 2016-09-28 | 2020-06-02 | Icon Health & Fitness, Inc. | Customizing recipe recommendations |
US11076777B2 (en) | 2016-10-13 | 2021-08-03 | Masimo Corporation | Systems and methods for monitoring orientation to reduce pressure ulcer formation |
CN106344023B (en) * | 2016-11-10 | 2020-02-11 | 重庆邮电大学 | Unsteady state respiratory wave detection device based on atmospheric pressure and acceleration |
US10238301B2 (en) | 2016-11-15 | 2019-03-26 | Avidhrt, Inc. | Vital monitoring device, system, and method |
US9905105B1 (en) | 2016-12-01 | 2018-02-27 | General Electric Company | Method of increasing sensing device noticeability upon low battery level |
USD821587S1 (en) | 2017-01-26 | 2018-06-26 | Michael J. Vosch | Electrode patch array |
USD821588S1 (en) | 2017-01-26 | 2018-06-26 | Michael J. Vosch | Electrode patch array |
US20180235478A1 (en) * | 2017-02-18 | 2018-08-23 | VVV IP Holdings Limited | Multi-Vital Sign Detector in an Electronic Medical Records System |
US10524735B2 (en) * | 2017-03-28 | 2020-01-07 | Apple Inc. | Detecting conditions using heart rate sensors |
US20180333573A1 (en) * | 2017-05-18 | 2018-11-22 | Frederick Stephen Felt | Protection of biological systems |
EP3417770A1 (en) * | 2017-06-23 | 2018-12-26 | Koninklijke Philips N.V. | Device, system and method for detection of pulse and/or pulse-related information of a patient |
USD838923S1 (en) * | 2017-07-21 | 2019-01-22 | Shenzhen Dogcare Innovation & Technology Co., Ltd. | Training mat controller |
US11089962B2 (en) * | 2017-08-07 | 2021-08-17 | General Electric Company | Patient monitoring system and method with volume assessment |
US10123702B1 (en) * | 2017-08-31 | 2018-11-13 | Jennifer Wilkins | Patient monitoring system |
US10806933B2 (en) | 2017-09-06 | 2020-10-20 | General Electric Company | Patient monitoring systems and methods that detect interference with pacemaker |
US10727956B2 (en) * | 2017-09-06 | 2020-07-28 | Hill-Rom Services, Inc. | Wireless sensors in medical environments |
USD907213S1 (en) | 2017-09-18 | 2021-01-05 | Dms-Service Llc | Patch with electrode array |
US11237712B2 (en) * | 2017-10-31 | 2022-02-01 | Ricoh Company, Ltd. | Information processing device, biomedical-signal measuring system, display method, and recording medium storing program code |
USD898202S1 (en) | 2017-11-12 | 2020-10-06 | Dms-Service Llc | Patch with electrode array |
US10098587B1 (en) | 2017-12-27 | 2018-10-16 | Industrial Technology Research Institute | Physiology detecting garment and method thereof |
US10937414B2 (en) | 2018-05-08 | 2021-03-02 | Facebook Technologies, Llc | Systems and methods for text input using neuromuscular information |
US11907423B2 (en) | 2019-11-25 | 2024-02-20 | Meta Platforms Technologies, Llc | Systems and methods for contextualized interactions with an environment |
US11481030B2 (en) | 2019-03-29 | 2022-10-25 | Meta Platforms Technologies, Llc | Methods and apparatus for gesture detection and classification |
US11493993B2 (en) | 2019-09-04 | 2022-11-08 | Meta Platforms Technologies, Llc | Systems, methods, and interfaces for performing inputs based on neuromuscular control |
US11961494B1 (en) | 2019-03-29 | 2024-04-16 | Meta Platforms Technologies, Llc | Electromagnetic interference reduction in extended reality environments |
US11150730B1 (en) | 2019-04-30 | 2021-10-19 | Facebook Technologies, Llc | Devices, systems, and methods for controlling computing devices via neuromuscular signals of users |
US10659963B1 (en) | 2018-02-12 | 2020-05-19 | True Wearables, Inc. | Single use medical device apparatus and methods |
EP3537351A1 (en) * | 2018-03-09 | 2019-09-11 | Smart Textiles Sp. z o.o | Monitoring device |
US11712637B1 (en) | 2018-03-23 | 2023-08-01 | Steven M. Hoffberg | Steerable disk or ball |
US10592001B2 (en) | 2018-05-08 | 2020-03-17 | Facebook Technologies, Llc | Systems and methods for improved speech recognition using neuromuscular information |
US11004322B2 (en) | 2018-07-20 | 2021-05-11 | General Electric Company | Systems and methods for adjusting medical device behavior |
US11026587B2 (en) | 2018-07-24 | 2021-06-08 | Baxter International Inc. | Physiological sensor resembling a neck-worn collar |
US10842392B2 (en) | 2018-07-24 | 2020-11-24 | Baxter International Inc. | Patch-based physiological sensor |
US11058340B2 (en) | 2018-07-24 | 2021-07-13 | Baxter International Inc. | Patch-based physiological sensor |
US11045094B2 (en) | 2018-07-24 | 2021-06-29 | Baxter International Inc. | Patch-based physiological sensor |
US11202578B2 (en) | 2018-07-24 | 2021-12-21 | Welch Allyn, Inc. | Patch-based physiological sensor |
US11096590B2 (en) | 2018-07-24 | 2021-08-24 | Baxter International Inc. | Patch-based physiological sensor |
US11064918B2 (en) | 2018-07-24 | 2021-07-20 | Baxter International Inc. | Patch-based physiological sensor |
US11039751B2 (en) | 2018-07-24 | 2021-06-22 | Baxter International Inc. | Physiological sensor resembling a neck-worn collar |
US11116410B2 (en) | 2018-07-24 | 2021-09-14 | Baxter International Inc. | Patch-based physiological sensor |
EP4241661A1 (en) | 2018-08-31 | 2023-09-13 | Facebook Technologies, LLC | Camera-guided interpretation of neuromuscular signals |
WO2020061451A1 (en) | 2018-09-20 | 2020-03-26 | Ctrl-Labs Corporation | Neuromuscular text entry, writing and drawing in augmented reality systems |
EP3866673A4 (en) * | 2018-10-09 | 2022-09-14 | Inovytec Medical Solutions Ltd. | A system for immediate personalized treatment of a patient in a medical emergency |
WO2020077149A1 (en) * | 2018-10-12 | 2020-04-16 | Masimo Corporation | System for transmission of sensor data using dual communication protocol |
CN112867443B (en) | 2018-10-16 | 2024-04-26 | 巴德阿克塞斯系统股份有限公司 | Safety equipment connection system for establishing electrical connection and method thereof |
CA3120321A1 (en) * | 2018-11-28 | 2020-06-04 | Easyg Llc | Contactless electrode for sensing physiological electrical activity |
US20210346651A1 (en) | 2018-12-31 | 2021-11-11 | Nuwellis, Inc. | Blood flow assisting portable arm support |
CN110010242B (en) * | 2019-04-03 | 2021-09-17 | 吉林大学第一医院 | Intensive care system based on Internet of things |
US11398305B2 (en) | 2019-05-13 | 2022-07-26 | Hill-Rom Services, Inc. | Patient request system and method |
US11191466B1 (en) | 2019-06-28 | 2021-12-07 | Fitbit Inc. | Determining mental health and cognitive state through physiological and other non-invasively obtained data |
US11116451B2 (en) | 2019-07-03 | 2021-09-14 | Bardy Diagnostics, Inc. | Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities |
US11696681B2 (en) | 2019-07-03 | 2023-07-11 | Bardy Diagnostics Inc. | Configurable hardware platform for physiological monitoring of a living body |
US11096579B2 (en) | 2019-07-03 | 2021-08-24 | Bardy Diagnostics, Inc. | System and method for remote ECG data streaming in real-time |
US20210020278A1 (en) * | 2019-07-15 | 2021-01-21 | Hill-Rom Services, Inc. | Personalized baselines, visualizations, and handoffs |
US11045096B2 (en) | 2019-07-24 | 2021-06-29 | Francis Ndeithi | Finger blood monitor apparatus |
US11717186B2 (en) | 2019-08-27 | 2023-08-08 | Medtronic, Inc. | Body stability measurement |
US11783944B2 (en) * | 2019-09-09 | 2023-10-10 | Neal F. Krouse | System for live monitoring of vitals for patients and physicians |
EP3792932A1 (en) * | 2019-09-13 | 2021-03-17 | Hill-Rom Services, Inc. | Personalized vital sign monitors |
EP4037555A4 (en) | 2019-10-01 | 2023-05-31 | Riva Health, Inc. | Method and system for determining cardiovascular parameters |
USD936916S1 (en) * | 2019-10-01 | 2021-11-23 | Shenzhen Patpet Technology CO., LTD | Transmitter of dog training collar |
US11157079B2 (en) * | 2019-10-31 | 2021-10-26 | Sony Interactive Entertainment Inc. | Multi-player calibration of various stand-alone capture systems |
AU2019101396A4 (en) * | 2019-11-14 | 2020-01-02 | Pulse Link Pty Ltd | Smart Personal Monitoring Systems and Methods thereof |
US20210145356A1 (en) * | 2019-11-14 | 2021-05-20 | Medicomp, Inc. | Mobile enabled chest worn ecg monitor |
US11375905B2 (en) | 2019-11-21 | 2022-07-05 | Medtronic, Inc. | Performing one or more pulse transit time measurements based on an electrogram signal and a photoplethysmography signal |
US10813438B1 (en) * | 2019-12-15 | 2020-10-27 | Valerie Herman | Barcode scanner glove with thumb activation |
US20210275110A1 (en) | 2019-12-30 | 2021-09-09 | RubyElf, LLC | Systems For Synchronizing Different Devices To A Cardiac Cycle And For Generating Pulse Waveforms From Synchronized ECG and PPG Systems |
US11730379B2 (en) | 2020-03-20 | 2023-08-22 | Masimo Corporation | Remote patient management and monitoring systems and methods |
USD974193S1 (en) | 2020-07-27 | 2023-01-03 | Masimo Corporation | Wearable temperature measurement device |
USD980091S1 (en) | 2020-07-27 | 2023-03-07 | Masimo Corporation | Wearable temperature measurement device |
US20220047214A1 (en) * | 2020-08-14 | 2022-02-17 | Charles Edwards | Wearable monitor device |
CN112150765B (en) * | 2020-08-18 | 2024-08-09 | 来邦养老科技有限公司 | Fall alarm detection device and method |
WO2022187746A1 (en) | 2021-03-05 | 2022-09-09 | Riva Health, Inc. | System and method for validating cardiovascular parameter monitors |
US11868531B1 (en) | 2021-04-08 | 2024-01-09 | Meta Platforms Technologies, Llc | Wearable device providing for thumb-to-finger-based input gestures detected based on neuromuscular signals, and systems and methods of use thereof |
US11830624B2 (en) | 2021-09-07 | 2023-11-28 | Riva Health, Inc. | System and method for determining data quality for cardiovascular parameter determination |
USD1000975S1 (en) | 2021-09-22 | 2023-10-10 | Masimo Corporation | Wearable temperature measurement device |
US20240316309A1 (en) * | 2021-12-10 | 2024-09-26 | Atatürk Üniversitesi Bilimsel Arastirma Projeleri Birimi | Therapeutic touching device |
Family Cites Families (401)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4086916A (en) | 1975-09-19 | 1978-05-02 | Joseph J. Cayre | Cardiac monitor wristwatch |
US4263918A (en) * | 1977-03-21 | 1981-04-28 | Biomega Corporation | Methods of and apparatus for the measurement of blood pressure |
US4270547A (en) * | 1978-10-03 | 1981-06-02 | University Patents, Inc. | Vital signs monitoring system |
US4305400A (en) * | 1979-10-15 | 1981-12-15 | Squibb Vitatek Inc. | Respiration monitoring method and apparatus including cardio-vascular artifact detection |
US4722351A (en) * | 1981-12-21 | 1988-02-02 | American Home Products Corporation | Systems and methods for processing physiological signals |
US4582068A (en) * | 1981-12-21 | 1986-04-15 | American Home Products Corporation | Systems and methods for processing physiological signals |
US4653498A (en) * | 1982-09-13 | 1987-03-31 | Nellcor Incorporated | Pulse oximeter monitor |
US5224928A (en) * | 1983-08-18 | 1993-07-06 | Drug Delivery Systems Inc. | Mounting system for transdermal drug applicator |
US4710164A (en) | 1984-05-01 | 1987-12-01 | Henry Ford Hospital | Automated hemodialysis control based upon patient blood pressure and heart rate |
US4577639A (en) | 1984-11-08 | 1986-03-25 | Spacelabs, Inc. | Apparatus and method for automatic lead selection in electrocardiography |
US4802486A (en) * | 1985-04-01 | 1989-02-07 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4751642A (en) * | 1986-08-29 | 1988-06-14 | Silva John M | Interactive sports simulation system with physiological sensing and psychological conditioning |
US4807638A (en) * | 1987-10-21 | 1989-02-28 | Bomed Medical Manufacturing, Ltd. | Noninvasive continuous mean arterial blood prssure monitor |
US4905697A (en) * | 1989-02-14 | 1990-03-06 | Cook Pacemaker Corporation | Temperature-controlled cardiac pacemaker responsive to body motion |
JPH0315502U (en) * | 1989-06-28 | 1991-02-15 | ||
US5339818A (en) | 1989-09-20 | 1994-08-23 | University Of Utah Research Foundation | Method for determining blood pressure utilizing a neural network |
US5190038A (en) * | 1989-11-01 | 1993-03-02 | Novametrix Medical Systems, Inc. | Pulse oximeter with improved accuracy and response time |
EP0443267A1 (en) | 1990-02-23 | 1991-08-28 | Sentinel Monitoring, Inc. | Method and apparatus for continuous non-invasive blood pressure monitoring |
US5316008A (en) * | 1990-04-06 | 1994-05-31 | Casio Computer Co., Ltd. | Measurement of electrocardiographic wave and sphygmus |
US5465082A (en) * | 1990-07-27 | 1995-11-07 | Executone Information Systems, Inc. | Apparatus for automating routine communication in a facility |
US5140990A (en) * | 1990-09-06 | 1992-08-25 | Spacelabs, Inc. | Method of measuring blood pressure with a photoplethysmograph |
AU658177B2 (en) * | 1991-03-07 | 1995-04-06 | Masimo Corporation | Signal processing apparatus and method |
MX9702434A (en) | 1991-03-07 | 1998-05-31 | Masimo Corp | Signal processing apparatus. |
US5490505A (en) * | 1991-03-07 | 1996-02-13 | Masimo Corporation | Signal processing apparatus |
US5632272A (en) * | 1991-03-07 | 1997-05-27 | Masimo Corporation | Signal processing apparatus |
US6580086B1 (en) | 1999-08-26 | 2003-06-17 | Masimo Corporation | Shielded optical probe and method |
US6541756B2 (en) | 1991-03-21 | 2003-04-01 | Masimo Corporation | Shielded optical probe having an electrical connector |
US5197489A (en) * | 1991-06-17 | 1993-03-30 | Precision Control Design, Inc. | Activity monitoring apparatus with configurable filters |
US5247931A (en) * | 1991-09-16 | 1993-09-28 | Mine Safety Appliances Company | Diagnostic sensor clasp utilizing a slot, pivot and spring hinge mechanism |
US6471872B2 (en) | 1991-10-11 | 2002-10-29 | Children's Hospital Medical Center | Hemofiltration system and method based on monitored patient parameters |
US5289824A (en) * | 1991-12-26 | 1994-03-01 | Instromedix, Inc. | Wrist-worn ECG monitor |
FI92139C (en) * | 1992-02-28 | 1994-10-10 | Matti Myllymaeki | Monitoring device for the health condition, which is attached to the wrist |
US5853370A (en) * | 1996-09-13 | 1998-12-29 | Non-Invasive Technology, Inc. | Optical system and method for non-invasive imaging of biological tissue |
US5899855A (en) * | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
US6968375B1 (en) | 1997-03-28 | 2005-11-22 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US5485838A (en) * | 1992-12-07 | 1996-01-23 | Nihon Kohden Corporation | Non-invasive blood pressure measurement device |
US5394879A (en) * | 1993-03-19 | 1995-03-07 | Gorman; Peter G. | Biomedical response monitor-exercise equipment and technique using error correction |
EP0658331B1 (en) * | 1993-12-11 | 1996-10-02 | Hewlett-Packard GmbH | A method for detecting an irregular state in a non-invasive pulse oximeter system |
US5661632A (en) * | 1994-01-04 | 1997-08-26 | Dell Usa, L.P. | Hand held computer with dual display screen orientation capability controlled by toggle switches having first and second non-momentary positions |
JP2764702B2 (en) * | 1994-03-30 | 1998-06-11 | 日本光電工業株式会社 | Blood pressure monitoring device |
US5575284A (en) * | 1994-04-01 | 1996-11-19 | University Of South Florida | Portable pulse oximeter |
US6371921B1 (en) | 1994-04-15 | 2002-04-16 | Masimo Corporation | System and method of determining whether to recalibrate a blood pressure monitor |
JP3318727B2 (en) * | 1994-06-06 | 2002-08-26 | 日本光電工業株式会社 | Pulse wave transit time sphygmomanometer |
US5549650A (en) * | 1994-06-13 | 1996-08-27 | Pacesetter, Inc. | System and method for providing hemodynamically optimal pacing therapy |
US5848373A (en) * | 1994-06-24 | 1998-12-08 | Delorme Publishing Company | Computer aided map location system |
US5524637A (en) * | 1994-06-29 | 1996-06-11 | Erickson; Jon W. | Interactive system for measuring physiological exertion |
DE4429845C1 (en) * | 1994-08-23 | 1995-10-19 | Hewlett Packard Gmbh | Pulse oximeter with flexible strap for attachment to hand or foot |
JP3422128B2 (en) * | 1994-11-15 | 2003-06-30 | オムロン株式会社 | Blood pressure measurement device |
US5919141A (en) * | 1994-11-15 | 1999-07-06 | Life Sensing Instrument Company, Inc. | Vital sign remote monitoring device |
US5680870A (en) * | 1995-01-04 | 1997-10-28 | Johnson & Johnson Medical, Inc. | Oscillometric blood pressure monitor which acquires blood pressure signals from composite arterial pulse signal |
US5593431A (en) * | 1995-03-30 | 1997-01-14 | Medtronic, Inc. | Medical service employing multiple DC accelerometers for patient activity and posture sensing and method |
JPH08328282A (en) * | 1995-06-01 | 1996-12-13 | Fujitsu Ltd | Photoreceptor drum and image recorder having the same |
US6041783A (en) * | 1995-06-07 | 2000-03-28 | Nellcor Puritan Bennett Corporation | Integrated activity sensor |
US5645060A (en) * | 1995-06-14 | 1997-07-08 | Nellcor Puritan Bennett Incorporated | Method and apparatus for removing artifact and noise from pulse oximetry |
US5766131A (en) * | 1995-08-04 | 1998-06-16 | Seiko Epson Corporation | Pulse-wave measuring apparatus |
US5743856A (en) | 1995-11-06 | 1998-04-28 | Colin Corporation | Apparatus for measuring pulse-wave propagation velocity |
US5944659A (en) | 1995-11-13 | 1999-08-31 | Vitalcom Inc. | Architecture for TDMA medical telemetry system |
US5588427A (en) * | 1995-11-20 | 1996-12-31 | Spacelabs Medical, Inc. | Enhancement of physiological signals using fractal analysis |
US7190984B1 (en) | 1996-03-05 | 2007-03-13 | Nellcor Puritan Bennett Incorporated | Shunt barrier in pulse oximeter sensor |
US6030342A (en) | 1996-06-12 | 2000-02-29 | Seiko Epson Corporation | Device for measuring calorie expenditure and device for measuring body temperature |
US5941836A (en) * | 1996-06-12 | 1999-08-24 | Friedman; Mark B. | Patient position monitor |
US6027452A (en) | 1996-06-26 | 2000-02-22 | Vital Insite, Inc. | Rapid non-invasive blood pressure measuring device |
DE69736622T2 (en) | 1996-07-03 | 2007-09-13 | Hitachi, Ltd. | Motion detection system |
WO1998010699A1 (en) * | 1996-09-10 | 1998-03-19 | Seiko Epson Corporation | Organism state measuring device and relaxation instructing device |
US6018673A (en) | 1996-10-10 | 2000-01-25 | Nellcor Puritan Bennett Incorporated | Motion compatible sensor for non-invasive optical blood analysis |
US5865755A (en) * | 1996-10-11 | 1999-02-02 | Dxtek, Inc. | Method and apparatus for non-invasive, cuffless, continuous blood pressure determination |
US5800349A (en) * | 1996-10-15 | 1998-09-01 | Nonin Medical, Inc. | Offset pulse oximeter sensor |
EP0934021A2 (en) * | 1996-10-24 | 1999-08-11 | Massachusetts Institute Of Technology | Patient monitoring finger ring sensor |
IL119721A (en) * | 1996-11-29 | 2005-08-31 | Mindlife Ltd | Method and system for monitoring the physiological condition of a patient |
US6198394B1 (en) * | 1996-12-05 | 2001-03-06 | Stephen C. Jacobsen | System for remote monitoring of personnel |
US5876353A (en) * | 1997-01-31 | 1999-03-02 | Medtronic, Inc. | Impedance monitor for discerning edema through evaluation of respiratory rate |
US6159147A (en) * | 1997-02-28 | 2000-12-12 | Qrs Diagnostics, Llc | Personal computer card for collection of real-time biological data |
US7885697B2 (en) | 2004-07-13 | 2011-02-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
US6002952A (en) | 1997-04-14 | 1999-12-14 | Masimo Corporation | Signal processing apparatus and method |
US5865756A (en) * | 1997-06-06 | 1999-02-02 | Southwest Research Institute | System and method for identifying and correcting abnormal oscillometric pulse waves |
US5895359A (en) * | 1997-06-06 | 1999-04-20 | Southwest Research Institute | System and method for correcting a living subject's measured blood pressure |
US6732064B1 (en) | 1997-07-02 | 2004-05-04 | Nonlinear Solutions, Inc. | Detection and classification system for analyzing deterministic properties of data using correlation parameters |
US6262769B1 (en) | 1997-07-31 | 2001-07-17 | Flashpoint Technology, Inc. | Method and system for auto rotating a graphical user interface for managing portrait and landscape images in an image capture unit |
US7383069B2 (en) | 1997-08-14 | 2008-06-03 | Sensys Medical, Inc. | Method of sample control and calibration adjustment for use with a noninvasive analyzer |
US6198951B1 (en) * | 1997-09-05 | 2001-03-06 | Seiko Epson Corporation | Reflection photodetector and biological information measuring instrument |
GB2329250A (en) | 1997-09-11 | 1999-03-17 | Kevin Doughty | Non-intrusive electronic determination of the orientation and presence of a person or infant in a bed, cot or chair using primary and secondary coils |
US5971930A (en) * | 1997-10-17 | 1999-10-26 | Siemens Medical Systems, Inc. | Method and apparatus for removing artifact from physiological signals |
EP1041923A1 (en) | 1997-12-22 | 2000-10-11 | BTG INTERNATIONAL LIMITED (Company No. 2664412) | Artefact reduction in photoplethysmography |
US7299159B2 (en) | 1998-03-03 | 2007-11-20 | Reuven Nanikashvili | Health monitor system and method for health monitoring |
US7542878B2 (en) | 1998-03-03 | 2009-06-02 | Card Guard Scientific Survival Ltd. | Personal health monitor and a method for health monitoring |
US6057758A (en) | 1998-05-20 | 2000-05-02 | Hewlett-Packard Company | Handheld clinical terminal |
US6094592A (en) * | 1998-05-26 | 2000-07-25 | Nellcor Puritan Bennett, Inc. | Methods and apparatus for estimating a physiological parameter using transforms |
JP2002516689A (en) | 1998-06-03 | 2002-06-11 | マシモ・コーポレイション | Stereo pulse oximeter |
US6199550B1 (en) | 1998-08-14 | 2001-03-13 | Bioasyst, L.L.C. | Integrated physiologic sensor system |
AU1198100A (en) | 1998-09-23 | 2000-04-10 | Keith Bridger | Physiological sensing device |
US6160478A (en) * | 1998-10-27 | 2000-12-12 | Sarcos Lc | Wireless health monitoring system |
US20030158699A1 (en) | 1998-12-09 | 2003-08-21 | Christopher P. Townsend | Orientation sensor |
US6168569B1 (en) * | 1998-12-22 | 2001-01-02 | Mcewen James Allen | Apparatus and method for relating pain and activity of a patient |
US6398727B1 (en) | 1998-12-23 | 2002-06-04 | Baxter International Inc. | Method and apparatus for providing patient care |
AU3206900A (en) * | 1998-12-31 | 2000-07-31 | Ball Semiconductor Inc. | Position sensing system |
US6684090B2 (en) | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
US6117077A (en) * | 1999-01-22 | 2000-09-12 | Del Mar Medical Systems, Llc | Long-term, ambulatory physiological recorder |
US6770028B1 (en) | 1999-01-25 | 2004-08-03 | Masimo Corporation | Dual-mode pulse oximeter |
CA2358454C (en) | 1999-01-25 | 2010-03-23 | Masimo Corporation | Universal/upgrading pulse oximeter |
US6308089B1 (en) | 1999-04-14 | 2001-10-23 | O.B. Scientific, Inc. | Limited use medical probe |
US6251080B1 (en) * | 1999-05-13 | 2001-06-26 | Del Mar Medical Systems, Llc | Self contained ambulatory blood pressure cincture |
US7454359B2 (en) | 1999-06-23 | 2008-11-18 | Visicu, Inc. | System and method for displaying a health status of hospitalized patients |
IL130818A (en) | 1999-07-06 | 2005-07-25 | Intercure Ltd | Interventive-diagnostic device |
US7628730B1 (en) | 1999-07-08 | 2009-12-08 | Icon Ip, Inc. | Methods and systems for controlling an exercise apparatus using a USB compatible portable remote device |
CA2376011C (en) | 1999-07-21 | 2010-01-19 | Daniel David | Physiological measuring system comprising a garment in the form of a sleeve or glove and sensing apparatus incorporated in the garment |
US6515273B2 (en) | 1999-08-26 | 2003-02-04 | Masimo Corporation | System for indicating the expiration of the useful operating life of a pulse oximetry sensor |
US7145461B2 (en) | 2001-01-31 | 2006-12-05 | Ilife Solutions, Inc. | System and method for analyzing activity of a body |
EP1217942A1 (en) | 1999-09-24 | 2002-07-03 | Healthetech, Inc. | Physiological monitor and associated computation, display and communication unit |
US20010013826A1 (en) * | 1999-09-24 | 2001-08-16 | Kavlico Corporation | Versatile smart networkable sensor |
US6537225B1 (en) | 1999-10-07 | 2003-03-25 | Alexander K. Mills | Device and method for noninvasive continuous determination of physiologic characteristics |
US6527729B1 (en) | 1999-11-10 | 2003-03-04 | Pacesetter, Inc. | Method for monitoring patient using acoustic sensor |
JP2001149349A (en) | 1999-11-26 | 2001-06-05 | Nippon Koden Corp | Sensor for living body |
US6950687B2 (en) | 1999-12-09 | 2005-09-27 | Masimo Corporation | Isolation and communication element for a resposable pulse oximetry sensor |
US6976958B2 (en) | 2000-12-15 | 2005-12-20 | Q-Tec Systems Llc | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
US7156809B2 (en) | 1999-12-17 | 2007-01-02 | Q-Tec Systems Llc | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
US6597384B1 (en) * | 1999-12-22 | 2003-07-22 | Intel Corporation | Automatic reorienting of screen orientation using touch sensitive system |
CN1217255C (en) * | 1999-12-28 | 2005-08-31 | 索尼株式会社 | Electronic device with dispaly function |
US6294999B1 (en) * | 1999-12-29 | 2001-09-25 | Becton, Dickinson And Company | Systems and methods for monitoring patient compliance with medication regimens |
ATE438337T1 (en) | 2000-02-02 | 2009-08-15 | Gen Hospital Corp | METHOD FOR EVALUATION NEW BRAIN TREATMENTS USING A TISSUE RISK MAP |
GB2359177A (en) * | 2000-02-08 | 2001-08-15 | Nokia Corp | Orientation sensitive display and selection mechanism |
US6941271B1 (en) * | 2000-02-15 | 2005-09-06 | James W. Soong | Method for accessing component fields of a patient record by applying access rules determined by the patient |
US6443890B1 (en) * | 2000-03-01 | 2002-09-03 | I-Medik, Inc. | Wireless internet bio-telemetry monitoring system |
US6893396B2 (en) * | 2000-03-01 | 2005-05-17 | I-Medik, Inc. | Wireless internet bio-telemetry monitoring system and interface |
JP3846844B2 (en) * | 2000-03-14 | 2006-11-15 | 株式会社東芝 | Body-mounted life support device |
EP1296591B1 (en) * | 2000-04-17 | 2018-11-14 | Adidas AG | Systems for ambulatory monitoring of physiological signs |
WO2001082790A2 (en) | 2000-04-28 | 2001-11-08 | Kinderlife Instruments, Inc. | Method for determining blood constituents |
US20030036683A1 (en) * | 2000-05-01 | 2003-02-20 | Kehr Bruce A. | Method, system and computer program product for internet-enabled, patient monitoring system |
FR2808609B1 (en) | 2000-05-05 | 2006-02-10 | Univ Rennes | DEVICE AND METHOD FOR DETECTING ABNORMAL SITUATIONS |
US6533729B1 (en) | 2000-05-10 | 2003-03-18 | Motorola Inc. | Optical noninvasive blood pressure sensor and method |
JP4318062B2 (en) | 2000-05-16 | 2009-08-19 | 日本光電工業株式会社 | Biological signal monitor |
ATE502567T1 (en) | 2000-05-19 | 2011-04-15 | Welch Allyn Protocol Inc | DEVICE FOR MONITORING PATIENTS |
US6645155B2 (en) | 2000-05-26 | 2003-11-11 | Colin Corporation | Blood pressure monitor apparatus |
US7485095B2 (en) | 2000-05-30 | 2009-02-03 | Vladimir Shusterman | Measurement and analysis of trends in physiological and/or health data |
US7689437B1 (en) | 2000-06-16 | 2010-03-30 | Bodymedia, Inc. | System for monitoring health, wellness and fitness |
US6605038B1 (en) | 2000-06-16 | 2003-08-12 | Bodymedia, Inc. | System for monitoring health, wellness and fitness |
EP1311189A4 (en) | 2000-08-21 | 2005-03-09 | Euro Celtique Sa | Near infrared blood glucose monitoring system |
US20040054821A1 (en) | 2000-08-22 | 2004-03-18 | Warren Christopher E. | Multifunctional network interface node |
JP3784630B2 (en) | 2000-10-06 | 2006-06-14 | 株式会社総合医科学研究所 | Mental examination method and mental function examination apparatus |
EP1353594B1 (en) | 2000-12-29 | 2008-10-29 | Ares Medical, Inc. | Sleep apnea risk evaluation |
US6834436B2 (en) | 2001-02-23 | 2004-12-28 | Microstrain, Inc. | Posture and body movement measuring system |
JP2002253519A (en) | 2001-03-01 | 2002-09-10 | Nippon Koden Corp | Method for measuring blood quantity, and living body signal monitoring device |
US6526310B1 (en) | 2001-03-02 | 2003-02-25 | Ge Medical Systems Information Technologies, Inc. | Patient transceiver system which uses conductors within leads of leadset to provide phased antenna array |
US6595929B2 (en) * | 2001-03-30 | 2003-07-22 | Bodymedia, Inc. | System for monitoring health, wellness and fitness having a method and apparatus for improved measurement of heat flow |
US20020156354A1 (en) | 2001-04-20 | 2002-10-24 | Larson Eric Russell | Pulse oximetry sensor with improved spring |
US6694177B2 (en) | 2001-04-23 | 2004-02-17 | Cardionet, Inc. | Control of data transmission between a remote monitoring unit and a central unit |
EP1407370B1 (en) | 2001-06-22 | 2011-12-28 | Invensys Systems, Inc. | Method and system for collecting and retrieving time-series, real-time and non-real-time data |
US6850787B2 (en) | 2001-06-29 | 2005-02-01 | Masimo Laboratories, Inc. | Signal component processor |
JP3495348B2 (en) | 2001-07-02 | 2004-02-09 | 日本コーリン株式会社 | Pulse wave velocity information measurement device |
US7257438B2 (en) | 2002-07-23 | 2007-08-14 | Datascope Investment Corp. | Patient-worn medical monitoring device |
US6503206B1 (en) | 2001-07-27 | 2003-01-07 | Vsm Medtech Ltd | Apparatus having redundant sensors for continuous monitoring of vital signs and related methods |
US20030107487A1 (en) | 2001-12-10 | 2003-06-12 | Ronen Korman | Method and device for measuring physiological parameters at the wrist |
GB0130010D0 (en) | 2001-12-14 | 2002-02-06 | Isis Innovation | Combining measurements from breathing rate sensors |
US20030139982A1 (en) * | 2001-12-20 | 2003-07-24 | Nexpress Solutions Llc | ORC online inventory management system |
US6997882B1 (en) | 2001-12-21 | 2006-02-14 | Barron Associates, Inc. | 6-DOF subject-monitoring device and method |
US7355512B1 (en) | 2002-01-24 | 2008-04-08 | Masimo Corporation | Parallel alarm processor |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US6648828B2 (en) | 2002-03-01 | 2003-11-18 | Ge Medical Systems Information Technologies, Inc. | Continuous, non-invasive technique for measuring blood pressure using impedance plethysmography |
US20030171662A1 (en) | 2002-03-07 | 2003-09-11 | O'connor Michael William | Non-adhesive flexible electro-optical sensor for fingertip trans-illumination |
US7022070B2 (en) | 2002-03-22 | 2006-04-04 | Mini-Mitter Co., Inc. | Method for continuous monitoring of patients to detect the potential onset of sepsis |
US8790272B2 (en) | 2002-03-26 | 2014-07-29 | Adidas Ag | Method and system for extracting cardiac parameters from plethysmographic signals |
US7079888B2 (en) | 2002-04-11 | 2006-07-18 | Ansar, Inc. | Method and apparatus for monitoring the autonomic nervous system using non-stationary spectral analysis of heart rate and respiratory activity |
GB2418258B (en) * | 2002-06-05 | 2006-08-23 | Diabetes Diagnostics Inc | Analyte testing device |
EP1388321A1 (en) | 2002-08-09 | 2004-02-11 | Instrumentarium Oyj | Method and system for continuous and non-invasive blood pressure measurement |
US6763256B2 (en) | 2002-08-16 | 2004-07-13 | Optical Sensors, Inc. | Pulse oximeter |
US6879850B2 (en) | 2002-08-16 | 2005-04-12 | Optical Sensors Incorporated | Pulse oximeter with motion detection |
US20070100666A1 (en) | 2002-08-22 | 2007-05-03 | Stivoric John M | Devices and systems for contextual and physiological-based detection, monitoring, reporting, entertainment, and control of other devices |
US7020508B2 (en) | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
US20040116969A1 (en) | 2002-08-26 | 2004-06-17 | Owen James M. | Pulse detection using patient physiological signals |
US7371214B2 (en) | 2002-08-27 | 2008-05-13 | Dainippon Sumitomo Pharma Co., Ltd. | Vital sign display device and method thereof |
WO2004021952A2 (en) | 2002-09-06 | 2004-03-18 | Hill-Rom Services, Inc. | Hospital bed |
US7118531B2 (en) | 2002-09-24 | 2006-10-10 | The Johns Hopkins University | Ingestible medical payload carrying capsule with wireless communication |
US7226422B2 (en) | 2002-10-09 | 2007-06-05 | Cardiac Pacemakers, Inc. | Detection of congestion from monitoring patient response to a recumbent position |
AU2003297060A1 (en) | 2002-12-13 | 2004-07-09 | Massachusetts Institute Of Technology | Vibratory venous and arterial oximetry sensor |
US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
US20060142648A1 (en) * | 2003-01-07 | 2006-06-29 | Triage Data Networks | Wireless, internet-based, medical diagnostic system |
US6920345B2 (en) | 2003-01-24 | 2005-07-19 | Masimo Corporation | Optical sensor including disposable and reusable elements |
JP3760920B2 (en) | 2003-02-28 | 2006-03-29 | 株式会社デンソー | Sensor |
EP1606758B1 (en) | 2003-03-21 | 2015-11-18 | Welch Allyn, Inc. | Personal status physiologic monitor system |
EP1622512B1 (en) | 2003-04-10 | 2013-02-27 | Adidas AG | Systems and methods for respiratory event detection |
KR100571811B1 (en) | 2003-05-09 | 2006-04-17 | 삼성전자주식회사 | Ear type measurement apparatus for bio signal |
US20040267099A1 (en) * | 2003-06-30 | 2004-12-30 | Mcmahon Michael D. | Pain assessment user interface |
US10231628B2 (en) | 2003-07-02 | 2019-03-19 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Method for measuring movements of a person wearing a portable detector |
US7455643B1 (en) | 2003-07-07 | 2008-11-25 | Nellcor Puritan Bennett Ireland | Continuous non-invasive blood pressure measurement apparatus and methods providing automatic recalibration |
US9135402B2 (en) * | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
AU2003904336A0 (en) | 2003-08-15 | 2003-08-28 | Medcare Systems Pty Ltd | An automated personal alarm monitor |
US7678061B2 (en) | 2003-09-18 | 2010-03-16 | Cardiac Pacemakers, Inc. | System and method for characterizing patient respiration |
US20050059870A1 (en) | 2003-08-25 | 2005-03-17 | Aceti John Gregory | Processing methods and apparatus for monitoring physiological parameters using physiological characteristics present within an auditory canal |
BRPI0414345A (en) | 2003-09-12 | 2006-11-07 | Bodymedia Inc | method and apparatus for measuring heart-related parameters |
US20070293781A1 (en) | 2003-11-04 | 2007-12-20 | Nathaniel Sims | Respiration Motion Detection and Health State Assesment System |
JP4801995B2 (en) * | 2003-11-06 | 2011-10-26 | 敦 松永 | Electronic computerized medical information system, electronic medical information program, and computer-readable recording medium storing medical information electronic program |
US20050124866A1 (en) | 2003-11-12 | 2005-06-09 | Joseph Elaz | Healthcare processing device and display system |
EP2508124A3 (en) | 2003-11-18 | 2014-01-01 | Adidas AG | System for processing data from ambulatory physiological monitoring |
US7129891B2 (en) | 2003-11-21 | 2006-10-31 | Xerox Corporation | Method for determining proximity of devices in a wireless network |
US7220230B2 (en) | 2003-12-05 | 2007-05-22 | Edwards Lifesciences Corporation | Pressure-based system and method for determining cardiac stroke volume |
JP4296570B2 (en) | 2003-12-08 | 2009-07-15 | 日本光電工業株式会社 | Vital telemeter |
US20050149350A1 (en) | 2003-12-24 | 2005-07-07 | Kerr Roger S. | Patient information management system and method |
US7301451B2 (en) | 2003-12-31 | 2007-11-27 | Ge Medical Systems Information Technologies, Inc. | Notification alarm transfer methods, system, and device |
US7314451B2 (en) | 2005-04-25 | 2008-01-01 | Earlysense Ltd. | Techniques for prediction and monitoring of clinical episodes |
US7190985B2 (en) | 2004-02-25 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Oximeter ambient light cancellation |
US7194293B2 (en) | 2004-03-08 | 2007-03-20 | Nellcor Puritan Bennett Incorporated | Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics |
US7491181B2 (en) | 2004-03-16 | 2009-02-17 | Medtronic, Inc. | Collecting activity and sleep quality information via a medical device |
US20050234317A1 (en) | 2004-03-19 | 2005-10-20 | Kiani Massi E | Low power and personal pulse oximetry systems |
JP3987053B2 (en) | 2004-03-30 | 2007-10-03 | 株式会社東芝 | Sleep state determination device and sleep state determination method |
US7179228B2 (en) | 2004-04-07 | 2007-02-20 | Triage Wireless, Inc. | Cuffless system for measuring blood pressure |
US7238159B2 (en) | 2004-04-07 | 2007-07-03 | Triage Wireless, Inc. | Device, system and method for monitoring vital signs |
US7004907B2 (en) | 2004-04-07 | 2006-02-28 | Triage Wireless, Inc. | Blood-pressure monitoring device featuring a calibration-based analysis |
US8199685B2 (en) | 2004-05-17 | 2012-06-12 | Sonosite, Inc. | Processing of medical signals |
US20050261565A1 (en) | 2004-05-18 | 2005-11-24 | Micron Medical Products | Discretely coated sensor for use in medical electrodes |
CN1698536A (en) | 2004-05-20 | 2005-11-23 | 香港中文大学 | Cuff-less type blood pressure continuous measuring method using automatic compensation |
US20080162496A1 (en) | 2004-06-02 | 2008-07-03 | Richard Postrel | System and method for centralized management and monitoring of healthcare services |
US20050270903A1 (en) | 2004-06-04 | 2005-12-08 | Schlumberger Technology Corporation | Method for continuous interpretation of monitoring data |
US7261697B2 (en) | 2004-06-16 | 2007-08-28 | Bernstein Donald P | Apparatus for determination of stroke volume using the brachial artery |
US7509131B2 (en) | 2004-06-29 | 2009-03-24 | Microsoft Corporation | Proximity detection using wireless signal strengths |
EP1781163A4 (en) | 2004-07-09 | 2009-09-09 | Telemedic Inc | Vital sign monitoring system and method |
US7173525B2 (en) | 2004-07-23 | 2007-02-06 | Innovalarm Corporation | Enhanced fire, safety, security and health monitoring and alarm response method, system and device |
US7656287B2 (en) | 2004-07-23 | 2010-02-02 | Innovalarm Corporation | Alert system with enhanced waking capabilities |
US7148797B2 (en) | 2004-07-23 | 2006-12-12 | Innovalarm Corporation | Enhanced fire, safety, security and health monitoring and alarm response method, system and device |
US7115824B2 (en) | 2004-08-03 | 2006-10-03 | Kam Chun Lo | Tilt switch and system |
US20060047215A1 (en) | 2004-09-01 | 2006-03-02 | Welch Allyn, Inc. | Combined sensor assembly |
US9820658B2 (en) * | 2006-06-30 | 2017-11-21 | Bao Q. Tran | Systems and methods for providing interoperability among healthcare devices |
US7625344B1 (en) | 2007-06-13 | 2009-12-01 | Impact Sports Technologies, Inc. | Monitoring device, method and system |
US7468036B1 (en) | 2004-09-28 | 2008-12-23 | Impact Sports Technology, Inc. | Monitoring device, method and system |
US7544168B2 (en) | 2004-09-30 | 2009-06-09 | Jerusalem College Of Technology | Measuring systolic blood pressure by photoplethysmography |
US20080004507A1 (en) * | 2004-10-27 | 2008-01-03 | E-Z-Em, Inc. | Data collection device, system, method, and computer program product for collecting data related to the dispensing of contrast media |
US20060122469A1 (en) | 2004-11-16 | 2006-06-08 | Martel Normand M | Remote medical monitoring system |
US20060178591A1 (en) | 2004-11-19 | 2006-08-10 | Hempfling Ralf H | Methods and systems for real time breath rate determination with limited processor resources |
JP4690705B2 (en) * | 2004-11-19 | 2011-06-01 | 株式会社東芝 | Medical equipment |
US7578793B2 (en) | 2004-11-22 | 2009-08-25 | Widemed Ltd. | Sleep staging based on cardio-respiratory signals |
US20080146887A1 (en) | 2004-11-30 | 2008-06-19 | Rao Raman K | Intelligent personal health management appliances for external and internal visualization of the human anatomy and for dental/personal hygiene |
US20060128263A1 (en) | 2004-12-09 | 2006-06-15 | Baird John C | Computerized assessment system and method for assessing opinions or feelings |
US7976480B2 (en) | 2004-12-09 | 2011-07-12 | Motorola Solutions, Inc. | Wearable auscultation system and method |
US20060155589A1 (en) | 2005-01-10 | 2006-07-13 | Welch Allyn, Inc. | Portable vital signs measurement instrument and method of use thereof |
JP2008526443A (en) * | 2005-01-13 | 2008-07-24 | ウェルチ・アリン・インコーポレーテッド | Vital signs monitor |
EP1688085A1 (en) | 2005-02-02 | 2006-08-09 | Disetronic Licensing AG | Ambulatory medical device and method of communication between medical devices |
EP2286721B1 (en) | 2005-03-01 | 2018-10-24 | Masimo Laboratories, Inc. | Physiological Parameter Confidence Measure |
US20060200029A1 (en) | 2005-03-04 | 2006-09-07 | Medwave, Inc. | Universal transportable vital signs monitor |
US7616110B2 (en) | 2005-03-11 | 2009-11-10 | Aframe Digital, Inc. | Mobile wireless customizable health and condition monitor |
US20060252999A1 (en) | 2005-05-03 | 2006-11-09 | Devaul Richard W | Method and system for wearable vital signs and physiology, activity, and environmental monitoring |
US7827011B2 (en) | 2005-05-03 | 2010-11-02 | Aware, Inc. | Method and system for real-time signal classification |
JP5113742B2 (en) | 2005-05-10 | 2013-01-09 | ケアフュージョン 303、インコーポレイテッド | Medication safety system with multiplexed RFID interrogator panel |
US7925022B2 (en) * | 2005-05-23 | 2011-04-12 | The Invention Science Fund I, Llc | Device pairing via device to device contact |
US7558057B1 (en) * | 2005-06-06 | 2009-07-07 | Alex Naksen | Personal digital device with adjustable interface |
JP2006341062A (en) | 2005-06-09 | 2006-12-21 | Nex1 Future Co Ltd | Emergency sensor |
US7782189B2 (en) | 2005-06-20 | 2010-08-24 | Carestream Health, Inc. | System to monitor the ingestion of medicines |
US8121856B2 (en) | 2005-06-28 | 2012-02-21 | Hill-Rom Services, Inc. | Remote access to healthcare device diagnostic information |
DE102005035916A1 (en) | 2005-07-28 | 2007-02-01 | Clariant Produkte (Deutschland) Gmbh | Process for the preparation of bleach catalyst granules |
WO2007018921A2 (en) | 2005-07-28 | 2007-02-15 | The General Hospital Corporation | Electro-optical system, aparatus, and method for ambulatory monitoring |
US7641614B2 (en) | 2005-08-22 | 2010-01-05 | Massachusetts Institute Of Technology | Wearable blood pressure sensor and method of calibration |
US7674231B2 (en) | 2005-08-22 | 2010-03-09 | Massachusetts Institute Of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
US7237446B2 (en) * | 2005-09-16 | 2007-07-03 | Raymond Chan | System and method for measuring gait kinematics information |
US20080046286A1 (en) * | 2005-09-16 | 2008-02-21 | Halsted Mark J | Computer implemented healthcare monitoring, notifying and/or scheduling system |
JP4754915B2 (en) | 2005-09-21 | 2011-08-24 | フクダ電子株式会社 | Blood pressure monitoring device |
WO2007040963A2 (en) | 2005-09-29 | 2007-04-12 | Berkeley Heartlab, Inc. | Internet-based system for monitoring blood test, vital sign, and exercise information from a patient |
US7725147B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for removing artifacts from waveforms |
US7420472B2 (en) | 2005-10-16 | 2008-09-02 | Bao Tran | Patient monitoring apparatus |
US8706515B2 (en) | 2005-10-20 | 2014-04-22 | Mckesson Information Solutions Llc | Methods, systems, and apparatus for providing a notification of a message in a health care environment |
US7215987B1 (en) | 2005-11-08 | 2007-05-08 | Woolsthorpe Technologies | Method and apparatus for processing signals reflecting physiological characteristics |
US7184809B1 (en) | 2005-11-08 | 2007-02-27 | Woolsthorpe Technologies, Llc | Pulse amplitude indexing method and apparatus |
US8366641B2 (en) | 2005-11-18 | 2013-02-05 | Cardiac Pacemakers, Inc. | Posture detector calibration and use |
US20070129769A1 (en) | 2005-12-02 | 2007-06-07 | Medtronic, Inc. | Wearable ambulatory data recorder |
DE102005059435A1 (en) | 2005-12-13 | 2007-06-14 | Robert Bosch Gmbh | Device for noninvasive blood pressure measurement |
US7648463B1 (en) | 2005-12-15 | 2010-01-19 | Impact Sports Technologies, Inc. | Monitoring device, method and system |
US20070142715A1 (en) | 2005-12-20 | 2007-06-21 | Triage Wireless, Inc. | Chest strap for measuring vital signs |
US20070156456A1 (en) | 2006-01-04 | 2007-07-05 | Siemens Medical Solutions Health Services Corporation | System for Monitoring Healthcare Related Activity In A Healthcare Enterprise |
US7602301B1 (en) | 2006-01-09 | 2009-10-13 | Applied Technology Holdings, Inc. | Apparatus, systems, and methods for gathering and processing biometric and biomechanical data |
US8109879B2 (en) | 2006-01-10 | 2012-02-07 | Cardiac Pacemakers, Inc. | Assessing autonomic activity using baroreflex analysis |
US7427926B2 (en) * | 2006-01-26 | 2008-09-23 | Microsoft Corporation | Establishing communication between computing-based devices through motion detection |
US20070185393A1 (en) | 2006-02-03 | 2007-08-09 | Triage Wireless, Inc. | System for measuring vital signs using an optical module featuring a green light source |
CN101467185A (en) | 2006-02-21 | 2009-06-24 | Adt安全服务公司 | System and method for remotely attended delivery |
US8200320B2 (en) | 2006-03-03 | 2012-06-12 | PhysioWave, Inc. | Integrated physiologic monitoring systems and methods |
US7668588B2 (en) | 2006-03-03 | 2010-02-23 | PhysioWave, Inc. | Dual-mode physiologic monitoring systems and methods |
CN101416194A (en) | 2006-03-30 | 2009-04-22 | 陶氏环球技术公司 | Method and system for monitoring and analyzing compliance with internal dosing regimen |
DE102006015291B4 (en) | 2006-04-01 | 2015-10-29 | Drägerwerk AG & Co. KGaA | Procedure for setting a patient monitor |
US20070270671A1 (en) | 2006-04-10 | 2007-11-22 | Vivometrics, Inc. | Physiological signal processing devices and associated processing methods |
GB0607270D0 (en) | 2006-04-11 | 2006-05-17 | Univ Nottingham | The pulsing blood supply |
US8886125B2 (en) | 2006-04-14 | 2014-11-11 | Qualcomm Incorporated | Distance-based association |
TW200740409A (en) | 2006-04-18 | 2007-11-01 | Wei-Kung Wang | A physiological signals monitor with digital real time calibration |
US7561960B2 (en) | 2006-04-20 | 2009-07-14 | Honeywell International Inc. | Motion classification methods for personal navigation |
US20070252853A1 (en) | 2006-04-28 | 2007-11-01 | Samsung Electronics Co., Ltd. | Method and apparatus to control screen orientation of user interface of portable device |
US20070255126A1 (en) | 2006-04-28 | 2007-11-01 | Moberg Sheldon B | Data communication in networked fluid infusion systems |
US9031853B2 (en) | 2006-05-06 | 2015-05-12 | Irody, Inc. | Apparatus and method for obtaining an identification of drugs for enhanced safety |
US7558622B2 (en) * | 2006-05-24 | 2009-07-07 | Bao Tran | Mesh network stroke monitoring appliance |
US7539532B2 (en) | 2006-05-12 | 2009-05-26 | Bao Tran | Cuffless blood pressure monitoring appliance |
US7993275B2 (en) | 2006-05-25 | 2011-08-09 | Sotera Wireless, Inc. | Bilateral device, system and method for monitoring vital signs |
EP2020919B1 (en) | 2006-06-01 | 2019-07-31 | ResMed Sensor Technologies Limited | Apparatus, system, and method for monitoring physiological signs |
US20070282208A1 (en) | 2006-06-06 | 2007-12-06 | Bob Jacobs | Mobile computing device with integrated medical devices |
US7373912B2 (en) | 2006-06-07 | 2008-05-20 | Ford Global Technologies, Llc | Oil level indicating system for internal combustion engine |
US7621871B2 (en) * | 2006-06-16 | 2009-11-24 | Archinoetics, Llc | Systems and methods for monitoring and evaluating individual performance |
US7569019B2 (en) | 2006-06-16 | 2009-08-04 | Frank Bour | Analysis and use of cardiographic bioimpedance measurements |
US7783356B2 (en) | 2006-06-29 | 2010-08-24 | Cardiac Pacemakers, Inc. | Automated device programming at changeout |
RU2470577C2 (en) | 2006-07-28 | 2012-12-27 | Конинклейке Филипс Электроникс, Н.В. | Automatic transmission and identification of monitoring data with hierarchical infrastructure of key control |
EP2049012B1 (en) | 2006-08-02 | 2015-04-15 | Philips Intellectual Property & Standards GmbH | Sensor for detecting the passing of a pulse wave from a subject´s arterial system |
US8343049B2 (en) | 2006-08-24 | 2013-01-01 | Cardiac Pacemakers, Inc. | Physiological response to posture change |
US8442607B2 (en) | 2006-09-07 | 2013-05-14 | Sotera Wireless, Inc. | Hand-held vital signs monitor |
US7610085B2 (en) | 2006-09-12 | 2009-10-27 | Allgeyer Dean O | Simplified ECG monitoring system |
US20080076972A1 (en) | 2006-09-21 | 2008-03-27 | Apple Inc. | Integrated sensors for tracking performance metrics |
ES2298060B2 (en) | 2006-09-27 | 2009-09-03 | Universidad De Cadiz. | SYSTEM FOR MONITORING AND ANALYSIS OF CARDIORESPIRATORY AND RONQUID SIGNS. |
US20080101160A1 (en) | 2006-11-01 | 2008-05-01 | Rodney Besson | Med Alert Watch |
US8449469B2 (en) | 2006-11-10 | 2013-05-28 | Sotera Wireless, Inc. | Two-part patch sensor for monitoring vital signs |
US20080221404A1 (en) | 2006-11-13 | 2008-09-11 | Shun-Wun Tso | Multifunction health apparatus |
US7586418B2 (en) | 2006-11-17 | 2009-09-08 | General Electric Company | Multifunctional personal emergency response system |
US8668651B2 (en) | 2006-12-05 | 2014-03-11 | Covidien Lp | ECG lead set and ECG adapter system |
US7983933B2 (en) | 2006-12-06 | 2011-07-19 | Microsoft Corporation | Patient monitoring via image capture |
DE102006057709B4 (en) | 2006-12-07 | 2015-04-02 | Dräger Medical GmbH | Apparatus and method for determining a respiratory rate |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US20090262074A1 (en) | 2007-01-05 | 2009-10-22 | Invensense Inc. | Controlling and accessing content using motion processing on mobile devices |
US20080171927A1 (en) | 2007-01-11 | 2008-07-17 | Health & Life Co., Ltd. | Physiological detector with a waterproof structure |
US8391786B2 (en) | 2007-01-25 | 2013-03-05 | Stephen Hodges | Motion triggered data transfer |
US20080194918A1 (en) | 2007-02-09 | 2008-08-14 | Kulik Robert S | Vital signs monitor with patient entertainment console |
JP4818162B2 (en) | 2007-02-27 | 2011-11-16 | パラマウントベッド株式会社 | Movable floor board type bed device |
US20080221399A1 (en) | 2007-03-05 | 2008-09-11 | Triage Wireless, Inc. | Monitor for measuring vital signs and rendering video images |
US7698101B2 (en) | 2007-03-07 | 2010-04-13 | Apple Inc. | Smart garment |
GB0705033D0 (en) | 2007-03-15 | 2007-04-25 | Imp Innovations Ltd | Heart rate measurement |
US7541939B2 (en) | 2007-03-15 | 2009-06-02 | Apple Inc. | Mounted shock sensor |
US8047998B2 (en) | 2007-04-17 | 2011-11-01 | General Electric Company | Non-invasive blood pressure determination method |
US20080266326A1 (en) * | 2007-04-25 | 2008-10-30 | Ati Technologies Ulc | Automatic image reorientation |
US20080275349A1 (en) | 2007-05-02 | 2008-11-06 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US8231614B2 (en) | 2007-05-11 | 2012-07-31 | Tyco Healthcare Group Lp | Temperature monitoring return electrode |
US7884727B2 (en) * | 2007-05-24 | 2011-02-08 | Bao Tran | Wireless occupancy and day-light sensing |
US8419649B2 (en) | 2007-06-12 | 2013-04-16 | Sotera Wireless, Inc. | Vital sign monitor for measuring blood pressure using optical, electrical and pressure waveforms |
US8602997B2 (en) | 2007-06-12 | 2013-12-10 | Sotera Wireless, Inc. | Body-worn system for measuring continuous non-invasive blood pressure (cNIBP) |
US7530956B2 (en) | 2007-06-15 | 2009-05-12 | Cardiac Pacemakers, Inc. | Daytime/nighttime respiration rate monitoring |
US7698941B2 (en) | 2007-06-20 | 2010-04-20 | Headway Technologies, Inc. | Sensing unit and method of making same |
US7628071B2 (en) | 2007-06-20 | 2009-12-08 | Headway Techologies, Inc. | Sensing unit and method of making same |
US20080319327A1 (en) | 2007-06-25 | 2008-12-25 | Triage Wireless, Inc. | Body-worn sensor featuring a low-power processor and multi-sensor array for measuring blood pressure |
JP5060186B2 (en) * | 2007-07-05 | 2012-10-31 | 株式会社東芝 | Pulse wave processing apparatus and method |
WO2009009761A1 (en) | 2007-07-11 | 2009-01-15 | Triage Wireless, Inc. | Device for determining respiratory rate and other vital signs |
US20090198132A1 (en) * | 2007-08-10 | 2009-08-06 | Laurent Pelissier | Hand-held ultrasound imaging device having reconfigurable user interface |
US7825794B2 (en) | 2007-08-10 | 2010-11-02 | Integrity Tracking, Llc | Alzheimer's patient tracking system |
US8221290B2 (en) | 2007-08-17 | 2012-07-17 | Adidas International Marketing B.V. | Sports electronic training system with electronic gaming features, and applications thereof |
US20090054752A1 (en) | 2007-08-22 | 2009-02-26 | Motorola, Inc. | Method and apparatus for photoplethysmographic sensing |
WO2009036150A2 (en) | 2007-09-11 | 2009-03-19 | Aid Networks, Llc | Wearable wireless electronic patient data communications and physiological monitoring device |
US8535522B2 (en) | 2009-02-12 | 2013-09-17 | Fresenius Medical Care Holdings, Inc. | System and method for detection of disconnection in an extracorporeal blood circuit |
US8249686B2 (en) | 2007-09-14 | 2012-08-21 | Corventis, Inc. | Adherent device for sleep disordered breathing |
EP2194847A1 (en) | 2007-09-14 | 2010-06-16 | Corventis, Inc. | Adherent device with multiple physiological sensors |
US20090076397A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Emergency Patient Monitor |
JP2009072417A (en) | 2007-09-21 | 2009-04-09 | Toshiba Corp | Biological information processor and processing method |
US8082160B2 (en) * | 2007-10-26 | 2011-12-20 | Hill-Rom Services, Inc. | System and method for collection and communication of data from multiple patient care devices |
US7983757B2 (en) | 2007-10-26 | 2011-07-19 | Medtronic, Inc. | Medical device configuration based on sensed brain signals |
US20090118626A1 (en) | 2007-11-01 | 2009-05-07 | Transoma Medical, Inc. | Calculating Respiration Parameters Using Impedance Plethysmography |
US20090124863A1 (en) | 2007-11-08 | 2009-05-14 | General Electric Company | Method and system for recording patient-status |
US8442608B2 (en) | 2007-12-28 | 2013-05-14 | Covidien Lp | System and method for estimating physiological parameters by deconvolving artifacts |
US7684954B2 (en) | 2007-12-31 | 2010-03-23 | Intel Corporation | Apparatus and method for classification of physical orientation |
DE102008003978A1 (en) | 2008-01-11 | 2009-08-13 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Pressure gauges, sphygmomanometer, method for determining pressure values, method for calibrating a pressure gauge and computer program |
US8152745B2 (en) | 2008-02-25 | 2012-04-10 | Shriners Hospitals For Children | Activity monitoring |
EP2096566B1 (en) | 2008-02-29 | 2018-04-04 | Fresenius Medical Care Holdings, Inc. | Instructional media system for dialysis machine |
US20100130811A1 (en) * | 2008-04-24 | 2010-05-27 | Searete Llc | Computational system and method for memory modification |
FR2930421A1 (en) * | 2008-04-28 | 2009-10-30 | Univ Sud Toulon Var Etablissem | DEVICE FOR ACQUIRING AND PROCESSING PHYSIOLOGICAL DATA OF AN ANIMAL OR A HUMAN DURING PHYSICAL ACTIVITY |
US20090295541A1 (en) | 2008-05-27 | 2009-12-03 | Intellidot Corporation | Directional rfid reader |
WO2009148595A2 (en) | 2008-06-03 | 2009-12-10 | Jonathan Arnold Bell | Wearable electronic system |
US8165840B2 (en) | 2008-06-12 | 2012-04-24 | Cardiac Pacemakers, Inc. | Posture sensor automatic calibration |
US20090322513A1 (en) | 2008-06-27 | 2009-12-31 | Franklin Dun-Jen Hwang | Medical emergency alert system and method |
US8958885B2 (en) | 2008-07-11 | 2015-02-17 | Medtronic, Inc. | Posture state classification for a medical device |
US9545215B2 (en) | 2008-07-31 | 2017-01-17 | Medtronic, Inc. | Apparatus and method for detecting cardiac events |
WO2010016025A1 (en) | 2008-08-06 | 2010-02-11 | E-Vitae Pte. Ltd. | Universal body sensor network |
US20100042430A1 (en) * | 2008-08-12 | 2010-02-18 | Irody Inc | System and method for collecting and authenticating medication consumption |
CN102123659B (en) | 2008-08-19 | 2014-07-23 | 皇家飞利浦电子股份有限公司 | Monitoring the blood pressure of a patient |
US20100056881A1 (en) | 2008-08-29 | 2010-03-04 | Corventis, Inc. | Method and Apparatus For Acute Cardiac Monitoring |
US8676602B2 (en) * | 2008-09-03 | 2014-03-18 | Ebroselow Llc | Computerized method of determining medical treatment values |
US20100125188A1 (en) | 2008-11-18 | 2010-05-20 | Nonin Medical, Inc. | Motion correlated pulse oximetry |
US20120123232A1 (en) | 2008-12-16 | 2012-05-17 | Kayvan Najarian | Method and apparatus for determining heart rate variability using wavelet transformation |
TWI425934B (en) | 2008-12-23 | 2014-02-11 | Ind Tech Res Inst | Biosignal measurement modules and methods |
US20100210930A1 (en) | 2009-02-13 | 2010-08-19 | Saylor Stephen D | Physiological Blood Gas Detection Apparatus and Method |
EP3127476A1 (en) | 2009-02-25 | 2017-02-08 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US20100222649A1 (en) | 2009-03-02 | 2010-09-02 | American Well Systems | Remote medical servicing |
US9596989B2 (en) | 2009-03-12 | 2017-03-21 | Raytheon Company | Networked symbiotic edge user infrastructure |
US8152694B2 (en) | 2009-03-16 | 2012-04-10 | Robert Bosch Gmbh | Activity monitoring device and method |
US8313439B2 (en) | 2009-03-20 | 2012-11-20 | Massachusetts Institute Of Technology | Calibration of pulse transit time measurements to arterial blood pressure using external arterial pressure applied along the pulse transit path |
US8175720B2 (en) | 2009-04-30 | 2012-05-08 | Medtronic, Inc. | Posture-responsive therapy control based on patient input |
US8909330B2 (en) | 2009-05-20 | 2014-12-09 | Sotera Wireless, Inc. | Body-worn device and associated system for alarms/alerts based on vital signs and motion |
US8672854B2 (en) | 2009-05-20 | 2014-03-18 | Sotera Wireless, Inc. | System for calibrating a PTT-based blood pressure measurement using arm height |
US9204857B2 (en) | 2009-06-05 | 2015-12-08 | General Electric Company | System and method for monitoring hemodynamic state |
US20100324388A1 (en) | 2009-06-17 | 2010-12-23 | Jim Moon | Body-worn pulse oximeter |
US20100331640A1 (en) | 2009-06-26 | 2010-12-30 | Nellcor Puritan Bennett Llc | Use of photodetector array to improve efficiency and accuracy of an optical medical sensor |
US8239010B2 (en) | 2009-09-14 | 2012-08-07 | Sotera Wireless, Inc. | System for measuring vital signs during hemodialysis |
US8545417B2 (en) | 2009-09-14 | 2013-10-01 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiration rate |
US20110066043A1 (en) | 2009-09-14 | 2011-03-17 | Matt Banet | System for measuring vital signs during hemodialysis |
SG10201405704QA (en) | 2009-09-15 | 2014-10-30 | Sotera Wireless Inc | Body-worn vital sign monitor |
US8364250B2 (en) | 2009-09-15 | 2013-01-29 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8321004B2 (en) | 2009-09-15 | 2012-11-27 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US10420476B2 (en) | 2009-09-15 | 2019-09-24 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US20110066044A1 (en) | 2009-09-15 | 2011-03-17 | Jim Moon | Body-worn vital sign monitor |
US10806351B2 (en) | 2009-09-15 | 2020-10-20 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8527038B2 (en) * | 2009-09-15 | 2013-09-03 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US9106275B2 (en) | 2009-09-24 | 2015-08-11 | Blackberry Limited | Accelerometer tap detection to initiate NFC communication |
US8781393B2 (en) * | 2009-09-30 | 2014-07-15 | Ebay Inc. | Network updates of time and location |
US20110082711A1 (en) * | 2009-10-06 | 2011-04-07 | Masimo Laboratories, Inc. | Personal digital assistant or organizer for monitoring glucose levels |
US8583453B2 (en) | 2009-10-20 | 2013-11-12 | Universal Research Solutions, Llc | Generation and data management of a medical study using instruments in an integrated media and medical system |
US20110178375A1 (en) | 2010-01-19 | 2011-07-21 | Avery Dennison Corporation | Remote physiological monitoring |
US20110224499A1 (en) | 2010-03-10 | 2011-09-15 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US9339209B2 (en) | 2010-04-19 | 2016-05-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US9173594B2 (en) | 2010-04-19 | 2015-11-03 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8747330B2 (en) | 2010-04-19 | 2014-06-10 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
SG10201503094VA (en) | 2010-04-19 | 2015-06-29 | Sotera Wireless Inc | Body-worn monitor for measuring respiratory rate |
US8888700B2 (en) | 2010-04-19 | 2014-11-18 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US8979765B2 (en) | 2010-04-19 | 2015-03-17 | Sotera Wireless, Inc. | Body-worn monitor for measuring respiratory rate |
US20110275907A1 (en) | 2010-05-07 | 2011-11-10 | Salvatore Richard Inciardi | Electronic Health Journal |
EP2405337B1 (en) * | 2010-07-06 | 2015-09-16 | HTC Corporation | Method for presenting human machine interface, handheld device using the same, and computer readable medium therefor |
EP2612212A1 (en) * | 2010-08-30 | 2013-07-10 | Telefonaktiebolaget L M Ericsson (publ) | Methods of launching applications responsive to device orientation and related electronic devices |
US9125630B2 (en) * | 2011-10-28 | 2015-09-08 | Shenzhen Mindray Bio-Medical Electronics Co. Ltd. | Dynamically reconfiguring a user interface of a patient monitor responsive to an orientation input |
US9436767B2 (en) * | 2013-03-07 | 2016-09-06 | Google Inc. | Serving content items based on device rotational orientation |
-
2010
- 2010-04-19 US US12/762,836 patent/US20110224499A1/en not_active Abandoned
- 2010-04-19 US US12/762,810 patent/US8727977B2/en active Active
- 2010-04-19 US US12/762,846 patent/US20110224500A1/en not_active Abandoned
- 2010-04-19 US US12/762,726 patent/US10213159B2/en active Active
- 2010-04-19 US US12/762,822 patent/US10278645B2/en active Active
- 2010-04-19 US US12/762,777 patent/US20110224556A1/en not_active Abandoned
- 2010-04-19 US US12/762,790 patent/US20110224498A1/en not_active Abandoned
- 2010-04-19 US US12/762,733 patent/US8591411B2/en active Active
- 2010-04-19 US US12/762,751 patent/US20110224564A1/en not_active Abandoned
-
2011
- 2011-03-10 WO PCT/US2011/027843 patent/WO2011112782A1/en active Application Filing
- 2011-03-10 SG SG2012066742A patent/SG183973A1/en unknown
- 2011-03-10 EP EP11754055.9A patent/EP2544584B1/en not_active Not-in-force
-
2019
- 2019-02-25 US US16/285,015 patent/US20190183422A1/en not_active Abandoned
- 2019-05-06 US US16/404,435 patent/US20190254600A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11657175B2 (en) * | 2016-02-23 | 2023-05-23 | Philips Medical Systems Technologies Ltd | Patient medical data acquisition system and method using an external device |
WO2024178376A1 (en) * | 2023-02-24 | 2024-08-29 | Arthur Wallace | Audio visual detection platform for patient monitoring |
Also Published As
Publication number | Publication date |
---|---|
US20110224556A1 (en) | 2011-09-15 |
US20110224564A1 (en) | 2011-09-15 |
US10213159B2 (en) | 2019-02-26 |
US8727977B2 (en) | 2014-05-20 |
US20110224507A1 (en) | 2011-09-15 |
US8591411B2 (en) | 2013-11-26 |
US20190183422A1 (en) | 2019-06-20 |
SG183973A1 (en) | 2012-10-30 |
US20110224557A1 (en) | 2011-09-15 |
US10278645B2 (en) | 2019-05-07 |
WO2011112782A1 (en) | 2011-09-15 |
US20110224499A1 (en) | 2011-09-15 |
US20110224508A1 (en) | 2011-09-15 |
EP2544584A4 (en) | 2015-07-15 |
US20110224498A1 (en) | 2011-09-15 |
US20110224506A1 (en) | 2011-09-15 |
EP2544584B1 (en) | 2017-09-20 |
US20110224500A1 (en) | 2011-09-15 |
EP2544584A1 (en) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190254600A1 (en) | Body-worn vital sign monitor | |
US11096596B2 (en) | Body-worn vital sign monitor | |
US11963736B2 (en) | Wireless patient monitoring system | |
US8321004B2 (en) | Body-worn vital sign monitor | |
US8364250B2 (en) | Body-worn vital sign monitor | |
US8527038B2 (en) | Body-worn vital sign monitor | |
US10806351B2 (en) | Body-worn vital sign monitor | |
US10420476B2 (en) | Body-worn vital sign monitor | |
EP2470067B1 (en) | Body-worn vital sign monitor | |
US20220211282A1 (en) | Hemodynamic monitoring system and method and harness for same | |
US20220031246A1 (en) | Body-worn vital sign monitor | |
US20220015704A1 (en) | Body-worn vital sign monitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SOTERA WIRELESS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MOON, JIM;REEL/FRAME:049094/0054 Effective date: 20100407 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |